{
    "testId": 396301731,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 103,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 4,
    "questionModeName": "CUSTOM",
    "testName": "",
    "totalQuestionCorrect": 26,
    "correctToIncorrect": 1,
    "incorrectToCorrect": 3,
    "incorrectToIncorrect": 1,
    "timeInSeconds": 2823,
    "averageTimeSpentInSeconds": 109,
    "otherAverageTimeSpentInSeconds": 64,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 40,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "4",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 3273,
            "questionIndex": 3273,
            "questionText": "<p>A 39-year-old woman, gravida 2 para 1, at 28 weeks gestation comes to the hospital due to painful uterine contractions for the past 4 hours accompanied by the passage of clear fluid from her vagina.&nbsp; She initiated prenatal care a week ago, during which an anatomy ultrasound revealed a fetus with anencephaly.&nbsp; Her prior pregnancy was uncomplicated.&nbsp; She has no chronic medical conditions and has had no surgeries.&nbsp; The patient does not use tobacco, alcohol, or illicit drugs.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 110/70 mm Hg, and pulse is 80/min.&nbsp; A sterile speculum examination reveals pooling of nitrazine-positive fluid in the vagina.&nbsp; The cervix is 4 cm dilated and 80% effaced.&nbsp; Bedside ultrasound reveals anhydramnios and an anencephalic fetus in breech presentation.&nbsp; Fetal heart rate is normal.&nbsp; Tocometer shows contractions every 3 minutes.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31838\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Delivery planning for a nonviable fetus</strong></p></td></tr><tr><td><p align=\"center\"><strong>Fetal diagnosis</strong></p></td><td><ul><li>Acardia</li><li>Anencephaly</li><li>Bilateral renal agenesis</li><li>Holoprosencephaly</li><li>Intrauterine fetal demise</li><li>Pulmonary hypoplasia</li><li>Thanatophoric dwarfism</li></ul></td></tr><tr><td><p align=\"center\"><strong>Obstetric management</strong></p></td><td><ul><li>Vaginal delivery</li><li>No fetal monitoring</li></ul></td></tr><tr><td><p align=\"center\"><strong>Neonatal management</strong></p></td><td><ul><li>Palliative care if not stillborn</li></ul></td></tr></tbody></table></div><p><a href=\"6242\">Anencephaly</a> is a <strong>lethal fetal anomaly</strong> characterized by the failure of neural tube closure, which results in the absence of the cerebrum, thalamus, hypothalamus, and portions of the brainstem.&nbsp; Affected infants typically die within hours of birth.&nbsp; The principle behind <strong>labor management</strong> of patients with lethal fetal anomalies (eg, anencephaly, bilateral renal agenesis) is to <strong>minimize maternal morbidity and mortality</strong>.&nbsp; Therefore, obstetric care for these patients is maternally focused.&nbsp; <strong>Vaginal delivery</strong> has a lower risk for maternal complications compared to cesarean delivery (eg, hemorrhage, infection, pulmonary embolism); therefore, it is the delivery modality of choice.</p><p>This patient, at 28 weeks gestation, is in labor after spontaneous rupture of membranes with a nonviable (anencephalic) fetus in breech presentation.&nbsp; Therefore, the best option for this patient is expectant management of her labor in anticipation of a spontaneous vaginal delivery.&nbsp; Fetal heart rate (FHR) monitoring is not indicated because it does not affect delivery management.</p><p><strong>(Choices A and B)</strong>&nbsp; Antenatal corticosteroids decrease prematurity-related neonatal morbidity and mortality when administered to women at risk for delivery at &lt;37 weeks gestation.&nbsp; Magnesium sulfate decreases the risk of cerebral palsy in infants of mothers at risk for delivery at &lt;32 weeks gestation.&nbsp; Because this fetus&#39;s anomaly is lethal, neither antenatal corticosteroids nor magnesium sulfate is indicated.</p><p><strong>(Choice D)</strong>&nbsp; Amnioinfusion is not indicated for anhydramnios (no amniotic fluid).&nbsp; Amnioinfusion is indicated for persistent variable decelerations; however, FHR monitoring is not performed in cases of lethal anomalies because the FHR does not affect delivery management.&nbsp; Tocolysis is indicated for preterm labor when prolongation of pregnancy can improve neonatal outcomes, but it would not be beneficial for this patient.</p><p><strong>(Choice E)</strong>&nbsp;&nbsp;A breech presentation is typically an indication for cesarean delivery because it decreases the risk of fetal trauma and asphyxia associated with vaginal delivery (eg, head entrapment).&nbsp; However, in fetuses with lethal anomalies in which entrapment does not affect fetal outcome, vaginal delivery is preferred due to the increased risk of maternal complications associated with cesarean delivery.</p><p><strong>Educational objective:</strong></p><p>The priority for patients with lethal fetal anomalies such as anencephaly is to minimize maternal morbidity and mortality.&nbsp; Obstetric care is maternally focused, and typical management of preterm labor for neonatal benefit is not indicated.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23791,
            "topic": "Labor management",
            "titleId": 23791,
            "title": "Labor management",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administer corticosteroids",
                    "choiceNumber": 1,
                    "correctTaken": 1677,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Administer magnesium sulfate",
                    "choiceNumber": 2,
                    "correctTaken": 518,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Allow spontaneous vaginal delivery",
                    "choiceNumber": 3,
                    "correctTaken": 9216,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Amnioinfusion and tocolysis",
                    "choiceNumber": 4,
                    "correctTaken": 1164,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform cesarean delivery",
                    "choiceNumber": 5,
                    "correctTaken": 4097,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20198650",
                    "mediaDataId": 0,
                    "title": "The natural history of anencephaly.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20198650",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 80,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 16672,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 55,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 11457,
            "questionIndex": 12617,
            "questionText": "<p>A 28-year-old woman, gravida 1 para 1, comes for a routine 4-week postpartum visit following an uncomplicated vaginal delivery.&nbsp; The patient describes some mild vaginal soreness and breast tenderness but has no other physical problems.&nbsp; She says, &#x22;The baby is adorable, but I worry about being a good mother.&#x22;&nbsp; She tearfully describes feeling exhausted and unable to return to sleep after getting up in the middle of the night to feed the baby.&nbsp; She says, &#x22;The baby cries all the time and nothing I do helps.&nbsp; I tried to breastfeed, but I gave it up because she was fussy and I was afraid she wasn&#39;t getting enough to eat.&nbsp; My husband tries to be supportive and has offered to help with nighttime feedings, but I am up at night anyway because I can&#39;t sleep.&#x22;&nbsp; The patient has little time to care for herself and has been eating poorly.&nbsp; She feels increasingly depressed and has little energy.&nbsp; The patient says, &#x22;Everyone expects me to be happy, but it has been so hard.&nbsp; I don&#39;t deserve to be a mother.&#x22;&nbsp; The patient has no psychiatric history and no thoughts of hurting herself or the baby.&nbsp; Physical examination is normal.&nbsp; Routine laboratory tests, including hemoglobin and TSH levels, are within normal range.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34609\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"4\"><p align=\"center\"><strong>Postpartum blues, depression &amp; psychosis</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Postpartum<br />blues</strong></p></td><td><p align=\"center\"><strong>Postpartum depression</strong></p></td><td><p align=\"center\"><strong>Postpartum psychosis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Prevalence</strong></p></td><td><p align=\"center\">40%-80%</p></td><td><p align=\"center\">8%-15%</p></td><td><p align=\"center\">0.1%-0.2%</p></td></tr><tr><td><p align=\"center\"><strong>Onset</strong></p></td><td><p align=\"center\">2-3 days (resolves within 14 days)</p></td><td><p align=\"center\">Typically within 4-6 weeks (can be up to 1 year)</p></td><td><p align=\"center\">Variable: days to&nbsp;weeks</p></td></tr><tr><td><p align=\"center\"><strong>Symptoms</strong></p></td><td><p align=\"center\">Mild depression, tearfulness, irritability</p></td><td><p align=\"center\">&ge;2 weeks of moderate to severe depression, sleep or appetite disturbance, low energy, psychomotor changes, guilt, concentration difficulty,<br />suicidal ideation</p></td><td><p align=\"center\">Delusions, hallucinations, thought disorganization,<br />bizarre behavior</p></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><p align=\"center\">Reassurance &amp; monitoring</p></td><td><p align=\"center\">Antidepressants, psychotherapy</p></td><td><p align=\"center\">Antipsychotics, antidepressants, mood stabilizers; hospitalization (do not leave mother alone with infant due to risk of infanticide)</p></td></tr></tbody></table></div><p>All women should be routinely assessed for depression at postpartum visits.&nbsp; This patient is showing signs and symptoms of <strong>postpartum depression</strong> (depressed mood, insomnia, appetite disturbance, low energy, and feelings of worthlessness) at her 4-week checkup.&nbsp; Postpartum depression should be distinguished from postpartum blues, a self-limited condition with milder symptoms that resolves within 2 weeks postpartum.&nbsp; When depressive symptoms persist beyond 2 weeks and cause functional impairment, treatment is indicated.&nbsp; Options include <strong>psychotherapy</strong>, <strong>pharmacotherapy</strong>, or both.</p><p>Among antidepressants, <strong>selective serotonin reuptake inhibitors</strong> are commonly used as first-line therapy in treatment-na&iuml;ve patients as they have demonstrated efficacy and tolerability in postpartum depression.&nbsp; In breastfeeding patients, sertraline is preferred as levels in infants are usually undetectable.</p><p><strong>(Choice A)</strong>&nbsp; Postpartum blues is a normal, self-limited condition characterized by mild depressive symptoms such as tearfulness, irritability, dysphoria, anxiety, insomnia, and impaired concentration.&nbsp; Symptoms typically peak at day 5 and resolve by 2 weeks.&nbsp; This patient&#39;s symptoms are more severe and persistent and require treatment.</p><p><strong>(Choices B and E)</strong>&nbsp; Although a new mother support group and parenting skills training would be helpful adjuncts, they are not sufficient to address this patient&#39;s untreated depression.</p><p><strong>(Choice C)</strong>&nbsp; Psychiatric hospitalization would be indicated if the patient posed a risk to herself or the baby and/or was unable to adhere to outpatient treatment.&nbsp; Assessment of postpartum depression should always include questions regarding thoughts of suicide or harming the baby.</p><p><strong>Educational objective:</strong><br>All women should be assessed for depression at their postpartum follow-up visits.&nbsp; Treatment options for postpartum depression include psychotherapy and/or pharmacotherapy.&nbsp; Selective serotonin reuptake inhibitors are used as first-line therapy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Reassure the patient that her postpartum blues will improve and schedule follow-up in 2 weeks",
                    "choiceNumber": 1,
                    "correctTaken": 1974,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend a support group for new mothers",
                    "choiceNumber": 2,
                    "correctTaken": 2223,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend psychiatric hospitalization",
                    "choiceNumber": 3,
                    "correctTaken": 321,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend treatment with a selective serotonin reuptake inhibitor",
                    "choiceNumber": 4,
                    "correctTaken": 12522,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Refer the patient for parenting skills training",
                    "choiceNumber": 5,
                    "correctTaken": 142,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24773410",
                    "mediaDataId": 0,
                    "title": "Pharmacotherapy of postpartum depression: an update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24773410",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 102,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 17182,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 17656,
            "questionIndex": 19116,
            "questionText": "<p>A 34-year-old woman comes to the labor and delivery unit via ambulance for contractions, rupture of membranes, and vaginal bleeding.&nbsp; The patient had rupture of membranes 4 hours ago, and her contractions have increased in intensity and frequency over the last hour, which required multiple doses of morphine in the ambulance.&nbsp; On arrival, temperature is 37.2 C (99 F), blood pressure is 130/80 mm Hg, and pulse is 94/min.&nbsp; On pelvic examination, the membranes are grossly ruptured with clear fluid, and there is scant, dark blood on the perineum.&nbsp; The cervix is 6 cm dilated and 80% effaced, and fetal position is occiput posterior.&nbsp; Fetal heart rate tracing is shown in the <a href=\"33726\">exhibit</a>.&nbsp; Which of the following is the most likely cause of this fetal heart rate tracing?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"2157\" src=\"https://www.uworld.com/media/L22719.jpg\"  ></p><p>During labor, <strong>fetal heart rate monitoring</strong> is performed to continuously assess for signs of fetal hypoxia and metabolic acidosis, which can lead to fetal compromise.&nbsp; Fetal heart rate features that are monitored include the baseline heart rate (normal: 110-160/min), presence of accelerations and/or decelerations, and heart rate variability.</p><p><strong>Variability</strong> is the beat-to-beat fluctuation in baseline fetal heart rate.&nbsp; These fluctuations are irregular in amplitude and frequency and categorized based on <strong>amplitude change</strong> (measured from peak to trough).&nbsp; Normal variability, a change in baseline of 6-25/min, is reassuring.&nbsp; In contrast, persistently <strong>absent or minimal variability</strong> (ie, &#8804;5/min), as in <a href=\"33727\">this patient</a>, can indicate fetal metabolic acidosis and impending fetal compromise.</p><p>However, <strong>certain medications</strong> can cause transient absent or minimal variability unrelated to fetal acid-base status.&nbsp; <strong>Opioids</strong> (eg, morphine) may decrease fetal heart rate variability due to <strong>fetal CNS depression</strong>; exposed fetuses also typically have decreased frequency of accelerations.&nbsp; These changes are temporary and normalize as the medication effect diminishes; therefore, these patients typically require only continued monitoring.</p><p><strong>(Choice A)</strong>&nbsp; A congenital cardiac anomaly may cause tachypnea and cyanosis in the newborn but does not typically change fetal heart rate variability in utero because fetal oxygenation is via the placenta.</p><p><strong>(Choice B)</strong>&nbsp; The fetal <a href=\"22287\">occiput posterior position</a> can increase the rate of <a href=\"2411\">early decelerations</a> due to greater fetal head compression; however, it does not cause decreased variability.</p><p><strong>(Choice C)</strong>&nbsp; An intraamniotic infection can cause minimal variability due to infection-induced fetal hypoxia; however, patients typically have maternal fever, causing <a href=\"4569\">fetal tachycardia</a> (baseline: &gt;160/min).&nbsp; This patient is afebrile and has a normal fetal baseline, making this diagnosis unlikely.</p><p><strong>(Choice E)</strong>&nbsp; Uteroplacental insufficiency, or inadequate blood flow to the placenta and fetus, may produce fetal hypoxia, acidosis, and resultant minimal variability.&nbsp; However, patients typically also have <a href=\"1820\">late decelerations</a>.&nbsp; This patient has no decelerations or risk factors for uteroplacental insufficiency (eg, preeclampsia).</p><p><strong>Educational objective:</strong><br>Persistently absent or minimal variability on fetal heart rate monitoring typically indicates fetal metabolic acidosis.&nbsp; However, certain medications (eg, opioids) can also cause decreased variability (eg, fetal CNS depression).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 22374,
            "topic": "Fetal heart tracing",
            "titleId": 22374,
            "title": "Fetal heart tracing",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Congenital cardiac anomaly",
                    "choiceNumber": 1,
                    "correctTaken": 732,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal occiput posterior position",
                    "choiceNumber": 2,
                    "correctTaken": 1847,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intraamniotic infection",
                    "choiceNumber": 3,
                    "correctTaken": 638,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication side effect",
                    "choiceNumber": 4,
                    "correctTaken": 11095,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uteroplacental insufficiency",
                    "choiceNumber": 5,
                    "correctTaken": 2285,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "161",
                    "mediaDataId": 0,
                    "title": "Fetal heart rate tracings",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26926317",
                    "mediaDataId": 0,
                    "title": "Variations on fetal heart rate variability.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26926317",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20966730",
                    "mediaDataId": 0,
                    "title": "Practice bulletin no. 116: management of intrapartum fetal heart rate tracings.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20966730",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 77,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 16597,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 15065,
            "questionIndex": 16489,
            "questionText": "<p>A 34-year-old woman is evaluated in the postpartum unit for vaginal bleeding.&nbsp; Two hours ago, she underwent an uncomplicated spontaneous vaginal delivery with an estimated blood loss of 250 mL.&nbsp; Bleeding was initially minimal, but there is now profuse vaginal bleeding, and the patient&#39;s perineal pad is soaked with blood and large clots.&nbsp; This was her eighth vaginal delivery; her only surgery was a dilation and curettage 4 years ago for a spontaneous abortion.&nbsp; The patient has chronic hypertension that has been managed throughout this pregnancy with labetalol.&nbsp; She has no medication allergies.&nbsp; Blood pressure is 148/102 mm Hg and pulse is 110/min.&nbsp; On pelvic examination, the uterine fundus is soft, and the lower uterine segment is distended with blood clots.&nbsp; Which of the following medications should be avoided in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T35375\" style=\"overflow-x:auto;\" tid=\"11239\"><table class=\"table-default-style\" style=\"width:537px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Postpartum uterine atony</strong></p></td></tr><tr><td style=\"width: 25%;\"><p align=\"center\"><strong>Risk factors</strong></p></td><td style=\"width: 75%;\"><ul><li>Uterine fatigue from prolonged, induced, or precipitous labor</li><li>Intraamniotic infection</li><li>Uterine overdistension (multiple gestation, macrosomia, polyhydramnios)</li><li>Retained placenta</li><li>Grand multiparity (&#8805;5 prior deliveries)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Most common cause of postpartum hemorrhage</li><li>Enlarged, soft, boggy, poorly contracted uterus</li></ul></td></tr><tr><td><p align=\"center\"><strong>Interventions</strong></p></td><td><ul><li>Bimanual uterine massage</li><li>Correction of bladder distension</li><li>High-dose oxytocin, misoprostol</li><li>Tranexamic acid</li><li>Carboprost, methylergonovine</li><li>Intrauterine balloon tamponade</li><li>Possible surgical intervention (if atony unresolved)</li></ul></td></tr></tbody></table></div><p>This patient with profuse vaginal bleeding and a soft uterine fundus has <strong>uterine atony</strong>, the most common cause of <strong>postpartum hemorrhage (PPH)</strong>.&nbsp; Uterine atony occurs because of insufficient uterine contractility after delivery, resulting in continued bleeding from open placental bed vessels.&nbsp; Risk factors include grand multiparity (eg, &#8805;5 prior deliveries), hypertensive disorders, and uterine overdistension (eg, macrosomia).</p><p>First-line treatment for uterine atony is <a href=\"6192\">bimanual uterine massage</a> and high-dose oxytocin.&nbsp; If heavy bleeding persists, additional medications are administered based on patient-specific contraindications:</p><ul><li>Tranexamic acid is an antifibrinolytic that prevents blood clot breakdown and significantly decreases blood loss if administered within 3 hours of delivery.&nbsp; Therefore, it is used for PPH of any etiology (eg, uterine atony, retained placenta).&nbsp; Tranexamic acid has no absolute contraindications but is used with caution in patients with hypercoagulability (eg, inherited thrombophilia) due to the potential increased risk of thromboembolism <strong>(Choice E)</strong>.</li><li>Carboprost tromethamine is a second-line uterotonic agent that stimulates contractions to increase uterine tone and decrease bleeding.&nbsp; It is a synthetic prostaglandin F2&#945; analog that can cause bronchospasm; therefore, it is contraindicated in patients with asthma <strong>(Choice A)</strong>.</li><li>Methylergonovine is another second-line uterotonic agent that stimulates contractions.&nbsp; It is a potent vasoconstrictor and therefore <strong>contraindicated</strong> in patients with <strong>hypertensive disorders</strong> (eg, this patient with chronic hypertension) due to <strong>increased risk of stroke</strong>.</li></ul><p><strong>(Choices C and D)</strong>&nbsp; Oxytocin is a first-line uterotonic agent administered to all patients after placental delivery for PPH prophylaxis; high-dose oxytocin is used for PPH treatment.&nbsp; Misoprostol is a prostaglandin E1 analog used for the induction of labor or as a second-line uterotonic to treat uterine atony.&nbsp; There are typically no contraindications to the use of either oxytocin or misoprostol in patients with PPH.</p><p><strong>Educational objective:</strong><br>The most common cause of postpartum hemorrhage is uterine atony, which typically presents with heavy vaginal bleeding and a soft uterine fundus.&nbsp; The choice of medical therapy for atony depends on patient contraindications: Methylergonovine is contraindicated in hypertensive patients, carboprost tromethamine is contraindicated in patients with asthma, and tranexamic acid is used with caution in patients with hypercoagulability.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4183,
            "topic": "Postpartum hemorrhage",
            "titleId": 4183,
            "title": "Postpartum hemorrhage",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Carboprost tromethamine",
                    "choiceNumber": 1,
                    "correctTaken": 423,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Methylergonovine",
                    "choiceNumber": 2,
                    "correctTaken": 2818,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Misoprostol",
                    "choiceNumber": 3,
                    "correctTaken": 669,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oxytocin",
                    "choiceNumber": 4,
                    "correctTaken": 568,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tranexamic acid",
                    "choiceNumber": 5,
                    "correctTaken": 581,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30379320",
                    "mediaDataId": 0,
                    "title": "Tranexamic acid for prevention and treatment of postpartum hemorrhage: an update on management and clinical outcomes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30379320",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28954732",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of postpartum haemorrhage.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28954732",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28937571",
                    "mediaDataId": 0,
                    "title": "ACOG practice bulletin no. 183: postpartum hemorrhage.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28937571",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28526143",
                    "mediaDataId": 0,
                    "title": "Uterotonic medications: oxytocin, methylergonovine, carboprost, misoprostol.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28526143",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 137,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 5059,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 17340,
            "questionIndex": 18795,
            "questionText": "<p>A boy is brought to the nursery shortly after birth.&nbsp; The patient was born at 36 weeks gestation to a 34-year-old primigravid woman via spontaneous vaginal delivery following a pregnancy complicated by chronic hypertension.&nbsp; The only prenatal care was at 10 weeks gestation in the emergency department due to vaginal discharge and spotting.&nbsp; At that visit, the mother&#39;s blood pressure was 130/89 mm Hg.&nbsp; BMI was 21 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Ultrasound confirmed a 10-week intrauterine gestation.&nbsp; The mother was diagnosed with <em>Chlamydia trachomatis</em> and treated with azithromycin.&nbsp; The patient was born vigorous with Apgar scores of 7 and 9 at 1 and 5 minutes, respectively.&nbsp; His measurements are charted in the image below, and the examination is otherwise unremarkable.</p><p><img  draggable=\"false\" id=\"33586\" src=\"https://www.uworld.com/media/highresdefault/L58308.jpg\"  ></p><p>Which of the following is the most likely cause of this patient&#39;s findings?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t59301\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Fetal growth restriction</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Symmetric</strong></p></td><td><p align=\"center\"><strong>Asymmetric</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td colspan=\"2\"><ul><li>Estimated fetal weight &lt;10th percentile or birth weight &lt;3rd percentile for gestational age</li></ul></td></tr><tr><td><p align=\"center\"><strong>Onset</strong></p></td><td><ul><li>1st trimester</li></ul></td><td><ul><li>2nd/3rd trimester</li></ul></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Chromosomal abnormalities</li><li>Congenital infection</li></ul></td><td><ul><li>Uteroplacental insufficiency</li><li>Maternal malnutrition</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Global growth lag</li></ul></td><td><ul><li>Head-sparing&nbsp;growth lag</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td colspan=\"2\"><ul><li>Monitor/treat complications (eg,&nbsp;hypoglycemia, hypothermia, polycythemia)</li><li>Hypoglycemia: frequent screening and frequent feedings</li><li>Hypothermia: skin to skin with mother, examinations in incubator</li><li>Polycythemia and hypocalcemia: screen if symptoms develop (eg, poor feeding, vomiting, jitteriness)</li></ul></td></tr></tbody></table></div><p><strong>Fetal growth restriction</strong> (FGR) is characterized by an estimated <strong>fetal weight &lt;10th percentile</strong> or <strong>birth weight &lt;3rd percentile</strong> for gestational age.&nbsp; Neonates who are small for gestational age (SGA) (ie, birth weight &lt;10th percentile) are also considered growth restricted if maternal risk factors for poor fetal growth (eg, maternal hypertension, preeclampsia) are present.</p><p>FGR is characterized as follows:</p><ul><li><p>Symmetric, in which all growth parameters are small</p></li><li><p><strong>Asymmetric</strong>, in which weight is low but <strong>head circumference is normal</strong> (&#x22;head-sparing&#x22;), as seen in this patient</p></li></ul><p>Whereas symmetric FGR is typically due to an insult early in pregnancy (eg, genetic condition, congenital infection), asymmetric FGR is most commonly caused by decreased blood flow and oxygen delivery to the fetus (ie, <strong>uteroplacental insufficiency</strong>) in the <strong>second/third trimester</strong>.&nbsp; Asymmetric FGR is &#x22;head-sparing&#x22; because nutrient delivery is preferentially redistributed to essential organs (eg, brain, heart).&nbsp; The most likely cause of uteroplacental insufficiency in this case is maternal <strong>chronic hypertension</strong>.</p><p>Management of newborns with FGR includes prevention and treatment of associated complications such as hypoglycemia, polycythemia, hypothermia, and poor feeding.&nbsp; Catch-up growth is typically achieved by age 2, but long-term growth and neurodevelopmental abnormalities can occur.</p><p><strong>(Choices A and D)</strong>&nbsp; Congenital infection (eg, cytomegalovirus) and teratogenic drug exposure (eg, warfarin) can cause symmetric FGR, which is not present in this patient with a normal head circumference.&nbsp; Untreated maternal chlamydial infection can be transmitted during delivery and cause neonatal conjunctivitis and pneumonia but does not affect fetal growth.&nbsp; In addition, azithromycin is not teratogenic.</p><p><strong>(Choice B)</strong>&nbsp; Constitutional SGA is a variant of normal growth in which a neonate is small in length and weight due to genetics (ie, small parents).&nbsp; In contrast, this patient has asymmetric growth parameters (ie, head-sparing) and risk factors for placental insufficiency (maternal chronic hypertension), making pathologic FGR more likely.</p><p><strong>(Choice C)</strong>&nbsp; Inaccurate pregnancy dating can make all growth parameters appear falsely low relative to presumed gestational age.&nbsp; However, the best sonographic estimate of gestational age is a first-trimester crown-rump length measurement, which this patient had.&nbsp; Therefore, inaccurate dating does not explain the low birth weight or asymmetric parameters seen in this neonate.</p><p><strong>Educational objective:</strong><br>Fetal growth restriction (FGR) is characterized by estimated fetal weight &lt;10th percentile or birth weight &lt;3rd percentile.&nbsp; Asymmetric FGR, in which head circumference is normal, is most commonly due to uteroplacental insufficiency (eg, maternal chronic hypertension) in the second/third trimester.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 29826,
            "topic": "Small for gestational age",
            "titleId": 29826,
            "title": "Small for gestational age",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Congenital infection",
                    "choiceNumber": 1,
                    "correctTaken": 1545,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Constitutional small growth",
                    "choiceNumber": 2,
                    "correctTaken": 1595,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inaccurate pregnancy dating",
                    "choiceNumber": 3,
                    "correctTaken": 713,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Teratogenic drug exposure",
                    "choiceNumber": 4,
                    "correctTaken": 667,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uteroplacental insufficiency",
                    "choiceNumber": 5,
                    "correctTaken": 11593,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "745",
                    "mediaDataId": 0,
                    "title": "Fetal growth restriction",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27441006",
                    "mediaDataId": 0,
                    "title": "Intrauterine growth restriction: antenatal and postnatal aspects.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27441006",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 129,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 16113,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 72,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 3953,
            "questionIndex": 3953,
            "questionText": "<p>A 29-year-old woman, gravida 1 para 0, at 12 weeks gestation comes to the office for prenatal care.&nbsp; The patient was hospitalized at 7 weeks gestation for hyperemesis gravidarum.&nbsp; Since the hospitalization, she has received intravenous hydration several times in the emergency department due to dehydration from persistent nausea and vomiting.&nbsp; Despite taking antiemetics frequently, the patient is unable to eat or drink much.&nbsp; She is able to tolerate prenatal vitamins, which she takes with metoclopramide.&nbsp; Blood pressure is 90/50 mm Hg.&nbsp; Prepregnancy BMI was 18 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Weight is 50 kg (110.2 lb), a decrease of 2 kg (4.4 lb) from her prepregnancy weight.&nbsp; Fetal heart tones are normal by Doppler.&nbsp; The patient is concerned about her weight loss and whether it will affect the baby.&nbsp; This patient is at greatest risk for which of the following pregnancy complications?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T44474\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Complications of inappropriate pregnancy weight gain</strong></p></td></tr><tr><td><p align=\"center\"><strong>Excessive weight gain</strong></p></td><td><ul><li>Gestational diabetes mellitus</li><li>Fetal macrosomia</li><li>Cesarean delivery</li></ul></td></tr><tr><td><p align=\"center\"><strong>Inadequate weight gain</strong></p></td><td><ul><li>Fetal growth restriction</li><li>Preterm delivery</li></ul></td></tr></tbody></table></div><p>Recommendations for weight gain in pregnancy depend on prepregnancy BMI, which is an indicator of baseline maternal fat and nutrient stores.&nbsp; A patient with an <strong>underweight prepregnancy BMI</strong> (ie, &lt;18.5 kg/m<font size=\"2\"><sup>2</sup></font>), such as this patient, has low baseline nutrient stores and therefore <strong>requires greater gestational weight gain</strong> (a total of 12.7-18 kg [28-40 lb]) to maintain a healthy pregnancy.</p><p>This patient is underweight and has <strong>hyperemesis gravidarum</strong>, which is characterized by severe, persistent nausea and vomiting that can extend past the first trimester.&nbsp; Although the pathophysiology of hyperemesis itself does not affect the fetus, mothers with hyperemesis gravidarum frequently have <strong>inadequate gestational weight gain</strong>.&nbsp; Low prepregnancy BMI and poor nutrient intake during pregnancy increase the risk of <strong>fetal growth restriction</strong>, low birth weight, and <strong>preterm delivery</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Risk factors for cervical insufficiency, a cause of painless second-trimester pregnancy loss, include inherited collagen defects (eg, Ehlers-Danlos syndrome) and prior cervical surgery (eg, cervical conization) because these conditions cause structural weakness of the cervix.&nbsp; Although patients with inadequate gestational weight gain are at increased risk for preterm delivery due to depletion of maternal nutrient stores, they are not at risk for cervical weakness.</p><p><strong>(Choice B)</strong>&nbsp; Unlike adult anemia, which is commonly due to iron deficiency (eg, inadequate nutrition), fetal anemia typically occurs due to fetal red blood cell destruction (ie, hemolysis).&nbsp; Risk factors include Rh alloimmunization and in utero infection (eg, <em>Parvovirus B19</em>) but not poor weight gain in pregnancy.</p><p><strong>(Choice D)</strong>&nbsp; The chief risk factor for neural tube defect is inadequate folate consumption.&nbsp; This patient is able to take her prenatal vitamins, which contain folate, making neural tube defect an unlikely complication.</p><p><strong>(Choice E)</strong>&nbsp; <a href=\"2778\">Placenta previa</a> occurs due to abnormal placentation such that the placenta overlies the cervical os.&nbsp; The most common risk factor is prior cesarean delivery.&nbsp; Hyperemesis gravidarum and inadequate gestational weight gain do not affect placental location.</p><p><strong>Educational objective:</strong><br>Hyperemesis gravidarum is severe, persistent nausea and vomiting in pregnancy that can lead to inadequate gestational weight gain.&nbsp; Underweight pregnant patients (ie, BMI &lt;18.5 kg/m<font size=\"2\"><sup>2</sup></font>) and those with inadequate gestational weight gain are at increased risk for fetal growth restriction and preterm delivery.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 12106,
            "topic": "Hyperemesis gravidarum",
            "titleId": 12106,
            "title": "Hyperemesis gravidarum",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cervical insufficiency",
                    "choiceNumber": 1,
                    "correctTaken": 264,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal anemia",
                    "choiceNumber": 2,
                    "correctTaken": 1225,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal growth restriction",
                    "choiceNumber": 3,
                    "correctTaken": 14761,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal neural tube defect",
                    "choiceNumber": 4,
                    "correctTaken": 453,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Placenta previa",
                    "choiceNumber": 5,
                    "correctTaken": 92,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "162",
                    "mediaDataId": 0,
                    "title": "Hyperemesis gravidarum",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28549978",
                    "mediaDataId": 0,
                    "title": "Gestational weight gain.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28549978",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 93,
            "othersAvgTimeSpent": 48,
            "notes": null,
            "peopleTaken": 16795,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 88,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 17180,
            "questionIndex": 18632,
            "questionText": "<p>A 29-year-old woman with type 1 diabetes mellitus comes to the office due to increasing fatigue and irritability.&nbsp; The symptoms started 2 weeks after the patient developed an upper respiratory infection.&nbsp; The cough and rhinorrhea have improved, but she continues to have fatigue and has lost 7 kg (15.43 lb) over the past month.&nbsp; The patient had an uncomplicated delivery 2 months ago and is exclusively formula-feeding her infant.&nbsp; Blood pressure is 148/72 mm Hg, pulse is 98/min, and respirations are 16/min.&nbsp; BMI is 26 kg/m&sup2;.&nbsp; The thyroid is symmetrically enlarged and nontender.&nbsp; Cardiopulmonary examination is unremarkable.&nbsp; The abdomen is soft and nontender.&nbsp; A hand tremor is present.&nbsp; TSH level is low, and free T3 and T4 levels are high.&nbsp; There is low uptake on a radioactive iodine uptake scan.&nbsp; Which of the following is the most likely cause of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31129\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>RAIU findings in thyrotoxicosis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Normal or increased</strong></p></td><td><ul><li>Graves disease</li><li>Toxic multinodular goiter</li><li>Toxic nodule</li></ul></td></tr><tr><td><p align=\"center\"><strong>Decreased</strong></p></td><td><ul><li>Painless (silent) thyroiditis</li><li>Subacute (de Quervain) thyroiditis</li><li>Amiodarone-induced thyroiditis</li><li>Surreptitious or excessive levothyroxine intake</li><li>Struma ovarii</li><li>Iodine induced</li><li>Metastatic thyroid cancer</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>RAIU</strong> = radioactive iodine uptake.</p></td></tr></tbody></table></div><p>This patient has clinical features (eg, fatigue, weight loss, tremor) and laboratory findings (ie, decreased TSH, elevated T4 and T3) consistent with <strong>hyperthyroidism</strong> (ie, thyrotoxicosis).&nbsp; The most common causes of hyperthyroidism are Graves disease and painless autoimmune thyroiditis (a variant of Hashimoto thyroiditis), which both can cause a <strong>painless, symmetrically enlarged thyroid</strong>.&nbsp; Patients with another autoimmune disease (eg, type 1 diabetes mellitus) are at increased risk for both disorders.</p><p>These disorders can be differentiated by a <strong>radioactive iodine uptake scan</strong>, which shows metabolic activity in the thyroid.</p><ul><li><p>In Graves disease, the thyroid is stimulated by autoantibodies to increase tissue metabolic activity, causing increased thyroid hormone synthesis (as evidenced by increased uptake of radioactive iodine) and increased release of thyroid hormone <strong>(Choice B)</strong>.</p></li><li><p>In contrast, in painless autoimmune thyroiditis, the thyroid tissue is destroyed, leading to increased release of preformed thyroid hormone and resulting hyperthyroidism.&nbsp; The destroyed thyroid cells are unable to synthesize thyroid hormone, as evidenced by <strong>low radioactive iodine uptake</strong>.</p></li></ul><p>A form of painless autoimmune thyroiditis is <strong>postpartum thyroiditis</strong>, which can occur within 12 months of delivery.&nbsp; Patients with postpartum thyroiditis can have a variable disease course (based on the amount of thyroid destruction and recovery), including being hyperthyroid only (as in this patient), hypothyroid only, or hyperthyroid then hypothyroid.&nbsp; The diagnosis can be confirmed with a positive thyroid peroxidase antibody assay.&nbsp; Most patients eventually return to a euthyroid state and do not require treatment.</p><p><strong>(Choice A)</strong>&nbsp; Exogenous thyroid ingestion suppresses thyroid hormone production, thereby causing decreased TSH levels and low radioiodine uptake.&nbsp; However, these patients typically have an atrophic, not enlarged, thyroid.</p><p><strong>(Choice C)</strong>&nbsp; Nonthyroidal illness (ie, euthyroid sick syndrome) is an abnormal pattern of thyroid markers seen in patients with severe, acute illness.&nbsp; T3 is typically low and free T4 and TSH are normal to low.</p><p><strong>(Choice E)</strong>&nbsp; Subacute granulomatous thyroiditis (ie, de Quervain thyroiditis) can cause hyperthyroidism and often presents after an upper respiratory infection.&nbsp; However, patients typically have fever and a severely painful, tender goiter, making this diagnosis unlikely.</p><p><strong>Educational objective:</strong><br>Postpartum thyroiditis, a form of painless autoimmune thyroiditis occurring within 12 months of delivery, can present with signs of hyperthyroidism (eg, weight loss, tremor, elevated T4 and T3 levels) and low uptake on a radioactive iodine uptake scan.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 11940,
            "topic": "Hyperthyroidism",
            "titleId": 11940,
            "title": "Hyperthyroidism",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Exogenous thyroid ingestion",
                    "choiceNumber": 1,
                    "correctTaken": 872,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Graves disease",
                    "choiceNumber": 2,
                    "correctTaken": 1124,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nonthyroidal illness (euthyroid sick syndrome)",
                    "choiceNumber": 3,
                    "correctTaken": 671,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Postpartum thyroiditis",
                    "choiceNumber": 4,
                    "correctTaken": 11699,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Subacute granulomatous thyroiditis",
                    "choiceNumber": 5,
                    "correctTaken": 2296,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28056690",
                    "mediaDataId": 0,
                    "title": "2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28056690",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22312089",
                    "mediaDataId": 0,
                    "title": "Approach to the patient with postpartum thyroiditis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22312089",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 63,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 16662,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 70,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 17183,
            "questionIndex": 18635,
            "questionText": "<p>A 30-year-old woman is evaluated in labor and delivery for acute-onset dyspnea.&nbsp; An hour ago, the patient underwent an emergency cesarean delivery requiring intubation and general anesthesia for a category III fetal heart rate tracing due to placental abruption.&nbsp; The procedure was complicated by postpartum hemorrhage, and intraoperative transfusion of 2 units of packed red blood cells was required.&nbsp; The patient was extubated 15 minutes ago and now has significant shortness of breath and hypoxemia.&nbsp; Temperature is 38.3 C (101 F), blood pressure is 122/70 mm Hg, pulse is 114/min, and respirations are 24/min.&nbsp; Oxygen saturation is 84% on room air.&nbsp; Cardiac examination reveals no rubs or murmurs.&nbsp; Jugular venous pressure is normal.&nbsp; Pulmonary examination reveals bilateral crackles.&nbsp; The remainder of the examination is within normal limits.&nbsp; Chest x-ray shows infiltrates in the superior segments of the bilateral lower lobes.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T60017\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Aspiration (chemical) pneumonitis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Gastric reflux (ie, &#8595; esophageal sphincter tone)</li><li>Delayed gastric emptying</li><li>&#8593; Intraabdominal pressure</li><li>Altered consciousness or sedation (eg, anesthesia)</li><li>Endotracheal intubation, nasogastric tube</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>Aspiration of gastric acid with direct tissue injury</li><li>Lung parenchymal inflammation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical</strong></p><p align=\"center\"><strong>presentation</strong></p></td><td><ul><li>Within hours of aspiration event</li><li>Acute-onset dyspnea, low-grade fever, hypoxemia</li><li>Diffuse crackles on lung examination</li><li>Chest x-ray infiltrates (dependent lung segments)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Supportive care (ie, no antibiotics)</li></ul></td></tr></tbody></table></div><p>This postpartum patient with acute-onset dyspnea and hypoxemia most likely has <strong>chemical pneumonitis</strong> from aspiration of acidic gastric contents.&nbsp; <strong>Pregnancy increases the risk for aspiration</strong> due to elevated progesterone, which delays gastric emptying and decreases esophageal sphincter tone.&nbsp; In addition, the gravid uterus increases intraabdominal pressure and promotes reflux.&nbsp; These obstetric factors, in combination with surgical risk factors (eg, sedation, recumbent positioning, emergency intubation), likely led this patient to aspirate.</p><p>Aspiration leads to chemical pneumonitis through direct pulmonary injury from gastric acid.&nbsp; There is an ensuing <strong>inflammatory response</strong>, which causes localized pulmonary edema and alveolar collapse (ie, atelectasis).&nbsp; Chemical pneumonitis manifests clinically with low-grade <strong>fever</strong>, <strong>hypoxemia</strong>, and <strong>diffuse crackles</strong> on lung examination <strong>within hours</strong> of the aspiration event.&nbsp; Chest x-ray typically shows <strong>alveolar infiltrates in the dependent lung segments</strong>, which, in the recumbent position (ie, during cesarean delivery), are the superior segments of the lower lobes.</p><p>The inflammatory process is usually self-limited and resolves with <strong>supportive treatment</strong> (eg, supplemental oxygen, ventilatory support).&nbsp; Unlike aspiration pneumonia (which often has an insidious presentation with cough), chemical pneumonitis does not typically require antibiotic therapy.&nbsp; A minority of patients may develop acute respiratory distress syndrome and have a more severe course.</p><p><strong>(Choice A)</strong>&nbsp; An acute hemolytic transfusion reaction due to ABO incompatibility can cause fever.&nbsp; However, the typical onset is within minutes of transfusion, and patients usually have hypotension and signs of hemolysis (eg, hemoglobinuria, acute renal failure, disseminated intravascular coagulation [DIC]).</p><p><strong>(Choice C)</strong>&nbsp; Left ventricular failure (eg, due to peripartum cardiomyopathy) can lead to cardiogenic shock with dyspnea due to acute pulmonary edema; however, increased jugular venous pressure and diffuse (not localized) infiltrates are expected.</p><p><strong>(Choice D)</strong>&nbsp; The risk of pulmonary embolism (PE) is increased in the peripartum period.&nbsp; Hypoxemia and respiratory distress can occur with acute PE; however, jugular venous distension and clear lungs are also expected.</p><p><strong>Educational objective:</strong><br>Chemical pneumonitis is typically a self-limited inflammatory response caused by direct pulmonary injury from aspirated acidic gastric contents.&nbsp; Patients typically develop dyspnea, hypoxemia, and alveolar infiltrates in the dependent lung segments within hours of aspiration.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 5525,
            "topic": "Aspiration pneumonia",
            "titleId": 5525,
            "title": "Aspiration pneumonia",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute hemolytic transfusion reaction",
                    "choiceNumber": 1,
                    "correctTaken": 7184,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chemical pneumonitis",
                    "choiceNumber": 2,
                    "correctTaken": 5777,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Left ventricular failure",
                    "choiceNumber": 3,
                    "correctTaken": 818,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pulmonary embolism",
                    "choiceNumber": 4,
                    "correctTaken": 2790,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26554613",
                    "mediaDataId": 0,
                    "title": "Ultrasound evaluation of the stomach and gastric emptying in pregnant women at term: a case-control study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26554613",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24497372",
                    "mediaDataId": 0,
                    "title": "Interventions at caesarean section for reducing the risk of aspiration pneumonitis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24497372",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 121,
            "othersAvgTimeSpent": 74,
            "notes": null,
            "peopleTaken": 16571,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 35,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 4808,
            "questionIndex": 4808,
            "questionText": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td id=\"vignettedescriptor\">The following vignette applies to the next <strong>2</strong> items.&nbsp; The items in the set must be answered in sequential order.&nbsp; Once you click <strong>Proceed to Next Item</strong>, you will not be able to add or change an answer.</td></tr></tbody></table><p>A 39-year-old woman, gravida 1 para 0, at 38 weeks gestation comes to the hospital for induction of labor.&nbsp; The patient has a history of hypertension for which she takes nifedipine.&nbsp; She also has a history of asthma for which she takes albuterol as needed, but she has had no recent exacerbations.&nbsp; On admission, blood pressure is 140/80 mm Hg and pulse is 94/min.&nbsp; After a prolonged labor, the patient delivers a 4.1-kg (9-lb) boy via forceps-assisted vaginal delivery and develops a third-degree perineal laceration.&nbsp; During delivery of the placenta, excessive traction is placed on the cord, causing it to avulse, and the placenta is manually extracted.&nbsp; Ultrasound after the extraction reveals a thin endometrial stripe.&nbsp; The perineal laceration is repaired in layers.&nbsp; Sixty minutes after delivery, the patient&#39;s perineal pad becomes soaked with blood.&nbsp; On bimanual uterine examination, 1,000 mL of clotted blood is expressed from the lower uterine segment.&nbsp; The uterus is soft and 4 cm above the umbilicus after expression of the clots.</p><p><strong>Item 1 of 2</strong><br>Which of the following is the most likely cause of this patient&#39;s bleeding?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t35375\"><table class=\"table-default-style\" style=\"width:537px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Postpartum uterine atony</strong></p></td></tr><tr><td style=\"width: 25%;\"><p align=\"center\"><strong>Risk factors</strong></p></td><td style=\"width: 75%;\"><ul><li>Uterine fatigue from prolonged, induced, or precipitous labor</li><li>Intraamniotic infection</li><li>Uterine overdistension (multiple gestation, macrosomia, polyhydramnios)</li><li>Retained placenta</li><li>Grand multiparity (&ge;5 prior deliveries)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Most common cause of postpartum hemorrhage</li><li>Enlarged, soft, boggy, poorly contracted uterus</li></ul></td></tr><tr><td><p align=\"center\"><strong>Interventions</strong></p></td><td><ul><li>Bimanual uterine massage</li><li>Correction of bladder distension</li><li>High-dose oxytocin, misoprostol</li><li>Tranexamic acid</li><li>Carboprost, methylergonovine</li><li>Intrauterine balloon tamponade</li><li>Possible surgical intervention (if atony unresolved)</li></ul></td></tr></tbody></table></div><p>This patient with heavy bleeding and blood clots in the lower uterine segment has <strong>uterine atony</strong>, the most common cause of <strong>postpartum hemorrhage</strong> (PPH) within 24 hours of delivery.&nbsp; Uterine atony occurs due to insufficient uterine contractility, resulting in the inability of the uterus to clamp down on bleeding placental bed vessels.&nbsp; Risk factors include uterine overdistension (often associated with <strong>fetal macrosomia</strong> [weight &#8805;4 kg]), uterine fatigue (eg, <strong>prolonged induction of labor</strong>), and <strong>operative vaginal delivery</strong> (eg, forceps-assisted), all of which are present in this patient.</p><p>Normally during the immediate postpartum period, contractions increase uterine tone, causing a firm uterine fundus to be palpable at or below the umbilicus.&nbsp; In contrast, patients with uterine atony have a <strong>soft, boggy, enlarged uterus</strong> with the <strong>fundus palpable above the umbilicus</strong> because of decreased uterine tone.&nbsp; Some patients may not have an immediate PPH, such as this patient whose bleeding was identified 60 minutes after delivery, because blood can gradually accumulate in the lower uterine segment (the least contractile portion of the uterus).</p><p><strong>(Choice A)</strong>&nbsp; Cervical lacerations can occur due to trauma from operative vaginal delivery, particularly forceps-assisted vaginal delivery.&nbsp; Cervical lacerations may cause PPH, but the onset is typically immediate rather than 60 minutes after fetal delivery.&nbsp; In addition, there is no associated uterine bogginess or enlargement.</p><p><strong>(Choice B)</strong>&nbsp; Although PPH can cause dilutional coagulopathy, this patient&#39;s blood is clotting, making coagulopathy unlikely.</p><p><strong>(Choice C)</strong>&nbsp; This patient had cord avulsion that necessitated manual placental extraction, which risks leaving behind placental fragments that can cause PPH.&nbsp; However, a retained placenta is unlikely in this patient with an ultrasound revealing a thin endometrial stripe (suggesting an empty intrauterine cavity).</p><p><strong>(Choice E)</strong>&nbsp; <a href=\"4513\">Uterine inversion</a> can occur due to excessive traction on the umbilical cord with an adherent placenta, causing the uterine fundus to invert and prolapse.&nbsp; Although it can cause PPH, patients typically have severe abdominal pain, a smooth mass protruding from the cervix or vagina, and no palpable uterine fundus.</p><p><strong>Educational objective:</strong><br>The most common cause of postpartum hemorrhage within 24 hours of delivery is uterine atony, which results from inadequate uterine contractility and inability to compress the placental bed blood vessels.&nbsp; Patients typically have a soft, boggy, enlarged uterus with blood clots in the lower uterine segment and profuse vaginal bleeding.&nbsp; Risk factors include fetal macrosomia, prolonged induction of labor, and operative vaginal delivery.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4183,
            "topic": "Postpartum hemorrhage",
            "titleId": 4183,
            "title": "Postpartum hemorrhage",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 4808,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cervical laceration",
                    "choiceNumber": 1,
                    "correctTaken": 635,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Coagulopathy",
                    "choiceNumber": 2,
                    "correctTaken": 445,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Retained placenta",
                    "choiceNumber": 3,
                    "correctTaken": 3813,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine atony",
                    "choiceNumber": 4,
                    "correctTaken": 12264,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine inversion",
                    "choiceNumber": 5,
                    "correctTaken": 824,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 6,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28068990",
                    "mediaDataId": 0,
                    "title": "Risk factors for severe postpartum hemorrhage: a case-control study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28068990",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "32334562",
                    "mediaDataId": 0,
                    "title": "Bimanual examination for clot evacuation: a retrospective cohort study of women with postpartum haemorrhage after vaginal delivery.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/32334562",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 123,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 17981,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 4809,
            "questionIndex": 4809,
            "questionText": "<p><strong>Item 2 of 2</strong><br>Bimanual massage of the uterus is performed, and 2 large-bore intravenous lines are placed due to ongoing bleeding.&nbsp; Blood pressure is 100/60 mm Hg, pulse is 112/min, and respirations are 18/min.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"42464\" src=\"https://www.uworld.com/media/L68087.png\" ></p><p><strong>Postpartum hemorrhage</strong> (PPH) is defined as an estimated blood loss &#8805;1,000 mL or bleeding with signs/symptoms of hypovolemia.&nbsp; The management of PPH <strong>due to uterine atony</strong> occurs in a stepwise approach:</p><ol type=\"1\"><li><p><strong>Initial management</strong> includes the placement of 2 large-bore intravenous lines for volume resuscitation.&nbsp; <a href=\"26479\">Bimanual uterine massage</a> and bladder catheterization are performed to improve uterine tone.&nbsp; <strong>High-dose oxytocin</strong>, the <strong>first-line uterotonic agent</strong>, is administered.</p></li><li><p>If uterine atony persists, the best next step in management is tranexamic acid, an antifibrinolytic agent that prevents the breakdown of blood clots to achieve hemostasis; its use reduces maternal mortality from hemorrhage.</p></li><li><p>Patients with continued bleeding are administered second-line uterotonic medications, including carboprost tromethamine, methylergonovine, and misoprostol.&nbsp; Carboprost tromethamine is contraindicated in patients with asthma due to the risk of bronchospasm.&nbsp; Methylergonovine is contraindicated in patients with hypertension (regardless of the patient&#39;s current blood pressure) due to an increased risk of stroke <strong>(Choices A and D)</strong>.</p></li><li><p>If PPH does not resolve with medical therapy, an <a href=\"10672\">intrauterine balloon tamponade</a> can be used to compress placental bed blood vessels for hemostasis <strong>(Choice C)</strong>.</p></li><li><p>Finally, patients with PPH refractory to medical and minimally invasive techniques require either uterine artery embolization or surgical management with laparotomy (and possible hysterectomy).</p></li></ol><p><strong>(Choice B)</strong>&nbsp; Dilation and curettage is indicated for PPH due to retained products of conception (eg, placenta, membranes).&nbsp; Although this patient&#39;s placenta was extracted in pieces, an ultrasound revealed no evidence of retained products of conception (eg, a thin endometrial stripe).</p><p><strong>(Choice F)</strong>&nbsp; Vaginal packing with sterile gauze can be used to apply pressure to bleeding vaginal mucosa (eg, after vaginal sulcal laceration repair) to allow for clot formation.&nbsp; However, vaginal packing is extrauterine and therefore does not compress the bleeding placental bed blood vessels.&nbsp; In addition, packing may delay the evaluation and diagnosis of PPH.</p><p><strong>Educational objective:</strong><br>Postpartum hemorrhage is defined as an estimated blood loss &#8805;1,000 mL or bleeding with signs/symptoms of hypovolemia.&nbsp; The management of postpartum hemorrhage due to uterine atony occurs in a stepwise approach.&nbsp; Initial treatment includes administration of high-dose oxytocin, the first-line uterotonic agent.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4183,
            "topic": "Postpartum hemorrhage",
            "titleId": 4183,
            "title": "Postpartum hemorrhage",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 4808,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 1,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Carboprost tromethamine",
                    "choiceNumber": 1,
                    "correctTaken": 664,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dilation and curettage",
                    "choiceNumber": 2,
                    "correctTaken": 400,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intrauterine balloon tamponade",
                    "choiceNumber": 3,
                    "correctTaken": 1767,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Methylergonovine",
                    "choiceNumber": 4,
                    "correctTaken": 1339,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oxytocin",
                    "choiceNumber": 5,
                    "correctTaken": 13474,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vaginal packing with sterile gauze",
                    "choiceNumber": 6,
                    "correctTaken": 335,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 6,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26079202",
                    "mediaDataId": 0,
                    "title": "Tranexamic acid for preventing postpartum haemorrhage.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26079202",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28409600",
                    "mediaDataId": 0,
                    "title": "Postpartum hemorrhage: prevention and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28409600",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 54,
            "othersAvgTimeSpent": 21,
            "notes": null,
            "peopleTaken": 17979,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 4797,
            "questionIndex": 4797,
            "questionText": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td id=\"vignettedescriptor\">The following vignette applies to the next <strong>2</strong> items.&nbsp; The items in the set must be answered in sequential order.&nbsp; Once you click <strong>Proceed to Next Item</strong>, you will not be able to add or change an answer.</td></tr></tbody></table><p>A 19-year-old woman, gravida 1 para 0, at 39 weeks gestation comes to the hospital due to increasing nausea and vomiting.&nbsp; The nausea began after dinner last night and has progressively worsened.&nbsp; Over the past few hours, she has had 2 episodes of vomiting and constant lower abdominal pain.&nbsp; The patient has had constant clear vaginal discharge over the past 2 days and intermittent vaginal spotting.&nbsp; She reports urinary frequency throughout the pregnancy, but no dysuria or hematuria.&nbsp; The patient was treated for a <em>Chlamydia trachomatis</em> infection in the first trimester; her third-trimester <em>C trachomatis</em> screen was negative.&nbsp; She has no chronic medical conditions and has had no surgeries.&nbsp; Temperature is 39.4 C (103 F), blood pressure is 120/68 mm Hg, and pulse is 100/min.&nbsp; The abdomen is nontender with no rebound or guarding; there is diffuse uterine tenderness.&nbsp; The cervix is 2 cm dilated, the fetal vertex is at -1 station, and nitrazine-positive clear fluid is pooled in the posterior fornix.&nbsp; Fetal heart monitoring shows a rate of 165/min, moderate variability, and no decelerations.&nbsp; Tocometry shows contractions every 10 minutes.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">10.2 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">198,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">18,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Neutrophils</td><td style=\"vertical-align:middle;\">86%</td></tr><tr><td style=\"vertical-align:middle;\">Lymphocytes</td><td style=\"vertical-align:middle;\">14%</td></tr></tbody></table><p><strong>Item 1 of 2</strong></p><p>Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient has an <strong>intra-amniotic infection (IAI)</strong>, also known as chorioamnionitis.&nbsp; This complication is common in patients with <strong>premature rupture of the membranes</strong>, which occurs before the onset of regular contractions, and in those with prolonged membrane rupture (&gt;18 hours).&nbsp; Patients with IAI typically have nausea, vomiting, and <strong>uterine fundal tenderness</strong>.&nbsp; The diagnosis is based on the presence of <strong>maternal fever</strong> plus at least 1 of the following: <strong>fetal tachycardia</strong> &gt;160/min for at least 10 minutes, <strong>maternal leukocytosis</strong>, maternal tachycardia, or purulent amniotic fluid.&nbsp; Patients may have an abnormal contraction pattern due to the effect of IAI on uterine muscle contractility.</p><p><strong>(Choice A)</strong>&nbsp; Premature rupture of membranes increases the risk of <a href=\"1113\">abruptio placentae</a>, which can present with uterine tenderness.&nbsp; However, patients commonly have heavy vaginal bleeding, <a href=\"6148\">nonreassuring fetal heart rate tracing</a> (eg, minimal variability, decelerations), and uterine tachysystole (eg, &gt;5 contractions in a 10 minute period).</p><p><strong>(Choice B)</strong>&nbsp; Acute appendicitis typically presents with an acute onset of fever, nausea, anorexia, and right lower quadrant pain.&nbsp; However, during the third trimester patients typically have right upper quadrant pain due to the enlarged uterus causing a shift in the appendiceal location, which is not seen in this patient.</p><p><strong>(Choice C)</strong>&nbsp; Chlamydial cervicitis presents with purulent cervical discharge; there is no associated uterine tenderness.&nbsp; Although this patient was treated for chlamydia in the first trimester, she had a third-trimester negative screen, making this diagnosis unlikely.</p><p><strong>(Choice E)</strong>&nbsp; Pelvic inflammatory disease is an ascending infection uncommon during the third trimester of pregnancy, as thickened cervical mucus provides protection to the uterus from lower pelvic pathogens.&nbsp; Pelvic inflammatory disease is more likely in nonpregnant or first-trimester patients.</p><p><strong>(Choice F)</strong>&nbsp; Viral gastroenteritis presents commonly as an acute-onset diarrheal illness accompanied by other gastrointestinal symptoms such as fever, nausea, vomiting, and abdominal pain.&nbsp; However, patients with viral gastroenteritis do not typically have a fever &gt;38.9 C (102 F) and have diffuse abdominal tenderness rather than uterine tenderness.</p><p><strong>Educational objective:</strong><br>Intra-amniotic infection (chorioamnionitis) typically presents in patients with premature or prolonged rupture of membranes as maternal fever, maternal and fetal tachycardia, uterine fundal tenderness, and maternal leukocytosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14528,
            "topic": "Chorioamnionitis",
            "titleId": 14528,
            "title": "Chorioamnionitis",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 4797,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Abruptio placentae",
                    "choiceNumber": 1,
                    "correctTaken": 410,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Acute appendicitis",
                    "choiceNumber": 2,
                    "correctTaken": 466,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chlamydial cervicitis",
                    "choiceNumber": 3,
                    "correctTaken": 306,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intra-amniotic infection",
                    "choiceNumber": 4,
                    "correctTaken": 14957,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pelvic inflammatory disease",
                    "choiceNumber": 5,
                    "correctTaken": 1119,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Viral gastroenteritis",
                    "choiceNumber": 6,
                    "correctTaken": 706,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 6,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26855098",
                    "mediaDataId": 0,
                    "title": "Evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis: summary of a workshop.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26855098",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 103,
            "othersAvgTimeSpent": 80,
            "notes": null,
            "peopleTaken": 17964,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 83,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 4798,
            "questionIndex": 4798,
            "questionText": "<p><strong>Item 2 of 2</strong></p><p>In addition to broad-spectrum antibiotics, which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t36642\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Intraamniotic infection (chorioamnionitis)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Prolonged rupture of membranes (&gt;18 hr)</li><li>Preterm prelabor rupture of membranes</li><li>Prolonged labor</li><li>Internal fetal/uterine monitoring devices</li><li>Repetitive vaginal examinations</li><li>Presence of genital tract pathogens</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><p>Maternal fever PLUS &ge;1 of the following:</p><ul><li>Fetal tachycardia (&gt;160/min)</li><li>Maternal leukocytosis</li><li>Purulent amniotic fluid</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Broad-spectrum antibiotics</li><li>Delivery</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Maternal: postpartum hemorrhage, endometritis</li><li>Neonatal: preterm birth, pneumonia, encephalopathy</li></ul></td></tr></tbody></table></div><p><strong>Intra-amniotic infections</strong> (IAIs) are usually <strong>polymicrobial</strong> and ascend from the vagina, spreading through the amniotic fluid, membranes, placenta, uterine decidua, and umbilical cord.&nbsp; Treatment is with <strong>broad-spectrum intravenous antibiotics</strong> (eg, ampicillin, gentamicin, clindamycin) and immediate delivery via <strong>augmentation of labor</strong> (to remove the source of infection).&nbsp; These interventions reduce the risk of neonatal morbidity and maternal complications (eg, postpartum endometritis).&nbsp; Antipyretics (eg, acetaminophen) and intravenous fluids are administered to reduce maternal fever, which in turn improves fetal tachycardia.</p><p><strong>(Choice A)</strong>&nbsp; Corticosteroids are administered to patients at risk for preterm delivery (&lt;37 weeks gestation) to promote fetal lung maturity and reduce the incidence of neonatal respiratory distress syndrome.</p><p><strong>(Choices B and D)</strong>&nbsp; Tocolytics (eg, nifedipine, indomethacin) are contraindicated in patients with an IAI, regardless of gestational age.&nbsp; Patients with an IAI are not managed expectantly as the risks of maternal and fetal complications of infection outweigh the risks of prematurity.</p><p><strong>(Choice C)</strong>&nbsp; Cesarean delivery is reserved for standard obstetric indications (eg, nonreassuring fetal tracing, breech presentation, prior uterine surgeries).&nbsp; Although this heart rate tracing indicates fetal tachycardia, it is reassuring overall due to moderate variability and no decelerations.</p><p><strong>Educational objective:</strong><br>Intra-amniotic infections are usually polymicrobial; treatment is with broad-spectrum intravenous antibiotics and expedited delivery to decrease neonatal and maternal morbidity.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14528,
            "topic": "Chorioamnionitis",
            "titleId": 14528,
            "title": "Chorioamnionitis",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 4797,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 1,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administration of corticosteroids",
                    "choiceNumber": 1,
                    "correctTaken": 459,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Administration of tocolytics",
                    "choiceNumber": 2,
                    "correctTaken": 364,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cesarean delivery",
                    "choiceNumber": 3,
                    "correctTaken": 7034,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Expectant management",
                    "choiceNumber": 4,
                    "correctTaken": 2820,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Labor augmentation",
                    "choiceNumber": 5,
                    "correctTaken": 7286,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 6,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21672080",
                    "mediaDataId": 0,
                    "title": "Chorioamnionitis: from pathogenesis to treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21672080",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26855098",
                    "mediaDataId": 0,
                    "title": "Evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis: summary of a workshop.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26855098",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 24,
            "othersAvgTimeSpent": 16,
            "notes": null,
            "peopleTaken": 17963,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 41,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 15738,
            "questionIndex": 17175,
            "questionText": "<p>A 39-year-old woman, gravida 2 para 1, at 38 weeks gestation, comes to the office for a routine prenatal visit.&nbsp; The patient feels well and reports normal fetal activity.&nbsp; Last week, she had nausea, vomiting, and diarrhea for 24 hours, but she has been able to eat and drink normally for the past several days.&nbsp; For the past 2 days, the patient has had increased clear vaginal discharge with irregular, painful contractions but no vaginal bleeding.&nbsp; She has no chronic medical conditions, and her only medication is a prenatal vitamin.&nbsp; Temperature is 99.6 F (37.6 C), blood pressure is 132/86 mm Hg, and pulse is 96/min.&nbsp; The uterus is nontender and the fundal height is 34 cm.&nbsp; Fetal heart tones are 135/min.&nbsp; Fetal ultrasound shows a cephalic fetus, measuring at the 50th percentile for gestational age, and an amniotic fluid index of 2 cm (normal: &gt;5 cm).&nbsp; Which of the following is the most likely cause of this patient&#39;s amniotic fluid level?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient has <strong>oligohydramnios</strong>, an amniotic fluid index of &#8804;5 cm.&nbsp; The etiology of oligohydramnios can vary with gestational age:</p><ul><li>Early-gestation oligohydramnios is concerning for fetal etiologies (eg, aneuploidy, renal agenesis, posterior urethral valves) because amniotic fluid volume is dependent on normal fetal urine production.</li><li><strong>Second- and third-trimester</strong> causes of oligohydramnios are typically due to uteroplacental insufficiency (with concomitant fetal growth restriction) or maternal causes, such as dehydration or rupture of membranes (with <strong>normal fetal growth</strong>).</li></ul><p>At term gestation, the most likely cause of new-onset oligohydramnios is <strong>spontaneous rupture of membranes</strong>.&nbsp; Although membrane rupture typically presents as a sudden gush of fluid, patients can have a subclinical presentation with slow leakage occurring over days, as in this patient with <strong>increased clear vaginal discharge</strong>.&nbsp; Because rupture of membranes is a common cause of oligohydramnios, even asymptomatic patients with oligohydramnios require speculum examination to evaluate for membrane rupture.</p><p><strong>(Choice A)</strong>&nbsp; Although fetal congenital infections (eg, cytomegalovirus) can cause oligohydramnios, they typically also cause fetal growth restriction and other abnormal ultrasound findings, which are not seen in this patient.</p><p><strong>(Choice B)</strong>&nbsp; Severe maternal dehydration may temporarily decrease maternal intravascular volume, uteroplacental perfusion, and fetal amniotic fluid production.&nbsp; However, this patient&#39;s self-limited, acute gastroenteritis resolved several days ago, and her vital signs are normal, making this diagnosis less likely.</p><p><strong>(Choice C)</strong>&nbsp; The amniotic fluid index (AFI) varies with gestational age and peaks at 30-32 weeks gestation before gradually declining; however, a third-trimester AFI of &#8804;5 cm is always abnormal.</p><p><strong>(Choice E)</strong>&nbsp; Maternal vascular disease (eg, chronic hypertension, systemic lupus erythematosus) increases the risk for uteroplacental insufficiency, which causes oligohydramnios due to decreased perfusion of the fetal kidneys.&nbsp; However, these patients typically have concomitant fetal growth restriction, which is not seen in this patient.</p><p><strong>Educational objective:</strong><br>The most common cause of oligohydramnios (amniotic fluid index &#8804;5 cm) at term gestation is spontaneous rupture of membranes.&nbsp; Patients typically have normal fetal growth and leakage of clear vaginal fluid.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 21778,
            "topic": "Oligohydramnios",
            "titleId": 21778,
            "title": "Oligohydramnios",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Fetal congenital infection",
                    "choiceNumber": 1,
                    "correctTaken": 925,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maternal dehydration",
                    "choiceNumber": 2,
                    "correctTaken": 2832,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal gestational age variant",
                    "choiceNumber": 3,
                    "correctTaken": 450,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rupture of membranes",
                    "choiceNumber": 4,
                    "correctTaken": 13923,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uteroplacental insufficiency",
                    "choiceNumber": 5,
                    "correctTaken": 2228,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "8598837",
                    "mediaDataId": 0,
                    "title": "Induction of labor compared with expectant management for prelabor rupture of the membranes at term. TERMPROM study group.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/8598837",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23543046",
                    "mediaDataId": 0,
                    "title": "Premature rupture of membranes at term: early induction versus expectant management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23543046",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 128,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 20358,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 2256,
            "questionIndex": 2256,
            "questionText": "<p>A 25-year-old woman, gravida 3 para 0 aborta 2, at 6 weeks gestation comes to the office for a routine prenatal visit.&nbsp; The patient says she feels fine except for mild nausea; she takes no medications other than a prenatal vitamin.&nbsp; Her 2 prior pregnancies ended in first-trimester spontaneous abortions.&nbsp; Prior to this pregnancy, the patient drank alcohol on social occasions, and she does not use tobacco or illicit drugs.&nbsp; She is in a monogamous relationship and has never been diagnosed with or treated for a sexually transmitted infection.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hematocrit</td><td style=\"vertical-align:middle;\">33%</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">98,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">7,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Coagulation studies</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Prothrombin time</td><td style=\"vertical-align:middle;\">10 sec</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Activated partial thromboplastin time</td><td style=\"vertical-align:middle;\">46 sec</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">VDRL</td><td style=\"vertical-align:middle;\">positive</td></tr><tr><td style=\"vertical-align:middle;\">FTA-ABS</td><td style=\"vertical-align:middle;\">negative</td></tr></tbody></table><p>Urinalysis shows no blood or protein.&nbsp; Sonogram shows a 6-week fetal pole with cardiac motion.&nbsp; Which of the following is the best next step in the management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t35373\"><table class=\"table-default-style\" style=\"width:510px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Diagnostic criteria for antiphospholipid-antibody syndrome</strong><br />(1 clinical &amp; 1 laboratory criterion must be met)</p></td></tr><tr><td><p align=\"center\"><strong>Clinical</strong></p></td><td><p><strong>Vascular thrombosis</strong></p><ul><li>Arterial or venous</li></ul><p><strong>Pregnancy morbidity</strong></p><ul><li>&ge;3 consecutive, unexplained fetal losses before 10th week</li><li>&ge;1 unexplained fetal losses after 10th week</li><li>&ge;1 premature births of normal neonates before 34th week due to preeclampsia, eclampsia, or placental insufficiency</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory</strong></p></td><td><ul><li>Lupus anticoagulant</li><li>Anticardiolipin antibody</li><li>Anti&ndash;&beta;2-glycoprotein I antibody</li></ul></td></tr></tbody></table></div><p>This patient with abnormal serologic test results (eg, positive VDRL, prolonged activated PTT) and 2 prior spontaneous abortions most likely has <strong>antiphospholipid-antibody syndrome</strong> (APS), a prothrombotic autoimmune disorder caused by antiphospholipid antibodies (eg, anticardiolipin antibody, lupus anticoagulant).&nbsp; These antibodies can cross-react with a <strong>VDRL</strong> test to produce a <strong>false-positive</strong> result; they can also interfere with coagulation test reagents, resulting in an artificially prolonged activated PTT.&nbsp; Mild thrombocytopenia (immune mediated) is typical.</p><p>Antiphospholipid antibodies disrupt the function of platelets and vascular endothelial cells to create a <strong>hypercoagulable state</strong>.&nbsp; For this reason, the initial presentation of APS is often an unprovoked arterial or venous thrombosis (eg, stroke, deep venous thrombosis).&nbsp; In pregnant patients with APS, persistent thrombosis of placental vessels causes pregnancy complications or <strong>recurrent pregnancy losses</strong>, as in this patient.</p><p>Although additional antibody testing is needed to confirm the diagnosis of APS in this patient, the best next step is to initiate <strong>anticoagulation</strong> to decrease her risk of thrombosis and pregnancy complications.&nbsp; In pregnant patients, the anticoagulant typically used is <strong>low-molecular-weight heparin</strong>, which is not associated with teratogenicity.</p><p><strong>(Choices A and B)</strong>&nbsp; Benzathine penicillin is used to treat syphilis, which is classically diagnosed when a screening test (eg, VDRL, a nontreponemal test) and a subsequent confirmatory test (eg, fluorescent treponemal antibody absorption [FTA-ABS], a treponemal test) are both positive.&nbsp; This patient&#39;s VDRL is likely a false-positive given her APS, and confirmatory testing with FTA-ABS (more specific than nontreponemal testing) is negative, making syphilis unlikely.&nbsp; Azithromycin is used to treat chlamydia, which is also unlikely in this low-risk patient (ie, age &gt;24, no prior sexually transmitted infections).</p><p><strong>(Choice D)</strong>&nbsp; Corticosteroids (eg, prednisone) can be used to treat <a href=\"4254\">systemic lupus erythematosus</a> (SLE), which is often associated with APS due to shared antibodies (eg, lupus anticoagulant).&nbsp; Although SLE can cause spontaneous abortion and thrombocytopenia, patients typically have additional renal and rheumatic disease (eg, lupus nephritis, arthritis).&nbsp; This patient&#39;s urinalysis shows no blood or protein, making SLE less likely.&nbsp; Corticosteroids are not used to treat APS.</p><p><strong>(Choice E)</strong>&nbsp; Warfarin is an anticoagulant commonly used for long-term management of APS; however, it is contraindicated in pregnancy due to teratogenicity.&nbsp; After delivery, this patient may be transitioned to warfarin.</p><p><strong>Educational objective:</strong><br>Antiphospholipid-antibody syndrome (APS) is a prothrombotic autoimmune disorder that can present with recurrent pregnancy losses, arterial or venous thrombosis, and mild thrombocytopenia.&nbsp; Patients with APS require anticoagulation (eg, low-molecular-weight heparin in pregnant patients) to decrease the risk of complications.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 15843,
            "topic": "Antiphospholipid syndrome",
            "titleId": 15843,
            "title": "Antiphospholipid syndrome",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Benzathine penicillin",
                    "choiceNumber": 1,
                    "correctTaken": 1145,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Benzathine penicillin and azithromycin",
                    "choiceNumber": 2,
                    "correctTaken": 117,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Low-molecular-weight heparin",
                    "choiceNumber": 3,
                    "correctTaken": 2994,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prednisone",
                    "choiceNumber": 4,
                    "correctTaken": 576,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Warfarin",
                    "choiceNumber": 5,
                    "correctTaken": 117,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26637701",
                    "mediaDataId": 0,
                    "title": "The antiphospholipid syndrome: still an enigma.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26637701",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 67,
            "othersAvgTimeSpent": 85,
            "notes": null,
            "peopleTaken": 5003,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 10964,
            "questionIndex": 12099,
            "questionText": "<p>A 25-year-old woman, gravida 2 para 1, at 33 weeks gestation comes to the emergency department due to intermittent contractions that began after intercourse.&nbsp; The contractions initially occurred every 10-15 minutes and lasted 1 or 2 minutes.&nbsp; The patient drank some water and tried to rest, but the contractions continued.&nbsp; She has no vaginal bleeding or leakage of fluid.&nbsp; Fetal movement is normal.&nbsp; At 12 weeks gestation, the patient had a urinary tract infection caused by group B <em>Streptococcus</em> that was treated with antibiotics.&nbsp; Prenatal care has otherwise been uncomplicated.&nbsp; The patient&#39;s prior pregnancy ended with a term vaginal delivery.&nbsp; Temperature is 36.7 C (98.1 F) and blood pressure is 100/70 mm Hg.&nbsp; Fetal heart rate tracing has a baseline of 150/min, moderate variability, and multiple accelerations.&nbsp; Tocodynamometry shows contractions every 5-8 minutes.&nbsp; On speculum examination, the cervix is visibly 3 cm dilated and there is no evidence of rupture of membranes.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"42620\" src=\"https://www.uworld.com/media/highresdefault/L68348.png\"  ></p><p>This patient at 33 weeks gestation has regular, painful contractions resulting in cervical dilation, findings consistent with <strong>preterm labor</strong> (ie, labor at &lt;37 weeks gestation).&nbsp; Risk factors include prior spontaneous preterm delivery, short interpregnancy interval (eg, &lt;6-18 months), and genitourinary tract infection (eg, group B S<em>treptococcus</em> [GBS], <em>Chlamydia trachomatis</em>).</p><p>Preterm labor management depends on gestational age.&nbsp; In patients at <strong>&lt;34 weeks gestation</strong>, management includes attempts to delay delivery and minimize neonatal morbidity and mortality associated with preterm delivery.&nbsp; These interventions include:</p><ul><li><p><strong>Antenatal corticosteroids</strong> (eg, <strong>intramuscular betamethasone</strong>) to decrease the risk of neonatal respiratory distress syndrome.&nbsp; Corticosteroids promote fetal pneumocyte development and induce fetal surfactant production (ie, <strong>fetal lung maturity</strong>).&nbsp; In addition, they decrease the risk of intraventricular hemorrhage, necrotizing enterocolitis, and overall neonatal morbidity and mortality.</p></li><li><p>Penicillin to prevent vertical transmission of GBS, which occurs more frequently at preterm gestations.</p></li><li><p>Nifedipine tocolysis (administered between 32 and 34 weeks gestation) to temporarily halt preterm contractions and delay delivery.</p></li></ul><p>In contrast, patients in preterm labor at 34-37 weeks gestation typically receive penicillin and expectant management only because the maternal risks (ie, adverse effects of tocolytic medications) outweigh the neonatal benefits.&nbsp; In addition, antenatal corticosteroids may be given, but its use at these gestational ages is not universal.</p><p><strong>(Choice A)</strong>&nbsp; Bed rest and pelvic rest do not decrease rates of preterm delivery.&nbsp; Instead, bed rest increases maternal risk for deep venous thrombosis and bone density loss and is not recommended.</p><p><strong>(Choice B)</strong>&nbsp; A <a href=\"1307\">cerclage</a> placed in the second trimester can prevent preterm delivery in patients with cervical insufficiency (ie, prior painless, second-trimester losses).&nbsp; However, uterine contractions and gestational age &gt;24 weeks are absolute contraindications for this procedure due to the increased risk of cervical injury.</p><p><strong>(Choice D)</strong>&nbsp; Antenatal magnesium sulfate infusion decreases the risk of cerebral palsy in very preterm neonates.&nbsp; However, because of unclear neonatal benefits at &#8805;32 weeks gestation and potential maternal risks (eg, respiratory depression, cardiac arrest) associated with magnesium toxicity, it is not typically administered for fetal neuroprotection after 32 weeks gestation.</p><p><strong>(Choice E)</strong>&nbsp; Patients with group B <em>Streptococcus</em> bacteriuria diagnosed during pregnancy, such as this patient, are considered persistently colonized and do not need rectovaginal culture.&nbsp; These patients require penicillin prophylaxis during labor.</p><p><strong>Educational objective:</strong><br>Intramuscular betamethasone, a corticosteroid, is indicated for patients at risk for preterm delivery at &lt;34 weeks gestation.&nbsp; Betamethasone stimulates fetal lung maturity and decreases the risk of neonatal respiratory distress syndrome, intraventricular hemorrhage, necrotizing enterocolitis, and overall morbidity and mortality associated with prematurity.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4239,
            "topic": "Preterm labor",
            "titleId": 4239,
            "title": "Preterm labor",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bed rest and pelvic rest",
                    "choiceNumber": 1,
                    "correctTaken": 2853,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cerclage placement",
                    "choiceNumber": 2,
                    "correctTaken": 867,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intramuscular betamethasone",
                    "choiceNumber": 3,
                    "correctTaken": 10232,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Magnesium sulfate infusion",
                    "choiceNumber": 4,
                    "correctTaken": 1228,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rectovaginal group B <em>Streptococcus</em> culture",
                    "choiceNumber": 5,
                    "correctTaken": 1438,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28321847",
                    "mediaDataId": 0,
                    "title": "Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28321847",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 132,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 16618,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 11055,
            "questionIndex": 12196,
            "questionText": "<p>A 33-year-old woman, gravida 7 para 6, at 39 weeks gestation undergoes induction of labor for new-onset hypertension.&nbsp; The patient became pregnant 5 months after her most recent delivery.&nbsp; She has a history of several lower uterine segment fibroids and has had significant pelvic pressure throughout this pregnancy.&nbsp; The patient&#39;s previous pregnancies ended in uncomplicated term vaginal deliveries.&nbsp; Blood pressure is 160/96 mm Hg.&nbsp; Prepregnancy BMI was 32 kg/m<font size=\"2\"><sup>2</sup></font>, and the patient gained 13.6 kg (30 lb) during the pregnancy.&nbsp; Fundal height is 43 cm.&nbsp; Approximately 22 hours after labor induction and after 2 hours of pushing, the fetal head delivers and retracts into the maternal perineum.&nbsp; Gentle traction fails to deliver the anterior fetal shoulder.&nbsp; Which of the following is the greatest risk factor for this patient&#39;s obstetric complication?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T81609\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Shoulder dystocia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>Failure of usual obstetric maneuvers to deliver fetal shoulders</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Fetal macrosomia</li><li>Maternal obesity</li><li>Excessive pregnancy weight gain</li><li>Gestational diabetes mellitus</li><li>Postterm pregnancy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Warning signs</strong></p></td><td><ul><li>Protracted labor</li><li>Retraction of fetal head into the perineum after delivery (turtle sign)</li></ul></td></tr></tbody></table></div><p>This patient with <strong>prolonged labor</strong> and retraction of the fetal head into the perineum after delivery (eg, <strong>turtle sign</strong>) likely has <strong>shoulder dystocia</strong>, or the <strong>inability to deliver the fetal shoulders</strong> with usual obstetric maneuvers.&nbsp; <a href=\"5890\">Shoulder dystocia</a> is an obstetric emergency due to the risk for neonatal <a href=\"2683\">brachial plexus injury</a>, clavicular and humeral fracture, and, if prolonged, hypoxic brain injury and death.</p><p>The greatest risk factor for shoulder dystocia is <strong>fetal macrosomia</strong>, defined as an estimated fetal weight &gt;4.5 kg (9 lb 14 oz).&nbsp; A common sign is <strong>uterine size greater than dates</strong>, as in this patient with a fundal height measuring 43 cm at 39 weeks gestation.</p><p>Other <strong>risk factors</strong> for shoulder dystocia are conditions that predispose to macrosomia, including postterm pregnancy, gestational diabetes mellitus, maternal obesity, and <strong>excessive maternal weight gain</strong>, as in this patient with a <a href=\"32799\">prepregnancy BMI</a> of 32 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; However, shoulder dystocia also frequently occurs in patients with no risk factors and can be difficult to predict.</p><p><strong>(Choice A)</strong>&nbsp; Postterm pregnancy (&#8805;42 weeks gestation) is a risk factor for shoulder dystocia due to increased birth weight.&nbsp; This patient&#39;s pregnancy is at term.</p><p><strong>(Choice B)</strong>&nbsp; Hypertension, which compromises placental perfusion and fetal oxygenation, is a risk factor for fetal growth restriction rather than fetal macrosomia; consequently, it is not associated with shoulder dystocia.</p><p><strong>(Choice D)</strong>&nbsp; A short interpregnancy interval (eg, &lt;6-18 months from delivery to next conception) is a risk factor for uterine rupture due to myometrial weakness.&nbsp; In contrast to the turtle sign (ie, head retracting tightly against the perineum), uterine rupture typically leads to <a href=\"28624\">loss of fetal station</a> while the infant is in utero; patients typically have acute abdominal pain and a new abdominal mass (ie, fetal body delivering into the abdomen).</p><p><strong>(Choice E)</strong>&nbsp; Bulky lower uterine segment fibroids may prolong the second stage of labor, but they are unlikely to obstruct delivery of the fetal shoulders if the head can be delivered.&nbsp; This is because the surrounding myometrium can stretch to accommodate fetal size.&nbsp; In contrast, the pubic bone is hard and unyielding.</p><p><strong>Educational objective:</strong><br>Shoulder dystocia is the inability to deliver the fetal shoulders with usual obstetric maneuvers.&nbsp; Warning signs include a prolonged first or second stage of labor and retraction of the fetal head into the perineum after it delivers (eg, turtle sign).&nbsp; Maternal obesity, which predisposes to fetal macrosomia, is an important risk factor.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14045,
            "topic": "Shoulder dystocia",
            "titleId": 14045,
            "title": "Shoulder dystocia",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Gestational age",
                    "choiceNumber": 1,
                    "correctTaken": 708,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypertension",
                    "choiceNumber": 2,
                    "correctTaken": 597,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maternal weight",
                    "choiceNumber": 3,
                    "correctTaken": 8299,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Short interpregnancy interval",
                    "choiceNumber": 4,
                    "correctTaken": 2436,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine fibroids",
                    "choiceNumber": 5,
                    "correctTaken": 3916,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "32667171",
                    "mediaDataId": 0,
                    "title": "Shoulder dystocia: managing an obstetric emergency.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/32667171",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 153,
            "othersAvgTimeSpent": 59,
            "notes": null,
            "peopleTaken": 15956,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 52,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 14283,
            "questionIndex": 15691,
            "questionText": "<p>A 30-year-old woman, gravida 3 para 2, at 37 weeks gestation comes to labor and delivery for regular, painful contractions.&nbsp; The contractions started an hour ago and are now 3-4 minutes apart.&nbsp; The patient has had no leakage of fluid or vaginal bleeding.&nbsp; Fetal movement has been normal.&nbsp; At her prenatal visit last week, examination showed a cephalic fetal presentation; group B <em>Streptococcus</em> rectovaginal culture was negative.&nbsp; Today, temperature is 36.7 C (98.1 F), blood pressure is 110/80 mm Hg, and pulse is 88/min.&nbsp; Fetal heart rate tracing shows moderate variability, multiple accelerations, and no decelerations.&nbsp; Tocodynamometer demonstrates contractions every 3-4 minutes.&nbsp; The abdomen is nontender when contractions subside.&nbsp; On digital cervical examination, the cervix is 4 cm dilated and 90% effaced, and a taut, bulging bag is palpable with no presenting fetal part.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"21932\" src=\"https://www.uworld.com/media/highresdefault/L47891.jpg\"  ></p><p><strong>Digital cervical examination</strong> is used to determine cervical dilation and fetal presentation (ie, the fetal part [eg, head, buttocks, umbilical cord] directly overlying the pelvic inlet), information required for labor management.&nbsp; Fetal presentation is variable and can change from week to week, even in term pregnancies.&nbsp; This patient at 37 weeks gestation is laboring and has a taut, bulging amniotic bag with <strong>no palpable presenting fetal part</strong> on cervical examination.</p><p>Digital cervical examination is usually adequate for determining fetal presentation (more so than Leopold maneuvers [ie, abdominal palpation]).&nbsp; However, it may be insufficient in patients with a bulging bag, which may be a normal finding (when uterine contractions tense the amniotic sac).&nbsp; If fetal presentation is indeterminate on cervical examination (due to a bulging amniotic sac or high fetal station), <strong>transabdominal ultrasonography</strong> is performed to confirm presentation, which is necessary to <strong>determine the route of delivery</strong>.</p><p>Patients with cephalic fetal presentation can be managed expectantly in anticipation of vaginal delivery.&nbsp; Conversely, breech or other noncephalic (eg, <a href=\"12167\">transverse</a>) fetal presentations should be managed by cesarean delivery to avoid the increased risk for neonatal death associated with breech vaginal delivery <strong>(Choice B)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Although amniotomy, or iatrogenic rupture of membranes, is often performed with labor inductions, it is often unnecessary for patients in spontaneous labor because it does not decrease the duration of the first stage of labor or reduce cesarean delivery rates.&nbsp; When there is no palpable presenting fetal part, transabdominal ultrasonography must be performed before amniotomy to avoid umbilical cord prolapse in patients with a <a href=\"21933\">funic</a> (ie, cord-first) presentation.</p><p><strong>(Choice C)</strong>&nbsp; An <a href=\"1183\">external cephalic version</a> is performed to convert noncephalic presentations to cephalic.&nbsp; Fetal presentation is determined via transabdominal ultrasonography prior to this procedure.</p><p><strong>(Choice D)</strong>&nbsp; Terbutaline, a beta-2 adrenergic agonist tocolytic, stops contractions by causing uterine relaxation.&nbsp; Terbutaline should not be administered without knowing the fetal presentation.&nbsp; If the fetus is cephalic, then terbutaline tocolysis will delay vaginal delivery.</p><p><strong>Educational objective:</strong><br>If fetal presentation (eg, cephalic, breech) is uncertain on digital cervical examination, transabdominal ultrasonography should be performed to confirm fetal presentation and determine the safest route of delivery.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23791,
            "topic": "Labor management",
            "titleId": 23791,
            "title": "Labor management",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amniotomy",
                    "choiceNumber": 1,
                    "correctTaken": 5170,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cesarean delivery",
                    "choiceNumber": 2,
                    "correctTaken": 1778,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "External cephalic version",
                    "choiceNumber": 3,
                    "correctTaken": 584,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Terbutaline tocolysis",
                    "choiceNumber": 4,
                    "correctTaken": 593,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transabdominal ultrasonography",
                    "choiceNumber": 5,
                    "correctTaken": 5508,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30045211",
                    "mediaDataId": 0,
                    "title": "ACOG committee opinion no. 745: mode of term singleton breech delivery.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30045211",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26196961",
                    "mediaDataId": 0,
                    "title": "Planned caesarean section for term breech delivery.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26196961",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 111,
            "othersAvgTimeSpent": 60,
            "notes": null,
            "peopleTaken": 13633,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 40,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 14836,
            "questionIndex": 16259,
            "questionText": "<p>A 33-year-old woman, gravida 2 para 1, at 29 weeks gestation comes to the emergency department due to right-sided abdominal pain.&nbsp; The pain developed yesterday morning, initially resolved with acetaminophen, but has become increasingly severe over the past few hours.&nbsp; The patient now has continuous nausea and has vomited twice.&nbsp; She has not had a bowel movement in 2 days.&nbsp; She has had uterine contractions, but no vaginal bleeding or leakage of fluid.&nbsp; The patient has no chronic medical conditions, and her only surgery was a cesarean delivery for failure to progress.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 130/80 mm Hg, and pulse is 118/min.&nbsp; BMI is 30 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Fetal heart rate monitoring shows a baseline of 160/min and no decelerations.&nbsp; Tocodynamometry shows regular uterine contractions every 1-2 minutes.&nbsp; The abdomen is tender to palpation, but has no rebound or guarding.&nbsp; The uterus has fundal tenderness and an associated firm, tender mass.&nbsp; On pelvic examination, the cervix is closed.&nbsp; Leukocyte count is 19,000/mm<font size=\"2\"><sup>3</sup></font>.&nbsp; Urinalysis is normal.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient at 29 weeks gestation has acute-onset, right-sided abdominal pain.&nbsp; <strong>Abdominal pain in pregnancy</strong> can have a variety of etiologies from both benign and life-threatening causes.&nbsp; This patient with fundal tenderness and a firm, tender mass most likely has a <strong>degenerating uterine leiomyoma</strong>.</p><p>Leiomyomata uteri (fibroids) are benign myometrial tumors that can grow rapidly during pregnancy due to elevated estrogen and progesterone levels.&nbsp; However, because myometrial blood flow shifts toward the developing fetus and placenta during pregnancy, fibroids can outgrow their blood supply, leading to fibroid infarction and necrosis.&nbsp; Therefore, degenerating fibroids cause <strong>uterine contractions</strong> (due to prostaglandin release) and <strong>fundal tenderness</strong>, a <strong>tender mass</strong>, and leukocytosis (due to inflammatory cytokine release), as seen in this patient.</p><p>Diagnosis is confirmed by ultrasound, and the condition is <strong>conservatively managed</strong> with acute pain control (eg, indomethacin for patients &lt;32 weeks gestation).</p><p><strong>(Choice A)</strong>&nbsp; Pregnant women are more likely to develop cholelithiasis and acute cholecystitis due to elevated estrogen levels.&nbsp; Patients can have right-sided abdominal pain, vomiting, and leukocytosis; however, acute cholecystitis is unlikely to cause a firm, tender mass with fundal tenderness, making this diagnosis less likely.</p><p><strong>(Choice B)</strong>&nbsp; Acute diverticulitis can cause abdominal pain and leukocytosis; however, patients typically have pain in the left lower, rather than the right upper, quadrant due to sigmoid colon involvement.&nbsp; In addition, this patient has fundal tenderness with an associated firm mass, making acute diverticulitis less likely.</p><p><strong>(Choice C)</strong>&nbsp; Acute pyelonephritis can cause preterm contractions and leukocytosis.&nbsp; In contrast to this patient with fibroid degeneration, those with pyelonephritis have flank pain, no associated abdominal mass, and an abnormal urinalysis (eg, nitrites, leukocyte esterase).</p><p><strong>(Choice E)</strong>&nbsp; Uterine rupture, which can occur in patients with prior cesarean delivery, can present with acute abdominal pain and a palpable mass (ie, <a href=\"1057\">fetal parts</a>).&nbsp; However, patients typically have fetal heart rate decelerations and an acute abdomen (eg, rebound, guarding), findings not seen in this patient.</p><p><strong>Educational objective:</strong><br>Leiomyomata uteri are more likely to degenerate during pregnancy because myometrial blood flow shifts toward the developing fetus and placenta.&nbsp; An infarcted, degenerating uterine fibroid can cause severe abdominal pain; uterine tenderness; a palpable, firm, and tender mass; and signs of inflammation (eg, leukocytosis).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 3143,
            "topic": "Uterine fibroids",
            "titleId": 3143,
            "title": "Uterine fibroids",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute cholecystitis",
                    "choiceNumber": 1,
                    "correctTaken": 3976,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Acute diverticulitis",
                    "choiceNumber": 2,
                    "correctTaken": 1559,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Acute pyelonephritis",
                    "choiceNumber": 3,
                    "correctTaken": 601,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine fibroid degeneration",
                    "choiceNumber": 4,
                    "correctTaken": 7784,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine rupture",
                    "choiceNumber": 5,
                    "correctTaken": 2939,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20508779",
                    "mediaDataId": 0,
                    "title": "Contemporary management of fibroids in pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20508779",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26557577",
                    "mediaDataId": 0,
                    "title": "Case series: pregnancy outcome in patients with uterine fibroids.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26557577",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 175,
            "othersAvgTimeSpent": 95,
            "notes": null,
            "peopleTaken": 16859,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 46,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 13211,
            "questionIndex": 14566,
            "questionText": "<p>A 31-year-old woman, gravida 2 para 1, at 10 weeks gestation comes to the office for an initial prenatal visit.&nbsp; The patient has had no vaginal bleeding or cramping.&nbsp; Her first pregnancy was uncomplicated and ended with a term spontaneous vaginal delivery.&nbsp; She has no chronic medical conditions and has had no previous surgeries.&nbsp; The patient takes a daily prenatal vitamin and does not use tobacco, alcohol, or illicit drugs.&nbsp; Blood pressure is 120/70 mm Hg and pulse is 68/min.&nbsp; BMI is 24 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The uterine fundus is palpated above the pubic symphysis.&nbsp; Pelvic ultrasound shows 2 viable intrauterine gestations, a single fundal placenta, and a thin intertwin membrane that meets the placenta at a 90-degree angle.&nbsp; This patient is at highest risk for which of the following complications?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"12246\" src=\"https://www.uworld.com/media/L36767.jpg\" ></p><p>Twin gestations are at increased risk for many pregnancy complications.&nbsp; This risk is further stratified based on the chorionicity (number of placentas) and amnionicity (number of amniotic sacs) of the gestation.&nbsp; This patient has <strong>monochorionic diamniotic twins</strong> (1 placenta, 2 amniotic sacs) based on 2 embryos, a <strong>single placenta</strong>, and a <strong>thin intertwin membrane</strong> (composed of 2 amniotic sacs) that meets the placenta at a 90-degree angle (<a href=\"16506\">&#x22;T sign&#x22;</a>).&nbsp; In patients who appear to have a single placenta, the base shape of the intertwin membrane distinguishes between a monochorionic (&#x22;T sign&#x22;) and fused dichorionic (<a href=\"16507\">&#x22;lambda sign&#x22;</a>) gestation.</p><p><strong>Monochorionic twins</strong> are at risk for <strong>twin-twin transfusion syndrome (TTTS)</strong>, a complication that can result in heart failure and fetal/neonatal mortality in both twins.&nbsp; In TTTS, <strong>unbalanced arteriovenous anastomoses</strong> are present between the <strong>shared placental vessels</strong> that supply the twins.&nbsp; Because of these anastomoses, blood from the placental arteries (high resistance/pressure) of one twin (donor) is shunted into the placental veins (low resistance/pressure) of the other twin (recipient).&nbsp; The shunting of blood away from the donor twin causes anemia that leads to renal failure, oligohydramnios, low-output heart failure, and fetal growth restriction.&nbsp; In contrast, the shunting of blood toward the recipient twin causes polycythemia, which leads to polyhydramnios, cardiomegaly, high-output heart failure, and hydrops fetalis.&nbsp; Both twins are at risk for intrauterine and neonatal death.</p><p>Mild TTTS is expectantly managed with serial ultrasounds to evaluate for worsening clinical features.&nbsp; Moderate-to-severe cases are treated with laser coagulation of the placental anastomoses.</p><p><strong>(Choices A and B)</strong>&nbsp; In monozygotic twins, placentation type is determined by timing of the twinning.&nbsp; Twinning that occurs shortly after fertilization yields a dichorionic diamniotic gestation.&nbsp; In contrast, the incomplete division (ie, fission) that can lead to conjoined twins occurs later in development and yields a monochorionic monoamniotic gestation.&nbsp; Because the twins are in the same sac, monochorionic monoamniotic gestations can be complicated by <a href=\"16508\">cord entanglement</a>.&nbsp; This patient has diamniotic twins.</p><p><strong>(Choice C)</strong>&nbsp; Risk factors for placenta accreta, implantation of the placenta directly into the myometrium, include placenta previa and prior uterine surgery (eg, cesarean delivery, myomectomy).</p><p><strong>(Choice D)</strong>&nbsp; Twins are at increased risk of placenta previa (placental tissue that covers the internal cervical os); however, this patient has a fundal placenta, making this complication unlikely.</p><p><strong>Educational objective:</strong><br>Monochorionic twin gestations can be complicated by twin-twin transfusion syndrome, a potentially fatal condition that results from unbalanced vascular anastomoses between the vessels supplying the umbilical cords of each twin.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 12216,
            "topic": "Multiple gestation",
            "titleId": 12216,
            "title": "Multiple gestation",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Conjoined twins",
                    "choiceNumber": 1,
                    "correctTaken": 283,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cord entanglement",
                    "choiceNumber": 2,
                    "correctTaken": 1691,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Placenta accreta",
                    "choiceNumber": 3,
                    "correctTaken": 364,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Placenta previa",
                    "choiceNumber": 4,
                    "correctTaken": 763,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Twin-twin transfusion syndrome",
                    "choiceNumber": 5,
                    "correctTaken": 13504,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21308842",
                    "mediaDataId": 0,
                    "title": "First-trimester ultrasound determination of chorionicity in twin pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21308842",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29122542",
                    "mediaDataId": 0,
                    "title": "Twin-twin transfusion syndrome—what we have learned from clinical trials.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29122542",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26165181",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of twin-twin transfusion syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26165181",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23006773",
                    "mediaDataId": 0,
                    "title": "A systematic approach to the differential diagnosis and management of the complications of monochorionic twin pregnancies.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23006773",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 47,
            "othersAvgTimeSpent": 52,
            "notes": null,
            "peopleTaken": 16605,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 81,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 14007,
            "questionIndex": 15409,
            "questionText": "<p>A 22-year-old woman, gravida 1 para 0, at 36 weeks gestation comes to the office for a routine prenatal visit.&nbsp; The patient has had no contractions, vaginal bleeding, or leakage of fluid.&nbsp; Fetal movement is normal.&nbsp; The patient has a history of genital herpes simplex virus but has not had an outbreak in several years.&nbsp; She has had no vulvar pain or pruritus and has not noticed any vulvar lesions.&nbsp; Her pregnancy has otherwise been uncomplicated, and her only medication is a daily prenatal vitamin.&nbsp; Vital signs are normal.&nbsp; Fetal heart rate is 145/min.&nbsp; Fundal height is 36 cm.&nbsp; On pelvic examination, no lesions are noted on the vulva, vagina, or cervix.&nbsp; The remainder of the physical examination is unremarkable.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"14063\" src=\"https://www.uworld.com/media/L32500.png\" ></p><p>This patient has a history of <strong>genital herpes simplex virus (HSV) infection</strong> with no recent outbreaks.&nbsp; During most of pregnancy, patients with a history of HSV infection typically require no additional management compared with uninfected patients.&nbsp; However, beginning at <strong>36 weeks gestation until delivery</strong>, pregnant women with a history of genital HSV receive <strong>antiviral prophylaxis</strong> (eg, acyclovir, valacyclovir) regardless of symptoms <strong>(Choices B and C)</strong>.</p><p>This management is recommended because active HSV at delivery increases the risk of vertical transmission due to direct neonatal contact with viral particles shed from the infected vulva, vagina, cervix, or buttock.&nbsp; Vertical transmission of HSV at delivery can cause neonatal meningoencephalitis or sepsis, which often results in long-term sequelae (eg, blindness, neurocognitive disability, persistent seizures).</p><p>HSV prophylaxis <strong>reduces asymptomatic</strong> viral <strong>shedding and outbreak recurrences</strong>; patients with no prodromal symptoms or active lesions (indicating low viral shedding) have a <strong>decreased risk of vertical transmission</strong>.&nbsp; In asymptomatic patients on antiviral prophylaxis, vaginal delivery is safe and recommended.&nbsp; In contrast, patients with prodromal symptoms or active lesions at delivery are at risk of neonatal transmission and require a cesarean delivery <strong>(Choice D)</strong>.</p><p><strong>(Choice E)</strong>&nbsp; Induction of labor is indicated in patients with an obstetric indication for delivery (eg, hypertension, gestational diabetes mellitus).&nbsp; Induction of labor does not reduce the risk of neonatal HSV and is therefore not indicated.</p><p><strong>Educational objective:</strong><br>Women with herpes simplex virus receive antiviral prophylaxis from 36 weeks gestation until delivery to decrease the risk of active lesions at delivery.&nbsp; Patients with active lesions during delivery require cesarean delivery to help prevent vertical transmission and neonatal infection; in contrast, those with no lesions can undergo vaginal delivery.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 11819,
            "topic": "HSV infection",
            "titleId": 11819,
            "title": "HSV infection",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administer acyclovir suppressive therapy until delivery",
                    "choiceNumber": 1,
                    "correctTaken": 6798,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Continue routine prenatal care only",
                    "choiceNumber": 2,
                    "correctTaken": 4888,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Initiate acyclovir therapy only if lesions develop",
                    "choiceNumber": 3,
                    "correctTaken": 4062,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Schedule cesarean delivery at 39 weeks gestation",
                    "choiceNumber": 4,
                    "correctTaken": 826,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Schedule induction of labor at 37 weeks gestation",
                    "choiceNumber": 5,
                    "correctTaken": 137,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22566740",
                    "mediaDataId": 0,
                    "title": "Herpes simplex virus infection in pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22566740",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25459782",
                    "mediaDataId": 0,
                    "title": "Preventing herpes simplex virus in the newborn.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25459782",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27281837",
                    "mediaDataId": 0,
                    "title": "Genital herpes: a review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27281837",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 136,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 16711,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 41,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 14279,
            "questionIndex": 15687,
            "questionText": "<p>A 23-year-old woman, gravida 1 para 0, at 41 weeks gestation is admitted to labor and delivery for contractions over the past 3 hours.&nbsp; The patient has no chronic medical conditions.&nbsp; She had an elevated 1-hour glucose challenge test but normal 3-hour glucose tolerance test at 28 weeks gestation.&nbsp; The patient receives epidural analgesia immediately upon admission and has spontaneous rupture of membranes 2 hours after admission.&nbsp; An intrauterine pressure catheter is placed for variable decelerations, which resolve with an amnioinfusion.&nbsp; Her cervical examinations are shown below:</p><p><img draggable=\"false\" id=\"21901\" src=\"https://www.uworld.com/media/U46741.jpg\" ></p><p>Current temperature is 36.7 C (98 F).&nbsp; Fetal heart rate tracing shows a baseline of 140/min, moderate variability, and multiple accelerations.&nbsp; Intrauterine pressure catheter shows an average of 200 Montevideo units every 10 minutes for the last 4 hours.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"21902\" src=\"https://www.uworld.com/media/L46741.jpg\" ></p><p>The active phase of labor (6-10 cm cervical dilation) has an expected, predictable rate of cervical dilation of &#8805;1 cm every 2 hours.&nbsp; This patient&#39;s labor curve shows she dilated from 5 cm to 7 cm in the first 2 hours, crossing from the latent phase into the active phase.&nbsp; Once in the active phase, she dilated from 7 cm to 8 cm in 2 hours (ie, an appropriate rate of dilation of 1 cm/2 hrs).</p><p>However, for the past <strong>4 hours</strong> her <strong>cervix has been unchanged</strong> (8 cm) <strong>despite adequate contractions</strong> (ie, &#8805;200 Montevideo units averaged over 10 minutes), which is consistent with <strong>active phase arrest</strong>.&nbsp; Active phase arrest is also defined as no cervical change in &#8805;6 hours with inadequate contractions.&nbsp; This patient&#39;s active phase arrest is likely due to her late-term gestation (&#8805;41 weeks) and possible fetal macrosomia (eg, abnormal 1-hour glucose challenge test), which contribute to <strong>cephalopelvic disproportion</strong>, a common cause of labor arrest.</p><p>In patients with active phase arrest, the best next step in management is <strong>cesarean delivery</strong> because no further cervical dilation is expected and continuing current management increases maternal-fetal morbidity (eg, intra-amniotic infection, fetal hypoxemia) <strong>(Choice B)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Prostaglandin is used for cervical ripening (softening and thinning of the cervix) in early labor induction.&nbsp; It is not used to augment active labor.</p><p><strong>(Choice C)</strong>&nbsp; An operative vaginal delivery (eg, vacuum-assisted vaginal delivery) is performed during the second stage of labor (10 cm dilation until fetal delivery) to expedite delivery for category III tracings or maternal exhaustion.&nbsp; This patient is 8 cm dilated.</p><p><strong>(Choice D)</strong>&nbsp; A fetal scalp electrode is an internal device placed after rupture of membranes when external monitoring cannot reliably measure fetal heart rate (eg, maternal obesity).&nbsp; The fetal heart rate tracing is category I (normal).</p><p><strong>(Choice F)</strong>&nbsp; Oxytocin is a uterotonic used to augment labor (by increasing the frequency and force of contractions) if contractions are inadequate (&lt;200 Montevideo units).&nbsp; Oxytocin augmentation is used in protracted labor (ie, cervical dilation rate &lt;1 cm/2 hours but not arrested).</p><p><strong>Educational objective:</strong><br>Active phase arrest is no cervical change in &#8805;4 hours with adequate contractions (&#8805;200 Montevideo units averaged over 10 minutes), or no change in &#8805;6 hours with inadequate contractions.&nbsp; Labor arrest is managed by cesarean delivery.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23791,
            "topic": "Labor management",
            "titleId": 23791,
            "title": "Labor management",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administer prostaglandin",
                    "choiceNumber": 1,
                    "correctTaken": 1008,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Continue current management",
                    "choiceNumber": 2,
                    "correctTaken": 1711,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform operative vaginal delivery",
                    "choiceNumber": 3,
                    "correctTaken": 1608,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Place fetal scalp electrode",
                    "choiceNumber": 4,
                    "correctTaken": 156,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Proceed to cesarean delivery",
                    "choiceNumber": 5,
                    "correctTaken": 7105,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start oxytocin infusion",
                    "choiceNumber": 6,
                    "correctTaken": 5111,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21099592",
                    "mediaDataId": 0,
                    "title": "Contemporary patterns of spontaneous labor with normal neonatal outcomes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21099592",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23090537",
                    "mediaDataId": 0,
                    "title": "Preventing the first cesarean delivery: summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, and American College of Obstetricians and Gynecologists Workshop.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23090537",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 140,
            "othersAvgTimeSpent": 73,
            "notes": null,
            "peopleTaken": 16699,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 43,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 14210,
            "questionIndex": 15618,
            "questionText": "<p>A 28-year-old woman, gravida 2 para 1, at 38 weeks gestation is admitted to labor and delivery due to prelabor rupture of membranes.&nbsp; Clear amniotic fluid has been leaking continuously for the last 2 hours.&nbsp; The patient has irregular, nonpainful contractions and no vaginal bleeding.&nbsp; Prenatal care during this pregnancy has been uncomplicated, and the patient&#39;s previous pregnancy ended in a term vaginal delivery.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 120/70 mm Hg, and pulse is 78/min.&nbsp; The cervix is 3 cm dilated and 50% effaced with the fetal vertex at &#8722;2 station.&nbsp; Fetal heart tracing on admission is as seen in the <a href=\"20768\">exhibit</a>.&nbsp; After an oxytocin infusion is started for labor augmentation, the patient begins to have regular, painful contractions that require epidural anesthesia.&nbsp; Two hours later, temperature is 37.2 C (99 F), blood pressure is 120/80 mm Hg, and pulse is 80/min.&nbsp; On repeat examination the cervix is now 7 cm dilated, 100% effaced, with the fetal vertex at +1 station; and current fetal heart tracing is as seen in the <a href=\"18696\">exhibit</a>.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s fetal heart rate tracing has recurrent <strong>late decelerations</strong> (ie, late decelerations in &#8805;50% of contractions).&nbsp; Late fetal decelerations are a sign of uteroplacental insufficiency and impending <strong>fetal hypoxemia and acidemia</strong>.&nbsp; This patient&#39;s fetal decelerations are most likely due to <strong>uterine tachysystole</strong>, defined as &gt;5 contractions/10 min.&nbsp; Uterine contractions temporarily <strong>interrupt intervillous blood flow</strong>; excessively frequent contractions, as in this patient, may cause fetal compromise as a result of decreased uteroplacental blood flow during contractions and <strong>inadequate recovery time</strong> (resumption of blood flow) between contractions.</p><p>Although <a href=\"18282\">uterine tachysystole</a> can occur in spontaneous labor, there is an increased risk with induced or augmented labor (eg, uterotonic agents).&nbsp; Uterine tachysystole is managed with supportive measures (eg, lateral maternal repositioning, tocolysis) and <strong>discontinuation of uterotonic agents</strong> (eg, oxytocin) until the excessive uterine activity and resulting fetal decelerations resolve <strong>(Choice B)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Broad-spectrum antibiotics are administered in the setting of intrauterine infection (chorioamnionitis), which causes maternal fever and fetal tachycardia (baseline &gt;160/min); intrauterine infection is not seen in this patient.</p><p><strong>(Choice C)</strong>&nbsp; Epidural anesthesia may cause maternal hypotension, with resulting fetal decelerations and loss of variability.&nbsp; However, decreasing the epidural infusion rate would not resolve this patient&#39;s tachysystole.&nbsp; In addition, this patient is normotensive.</p><p><strong>(Choice E)</strong>&nbsp; Amnioinfusion increases intrauterine fluid volume and is initiated to improve variable fetal decelerations caused by cord compression (eg, oligohydramnios) in labor.&nbsp; It is not indicated for late fetal decelerations or tachysystole.</p><p><strong>Educational objective:</strong><br>Uterine tachysystole, or &gt;5 contractions/10 min, may cause fetal compromise (eg, hypoxemia, acidemia) due to interruption of intervillous blood flow and inadequate recovery time between contractions (eg, late decelerations).&nbsp; Management is with supportive measures and discontinuation of uterotonic agents (eg, oxytocin).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 22374,
            "topic": "Fetal heart tracing",
            "titleId": 22374,
            "title": "Fetal heart tracing",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administer broad-spectrum antibiotics",
                    "choiceNumber": 1,
                    "correctTaken": 105,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Continue current management",
                    "choiceNumber": 2,
                    "correctTaken": 1185,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decrease epidural anesthesia",
                    "choiceNumber": 3,
                    "correctTaken": 205,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinue uterotonic agents",
                    "choiceNumber": 4,
                    "correctTaken": 2732,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Initiate amnioinfusion",
                    "choiceNumber": 5,
                    "correctTaken": 751,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "161",
                    "mediaDataId": 0,
                    "title": "Fetal heart rate tracings",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27074823",
                    "mediaDataId": 0,
                    "title": "Uterine tachysystole in spontaneous labor at term.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27074823",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27816973",
                    "mediaDataId": 0,
                    "title": "Tachysystole following cervical ripening and induction of labor is not associated with adverse outcomes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27816973",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29016497",
                    "mediaDataId": 0,
                    "title": "Discontinuing oxytocin infusion in the active phase of labor: a systematic review and meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29016497",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29971813",
                    "mediaDataId": 0,
                    "title": "Acute tocolysis for uterine tachysystole or suspected fetal distress.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29971813",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 95,
            "othersAvgTimeSpent": 107,
            "notes": null,
            "peopleTaken": 5052,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 54,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 21845,
            "questionIndex": 105694,
            "questionText": "<p>A 26-year-old woman, gravida 2 para 1, comes to the office for an initial prenatal visit.&nbsp; She has had daily nausea and multiple food aversions but no vomiting or weight loss.&nbsp; The patient has no known medical conditions and takes no daily medications or prenatal vitamins.&nbsp; Her last pregnancy was 2 years ago, and she did not receive prenatal care.&nbsp; That pregnancy ended at term with a vaginal delivery of an infant weighing 4.6 kg (10.1 lb).&nbsp; Since the delivery, the patient has had some irregular menstrual bleeding and is unsure of her last menstrual period.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 132/84 mm Hg, and pulse is 78/min.&nbsp; BMI is 30 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Pelvic examination shows an enlarged, nontender uterus.&nbsp; Pelvic ultrasound reveals a 10-week intrauterine pregnancy with normal cardiac activity.&nbsp; Urinalysis is negative for protein, glucose, and ketones.&nbsp; In addition to ordering routine prenatal laboratory tests, which of the following is the best next step in management of this patient at this visit?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"14118\" src=\"https://www.uworld.com/media/highresdefault/L37867.jpg\"  ></p><p><strong>Gestational diabetes mellitus (GDM)</strong> is common and is associated with obstetric complications (eg, stillbirth, shoulder dystocia, preeclampsia).&nbsp; Therefore, all pregnant patients require <strong>GDM screening</strong> with a 1-hr glucose challenge test (GCT); this is usually performed at 24-28 weeks gestation when maternal insulin resistance increases physiologically due to placental release of diabetogenic hormones.</p><p>However, <strong>early screening</strong> for undiagnosed pregestational diabetes mellitus (eg, GCT at the initial prenatal visit) is indicated for <strong>high-risk</strong> patients with <strong>obesity plus &#8805;1 of the following</strong>:</p><ul><li>Prior GDM</li><li><strong>Prior macrosomic infant</strong> (birth weight &#8805;4 kg [8.8 lb])</li><li>Family history of type 2 DM (first-degree relative)</li><li><strong>Polycystic ovary syndrome</strong> (as suggested by this patient&#39;s irregular, anovulatory menstrual cycles)</li><li>Maternal age &#8805;40</li></ul><p>Identifying <strong>undiagnosed pregestational diabetes mellitus</strong> during early pregnancy can help optimize glucose control and decrease the risk of pregnancy complications.&nbsp; Even if the early screening test is normal, a repeat 1-hr GCT is performed at 24-28 weeks gestation.</p><p><strong>(Choice A)</strong>&nbsp; The tetanus-diphtheria-pertussis (Tdap) vaccine protects against pertussis, which has high infant morbidity and mortality.&nbsp; Maternal vaccination occurs at 27-36 weeks gestation to maximize transplacental antibody transfer for fetal protection.&nbsp; Early (eg, initial prenatal visit) or late maternal vaccination results in suboptimal fetal protection.</p><p><strong>(Choice B)</strong>&nbsp; Serial quantitative &#946;-hCG levels are obtained for pregnancies of unknown location (ie, positive hCG but no visible intrauterine or extrauterine pregnancy); abnormally rising levels suggest an abnormal or ectopic pregnancy.&nbsp; This patient has a 10-week intrauterine gestation on ultrasound; additional &#946;-hCG levels would not change management.</p><p><strong>(Choice C)</strong>&nbsp; Progesterone, initially secreted by the corpus luteum, maintains early pregnancy.&nbsp; Low progesterone levels may occur due to corpus luteum removal (eg, oophorectomy for ovarian torsion), abnormal intrauterine pregnancy, or ectopic pregnancy.&nbsp; Progesterone levels, whether they are low or not, would not change management in a normal intrauterine pregnancy.</p><p><strong>(Choice D)</strong>&nbsp; Nausea and vomiting are common during pregnancy.&nbsp; In women with mild nausea and vomiting (as in this patient with nausea without vomiting), changes in vital signs, or weight loss, the initial approach is conservative treatment with dietary changes or vitamin B<font size=\"2\"><sub>6</sub></font> (pyridoxine) prior to prescribing antiemetic medications.</p><p><strong>Educational objective:</strong><br>All pregnant patients require gestational diabetes mellitus screening at 24-28 weeks gestation.&nbsp; However, earlier screening (eg, at the initial prenatal visit) is recommended in patients with obesity and additional risk factors for undiagnosed pregestational diabetes mellitus (eg, prior macrosomic infant, polycystic ovary syndrome).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 18237,
            "topic": "Gestational diabetes",
            "titleId": 18237,
            "title": "Gestational diabetes",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administer the tetanus-diphtheria-pertussis (Tdap) vaccination",
                    "choiceNumber": 1,
                    "correctTaken": 3458,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain a quantitative &#946;-hCG level",
                    "choiceNumber": 2,
                    "correctTaken": 2344,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain a serum progesterone level",
                    "choiceNumber": 3,
                    "correctTaken": 368,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe antiemetic medication",
                    "choiceNumber": 4,
                    "correctTaken": 1569,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Screen for diabetes mellitus",
                    "choiceNumber": 5,
                    "correctTaken": 8874,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24194617",
                    "mediaDataId": 0,
                    "title": "Diabetes and pregnancy: an Endocrine Society clinical practice guideline.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24194617",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 172,
            "othersAvgTimeSpent": 71,
            "notes": null,
            "peopleTaken": 16613,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 53,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 14610,
            "questionIndex": 16024,
            "questionText": "<p>A 32-year-old woman, gravida 1 para 1, is evaluated on the postpartum floor due to fluid leakage from her incision.&nbsp; Two days ago, the patient underwent a cesarean delivery after failed induction of labor and intraamniotic infection.&nbsp; She had her incision bandage removed this morning with minimal clear fluid on the bandage.&nbsp; The patient then walked to the nursery, where she noticed that serosanguineous fluid had stained her hospital gown.&nbsp; Fluid has continued to drain from her abdominal incision.&nbsp; Temperature is 37.2 C (99 F).&nbsp; BMI is 35 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The uterus is palpable below the umbilicus and has no fundal tenderness.&nbsp; The Pfannenstiel incision has a 4-cm defect at the right corner that is draining scant serosanguineous fluid.&nbsp; There is no surrounding erythema or induration.&nbsp; The subcutaneous tissue has no areas of necrosis or crepitus, and the rectus fascia is intact.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"22466\" src=\"https://www.uworld.com/media/L48916.jpg\" ></p><p>Abdominal surgery can result in a variety of <strong>postoperative wound complications</strong> (eg, infection, dehiscence).&nbsp; These complications are more common in obese patients (as seen in this case), those who are immunocompromised (eg, chronic corticosteroids, cancer), and those with increased intraabdominal straining (eg, excessive lifting, cough).</p><p>Postoperative abdominal wounds can be categorized based on fascial involvement:</p><ul><li><p><strong>Superficial wound dehiscence</strong> is a separation of the skin and subcutaneous tissue with an <strong>intact rectus fascia</strong> (as seen in this patient).&nbsp; It typically develops within the first postoperative week and occurs secondary to an abnormal subcutaneous fluid buildup (eg, seroma), resulting in a scant serosanguineous fluid drainage.</p></li><li><p>Deep (fascial) wound dehiscence involves the rectus fascia (ie, nonintact) and results in exposure of the intraabdominal organs to the external environment.</p></li></ul><p>Patients with a superficial dehiscence and no signs of infection (eg, induration, erythema, purulent drainage) are conservatively managed with <strong>regular dressing changes</strong>.&nbsp; These regular changes help with delayed (secondary) closure by removing excessive fluid and closing physiologic dead space, which debrides nonviable tissue and eliminates potential bacterial reservoirs.&nbsp; In contrast, fascial dehiscence is a surgical emergency because of the risk of bowel evisceration and strangulation <strong>(Choice B)</strong>.</p><p><strong>(Choices A and D)</strong>&nbsp; CT scan of the abdomen and pelvis may be used in patients with suspected necrotizing fasciitis or abscess.&nbsp; These patients typically have signs of infection (eg, edema, induration, purulent drainage); those with necrotizing fasciitis may also have associated crepitus.&nbsp; In both cases, treatment is with systemic antibiotics and wound debridement.</p><p><strong>(Choice E)</strong>&nbsp; Abdominal binders may be used temporarily in patients with fascial dehiscence (but no evisceration) in preparation for emergency surgery.&nbsp; They are not used for superficial dehiscence because they do not improve outcomes.</p><p><strong>Educational objective:</strong><br>Superficial wound dehiscence, separation of the epidermis and/or subcutaneous tissue with an intact fascia, is typically managed conservatively with regular dressing changes.&nbsp; In contrast, deep (fascial) dehiscence involves the fascia and is a surgical emergency.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 2557,
            "topic": "Wound dehiscence and evisceration",
            "titleId": 2557,
            "title": "Wound dehiscence and evisceration",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "CT scan of the abdomen and pelvis",
                    "choiceNumber": 1,
                    "correctTaken": 703,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Emergency surgical exploration",
                    "choiceNumber": 2,
                    "correctTaken": 1458,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Regular dressing changes only",
                    "choiceNumber": 3,
                    "correctTaken": 8396,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Systemic antibiotics and wound debridement",
                    "choiceNumber": 4,
                    "correctTaken": 1640,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Topical antibiotics and abdominal binder placement",
                    "choiceNumber": 5,
                    "correctTaken": 4693,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "175",
                    "mediaDataId": 0,
                    "title": "Perineal lacerations",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24738117",
                    "mediaDataId": 0,
                    "title": "Role of subcutaneous closure in preventing wound complications after cesarean delivery with Pfannenstiel incision: a randomized clinical trial.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24738117",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25683272",
                    "mediaDataId": 0,
                    "title": "Postoperative wound dehiscence: predictors and associations.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25683272",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28601567",
                    "mediaDataId": 0,
                    "title": "Impact of evidence-based interventions on wound complications after cesarean delivery.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28601567",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 138,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 16890,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 50,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 16307,
            "questionIndex": 17749,
            "questionText": "<p>A 19-year-old woman, gravida 1 para 0, comes to the emergency department for evaluation of right-sided abdominal pain, fever, and chills for the past 2 days.&nbsp; The pain has progressed over the last few hours and is now unbearable.&nbsp; The patient has had increasing fatigue and nausea but no vomiting or diarrhea.&nbsp; She has had some nonpainful contractions but no vaginal bleeding or discharge.&nbsp; The patient has had consistent prenatal care and is at 24 weeks gestation by date of her last sure, regular menstrual period.&nbsp; She has no chronic medical conditions and has had no prior surgeries.&nbsp; The patient does not use tobacco, alcohol, or recreational drugs.&nbsp; Temperature is 39 C (102.2 F), blood pressure is 116/70 mm Hg, pulse is 120/min, and pulse oximetry shows 94%.&nbsp; There is tenderness over the right flank, but no abdominal rebound or guarding.&nbsp; The uterus is nontender.&nbsp; The cervix is closed, and amniotic membranes are intact.&nbsp; The fetal heart rate tracing is shown in the <a href=\"20708\">exhibit</a>.&nbsp; Which of the following is the most likely diagnosis for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31274\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Pyelonephritis in pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Asymptomatic bacteriuria</li><li>Diabetes mellitus</li><li>Age &lt;20</li></ul></td></tr><tr><td><p align=\"center\"><strong>Common<br />pathogens</strong></p></td><td><ul><li><em>Escherichia coli</em> (most common)</li><li><em>Klebsiella</em></li><li><em>Enterobacter</em></li><li>Group B <em>Streptococcus</em></li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Preterm labor</li><li>Low birth weight</li><li>Acute respiratory distress syndrome</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Intravenous antibiotics</li><li>Supportive therapy</li></ul></td></tr></tbody></table></div><p><strong>Pregnant women</strong> are at increased risk for <strong>acute pyelonephritis</strong> due to increased urinary stasis, mild immunosuppression, and progesterone-related ureteral dilation.&nbsp; Like most patients, pregnant women with pyelonephritis typically have nausea, high-grade <strong>fever</strong>, and <strong>flank pain</strong>.&nbsp; Maternal fever and tachycardia also lead to <a href=\"6271\">fetal tachycardia</a> (ie, HR &gt;160/min), as seen in this patient.&nbsp; On examination, costovertebral angle tenderness (the angle created between the 12th rib and the spine) or flank pain is common due to retroperitoneal inflammation of the kidney.</p><p>Retroperitoneal inflammation can also extend to the abdominopelvic cavity.&nbsp; This can cause obstetric symptoms, such as uterine irritability (eg, <strong>nonpainful contractions</strong>, as seen in this patient), that can progress to preterm labor (ie, painful contractions with cervical dilation).&nbsp; Severe pyelonephritis can also cause maternal sepsis, acute respiratory distress syndrome, and fetal compromise (eg, premature birth, low birth weight).</p><p>Due to the high risk for severe complications, management of acute pyelonephritis in pregnancy is with hospitalization and empiric intravenous antibiotics (eg, ceftriaxone).</p><p><strong>(Choice A)</strong>&nbsp; Acute appendicitis in pregnancy can present with fever, nausea, anorexia, and right-sided or <a href=\"22369\">upper abdominal pain</a> due to uterine displacement of the appendix cephalad; however, appendicitis typically causes peritoneal signs, including rebound or guarding, which are not seen in this patient.&nbsp; In addition, high-grade fever is not typically an initial symptom but can develop later in the disease course (with increasing inflammation).</p><p><strong>(Choice C)</strong>&nbsp; A degenerating uterine fibroid in pregnancy can cause abdominal pain and low-grade fever; however, patients typically have focal uterine tenderness.&nbsp; This patient&#39;s uterus is nontender.</p><p><strong>(Choice D)</strong>&nbsp; Intraamniotic infection (IAI) is a common cause of abdominal pain in pregnancy.&nbsp; IAI is defined as maternal fever (without a clear source of infection) plus either maternal or fetal tachycardia, purulent amniotic fluid, or leukocytosis.&nbsp; Although this patient has fever and maternal and fetal tachycardia, IAI is a diagnosis of exclusion, and this patient has flank tenderness that makes acute pyelonephritis more likely.&nbsp; In addition, this patient&#39;s nontender uterus, closed cervix, and intact membranes make IAI less likely.</p><p><strong>(Choice E)</strong>&nbsp; <a href=\"5096\">Ovarian torsion</a> can present with unilateral abdominal pain, anorexia, and low-grade fever (ie, peritonitis); however, it typically begins as intermittent pain followed by sudden-onset, severe pain consistent with complete vessel occlusion.&nbsp; It is not typically associated with flank tenderness.</p><p><strong>Educational objective:</strong><br>Acute pyelonephritis in pregnancy typically presents with fever, maternal and fetal tachycardia, and flank pain or costovertebral angle tenderness.&nbsp; Due to the high risk for severe complications (eg, maternal sepsis, preterm delivery), management is with hospitalization and empiric intravenous antibiotics (eg, ceftriaxone).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 19887,
            "topic": "Urinary tract infection",
            "titleId": 19887,
            "title": "Urinary tract infection",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute appendicitis",
                    "choiceNumber": 1,
                    "correctTaken": 2211,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Acute pyelonephritis",
                    "choiceNumber": 2,
                    "correctTaken": 9728,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Degenerating uterine fibroid",
                    "choiceNumber": 3,
                    "correctTaken": 147,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intraamniotic infection",
                    "choiceNumber": 4,
                    "correctTaken": 4114,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ovarian torsion",
                    "choiceNumber": 5,
                    "correctTaken": 475,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20731473",
                    "mediaDataId": 0,
                    "title": "Pyelonephritis in pregnancy: an update on treatment options for optimal outcomes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20731473",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24194632",
                    "mediaDataId": 0,
                    "title": "Medical and infectious complications associated with pyelonephritis among pregnant women at delivery.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24194632",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 197,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 16675,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 58,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 17653,
            "questionIndex": 19113,
            "questionText": "<p>A 38-year-old woman at 6 weeks gestation comes to the office due to vaginal bleeding.&nbsp; The patient has had intermittent bleeding for the past week, which increases after intercourse.&nbsp; She has had no pelvic pain, nausea, or vomiting.&nbsp; Blood pressure is 124/68 mm Hg and pulse is 86/min.&nbsp; The abdomen is soft and nontender, without rebound or guarding.&nbsp; On pelvic examination, there is dark brown discharge pooling in the posterior vaginal vault.&nbsp; The cervix is closed, and there is a raised cervical mass that bleeds freely when manipulated with a swab.&nbsp; Ultrasound reveals a yolk sac and a 6-week intrauterine fetal pole with cardiac motion.&nbsp; Blood type is O, Rh positive.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"8311\" src=\"https://www.uworld.com/media/L31148.jpg\" ></p><p>This patient&#39;s irregular vaginal bleeding and cervical mass are classic for <strong>invasive cervical cancer</strong>, which typically presents in patients who have not had routine Pap test screening.&nbsp; Other risk factors include immunosuppression, tobacco use, and multiple sexual partners.</p><p>Although cervical cancer can be asymptomatic, patients typically have <strong>vaginal bleeding</strong>, particularly after intercourse (eg, <strong>postcoital</strong>) due to trauma to the cervix.&nbsp; Pregnancy, which increases pelvic vascularity, may increase the risk of bleeding from a cervical mass.&nbsp; On examination, patients typically have <strong>cervical friability</strong> (eg, bleeding with manipulation) and a <strong>raised, exophytic mass</strong>, as seen in this patient.&nbsp; Other features may include ulcerative lesions (due to tissue necrosis) and watery, mucoid vaginal discharge.</p><p>Cervical lesions suspicious for cancer require <strong>cervical biopsy</strong>, which can be performed safely during pregnancy.&nbsp; Patients with cervical cancer who are pregnant (such as this patient) require specialized oncology and obstetric management, and any diagnostic delay can increase the risk of cancer progression.</p><p><strong>(Choice A)</strong>&nbsp; Ceftriaxone and azithromycin are empiric treatment for <a href=\"2064\">acute cervicitis</a>, which can present with postcoital bleeding.&nbsp; However, cervicitis typically causes mucopurulent discharge, a finding not seen in this patient, and is not associated with a cervical mass.</p><p><strong>(Choice C)</strong>&nbsp; <a href=\"9333\">Endometrial biopsy</a> may be indicated in certain patients with abnormal uterine, not cervical, bleeding to exclude endometrial cancer.&nbsp; However, it is not performed in pregnancy due to the risk of pregnancy loss.&nbsp; Given her friable cervical mass with intermittent/postcoital vaginal bleeding consistent with cervical cancer, this patient should undergo cervical biopsy.</p><p><strong>(Choice D)</strong>&nbsp; Expectant management is indicated for first-trimester bleeding due to threatened abortion (eg, vaginal bleeding).&nbsp; Although this patient has a viable intrauterine pregnancy (eg, yolk sac, intrauterine fetal pole with cardiac motion), her cervical lesion requires further evaluation.</p><p><strong>(Choice E)</strong>&nbsp; <a href=\"1165\">Kleihauer-Betke testing</a> is required in Rh-negative patients with heavy vaginal bleeding during pregnancy to evaluate for fetomaternal hemorrhage that can lead to <a href=\"1151\">Rh-alloimmunization</a>; prevention is with anti-D immunoglobulin (ie, RhoGAM).&nbsp; This patient is Rh-positive.</p><p><strong>(Choice F)</strong>&nbsp; Quantitative &#946;-hCG levels are measured to evaluate for ectopic pregnancy.&nbsp; Once an intrauterine pregnancy with cardiac motion is identified, &#946;-hCG levels do not change management and therefore are not measured.</p><p><strong>Educational objective:</strong><br>Cervical cancer typically presents with irregular vaginal bleeding (eg, postcoital) and a friable, exophytic cervical mass.&nbsp; Suspicious cervical lesions require biopsy, which is typically safe during pregnancy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 3372,
            "topic": "Cervical cancer",
            "titleId": 3372,
            "title": "Cervical cancer",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Ceftriaxone and azithromycin",
                    "choiceNumber": 1,
                    "correctTaken": 754,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cervical biopsy",
                    "choiceNumber": 2,
                    "correctTaken": 12712,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial biopsy",
                    "choiceNumber": 3,
                    "correctTaken": 203,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Expectant management only",
                    "choiceNumber": 4,
                    "correctTaken": 3258,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Kleihauer-Betke test",
                    "choiceNumber": 5,
                    "correctTaken": 1102,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Quantitative &#946;-hCG level",
                    "choiceNumber": 6,
                    "correctTaken": 2145,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26467977",
                    "mediaDataId": 0,
                    "title": "Management of cervical cancer during pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26467977",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31385452",
                    "mediaDataId": 0,
                    "title": "Diagnosis and treatment of cervical cancer in pregnant women.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31385452",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 69,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 20174,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 27,
            "questionId": 10833,
            "questionIndex": 11963,
            "questionText": "<p>A 37-year-old woman, gravida 4 para 0 aborta 3, comes to the labor and delivery department with painful contractions.&nbsp; She has had no prenatal care this pregnancy, but states she is at 37 weeks gestation based on a first-trimester ultrasound performed in the emergency department.&nbsp; The patient has had 3 elective pregnancy terminations with dilation and curettage.&nbsp; On physical examination, the cervix is 6 cm dilated and 90% effaced with the fetal head at +1 station.&nbsp; She dilates quickly to 10 cm and vaginally delivers a 4.5-kg (10-lb) male infant.&nbsp; Following delivery of the infant, the umbilical cord avulses from the placenta, necessitating manual extraction.&nbsp; The placenta is extracted in pieces, and the patient suddenly develops profuse vaginal bleeding.&nbsp; The uterus is firm, and the bleeding is unresponsive to uterine massage and uterotonic medications.&nbsp; Which of the following is the most likely cause of this patient&#39;s bleeding?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t66529\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Placenta accreta</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>Morbidly adherent placental attachment to the myometrium</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Placenta previa + prior uterine surgery (eg, cesarean delivery, D&amp;C, myomectomy)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Prenatal diagnosis: US with placenta previa, numerous placental lacunae, myometrial thinning</li><li>Postpartum diagnosis: adherent placenta, postpartum hemorrhage</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Cesarean hysterectomy with placenta in situ</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>D&amp;C</strong> = dilation &amp; curettage; <strong>US</strong> = ultrasonography.</p></td></tr></tbody></table></div><p>This patient with postpartum bleeding likely has <strong>placenta accreta</strong>, the <a href=\"2906\">abnormal attachment</a> of placental villi to the uterine myometrium rather than the decidua basalis.&nbsp; This condition typically occurs in patients with endometrial scarring from prior uterine surgery (eg, <strong>dilation and curettage</strong>, cesarean delivery); the scarred areas do not undergo normal endometrial decidualization in early pregnancy.&nbsp; Therefore, fetal trophoblasts can implant directly onto the myometrium (rather than the endometrium) and form a <strong>morbidly adherent placenta</strong>.</p><p>Placenta accreta is usually diagnosed on routine second-trimester ultrasonography; however, in some cases (eg, limited prenatal care), diagnosis occurs after fetal delivery when there is <strong>difficulty detaching the placenta</strong> from the uterus.&nbsp; Excessive traction on the umbilical cord typically leads to cord avulsion.&nbsp; Attempts to remove the placenta (eg, <strong>manual extraction</strong>, sharp uterine curettage) are unsuccessful and cause <strong>profuse vaginal bleeding</strong> due to the disruption of highly vascular adhesions between the uterus and placenta.&nbsp; An <strong>emergency hysterectomy</strong> is typically required to minimize further maternal blood loss and achieve hemostasis.</p><p><strong>(Choice A)</strong>&nbsp; <a href=\"1113\">Abruptio placentae</a> is the premature detachment of the placenta from the uterus.&nbsp; It typically causes antepartum (not postpartum) bleeding associated with a painful, distended uterus and fetal heart rate abnormalities.</p><p><strong>(Choice C)</strong>&nbsp; <a href=\"4268\">Placenta previa</a> occurs due to abnormal placental implantation over the internal cervical os and is associated with prior uterine surgery (eg, cesarean delivery).&nbsp; In contrast to placenta accreta, placenta previa typically presents with painless antepartum bleeding.</p><p><strong>(Choice D)</strong>&nbsp; Uterine atony occurs when the myometrium fails to contract after delivery, thereby allowing continued bleeding from the placental bed vessels.&nbsp; This diagnosis is unlikely in this patient with a firm uterus and bleeding that is unresponsive to uterine massage and uterotonic medications.</p><p><strong>(Choice E)</strong>&nbsp; <a href=\"4513\">Uterine inversion</a> can cause postpartum hemorrhage as the result of excessive traction on the umbilical cord and an abnormally adherent placenta.&nbsp; However, patients typically have severe abdominal pain and a smooth mass protruding from the cervix or vagina.</p><p><strong>(Choice F)</strong>&nbsp; A vaginal hematoma occurs due to obstetric trauma and bleeding in the paravaginal space.&nbsp; Patients typically have a vaginal mass and concealed bleeding, not profuse vaginal bleeding.</p><p><strong>Educational objective:</strong><br>Placenta accreta is the abnormal attachment of placental villi to the uterine myometrium and can present with difficulty detaching the placenta after fetal delivery.&nbsp; Attempts at manual placental extraction are unsuccessful and can cause profuse vaginal bleeding.&nbsp; Treatment is typically with emergency hysterectomy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4183,
            "topic": "Postpartum hemorrhage",
            "titleId": 4183,
            "title": "Postpartum hemorrhage",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Abruptio placentae",
                    "choiceNumber": 1,
                    "correctTaken": 869,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Placenta accreta",
                    "choiceNumber": 2,
                    "correctTaken": 13142,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Placenta previa",
                    "choiceNumber": 3,
                    "correctTaken": 174,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine atony",
                    "choiceNumber": 4,
                    "correctTaken": 1481,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine inversion",
                    "choiceNumber": 5,
                    "correctTaken": 545,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vaginal hematoma",
                    "choiceNumber": 6,
                    "correctTaken": 463,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "165",
                    "mediaDataId": 0,
                    "title": "Placenta accreta spectrum",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20804337",
                    "mediaDataId": 0,
                    "title": "The morbidly adherent placenta: an overview of management options.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20804337",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22645616",
                    "mediaDataId": 0,
                    "title": "Epidemiology, etiology, diagnosis, and management of placenta accreta.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22645616",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26135782",
                    "mediaDataId": 0,
                    "title": "Placenta accreta: diagnosis, management and the molecular biology of the morbidly adherent placenta.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26135782",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 118,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 16674,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 79,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 28,
            "questionId": 2535,
            "questionIndex": 2535,
            "questionText": "<p>A 28-year-old woman, gravida 3 para 2, at 30 weeks gestation is brought to the emergency department due to vaginal bleeding after a motor vehicle collision.&nbsp; The patient was restrained by a lap and shoulder belt, but the steering wheel struck her abdomen.&nbsp; Her underwear and pants are soaked with blood, and she states that she is &#x22;not sure if my water broke.&#x22;&nbsp; Blood pressure is 90/60 mm Hg, pulse is 136/min, respirations are 22/min, and pulse oximetry is 98% on room air.&nbsp; Physical examination shows an alert but anxious-appearing woman with abdominal tenderness and cool extremities.&nbsp; On speculum examination, 100 mL of blood is evacuated from the vagina, and minimal active bleeding from the cervix is observed.&nbsp; Blood type is O, Rh positive.&nbsp; Fetal heart monitoring shows a baseline of 140/min with minimal to moderate variability; there are no late or variable decelerations.&nbsp; Tocometry reveals uterine contractions every 3 minutes.&nbsp; Intravenous fluids are started.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"2483\" src=\"https://www.uworld.com/media/L23981.jpg\" ></p><p>This pregnant patient with abdominal pain, contractions, and vaginal bleeding following <strong>blunt abdominal trauma</strong> (eg, motor vehicle collision) likely has <strong>abruptio placentae</strong> (ie, placental abruption).&nbsp; Due to the volume of blood supplied to the uterus, abruptio placentae can cause hypovolemic shock from hemorrhage (ie, <strong>hemorrhagic shock</strong>), as seen in this patient with hypotension, tachycardia, and cool extremities.</p><p>Management of the trauma patient with hemorrhagic shock requires rapid resuscitation with replacement of intravascular volume, transitioning from crystalloid to <strong>blood products</strong> as soon as possible.&nbsp; In addition, pregnant patients are placed in a left lateral decubitus position (if the spine is stable) to displace the uterus off the aortocaval vessels and maximize cardiac output.</p><p>If hemorrhage or hemodynamic instability continues despite initial resuscitation efforts, massive transfusion protocol (MTP) should be activated.&nbsp; MTP is the administration of packed red blood cells, platelets, and fresh frozen plasma in a 1:1:1 ratio to avoid coagulopathy from dilution of platelets and clotting factors.</p><p><strong>(Choice A)</strong>&nbsp; Emergency cesarean delivery after maternal trauma may be indicated for imminent fetal compromise (ie, category 3 tracing).&nbsp; This patient has a category 2 tracing (due to minimal variability) but otherwise the fetal heart rate is normal with no variable or late decelerations; therefore, she does not require emergency delivery.</p><p><strong>(Choice B)</strong>&nbsp; A fetal biophysical profile evaluates for fetal acidosis and may be indicated for fetal heart rate tracings without accelerations.&nbsp; However, maternal stabilization is the priority over further fetal evaluation in this patient.</p><p><strong>(Choice C)</strong>&nbsp; <a href=\"1165\">Kleihauer-Betke testing</a> measures the amount of fetal blood mixed into maternal circulation following trauma, which helps guide anti-D immunoglobulin dosing in Rh-negative patients (ie, to prevent <a href=\"1151\">Rh-alloimmunization</a>).&nbsp; Rh-positive patients (such as this one) are not at risk for Rh-alloimmunization, and testing does not change management.</p><p><strong>(Choice E)</strong>&nbsp; Vasopressor therapy (eg, norepinephrine) is contraindicated in the setting of isolated hemorrhagic shock because peripheral vascular tone is already increased to compensate for decreased blood volume.&nbsp; In addition, vasopressor use can decrease uterine blood flow and therefore impair fetal oxygenation.</p><p><strong>Educational objective:</strong><br>Blunt abdominal trauma (eg, motor vehicle collision) in pregnancy can cause severe maternal bleeding and hemorrhagic shock (eg, abruptio placentae).&nbsp; Trauma patients with hemorrhagic shock require replacement of intravascular volume, transitioning from crystalloid to blood product resuscitation as soon as possible.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14133,
            "topic": "Antepartum bleeding",
            "titleId": 14133,
            "title": "Antepartum bleeding",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Emergency cesarean delivery",
                    "choiceNumber": 1,
                    "correctTaken": 3521,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal biophysical profile",
                    "choiceNumber": 2,
                    "correctTaken": 4579,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Kleihauer-Betke test",
                    "choiceNumber": 3,
                    "correctTaken": 1739,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transfuse blood products",
                    "choiceNumber": 4,
                    "correctTaken": 5894,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vasopressor therapy",
                    "choiceNumber": 5,
                    "correctTaken": 1823,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27894494",
                    "mediaDataId": 0,
                    "title": "Optimal fluid therapy for traumatic hemorrhagic shock.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27894494",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25403036",
                    "mediaDataId": 0,
                    "title": "Trauma in pregnancy: assessment, management, and prevention.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25403036",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 97,
            "othersAvgTimeSpent": 70,
            "notes": null,
            "peopleTaken": 17556,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 34,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 29,
            "questionId": 2543,
            "questionIndex": 2543,
            "questionText": "<p>A 34-year-old primigravida at 13 weeks gestation comes to the emergency department due to 2 hours of severe lower abdominal pain and heavy vaginal bleeding.&nbsp; She has no chronic medical conditions and has had no surgeries.&nbsp; The patient does not use alcohol, tobacco, or recreational drugs.&nbsp; Blood pressure is 80/60 mm Hg and pulse is 128/min.&nbsp; Speculum examination shows several large blood clots in the vagina and active bleeding from the uterus.&nbsp; The cervix is dilated and products of conception are visible protruding through the os.&nbsp; After suction curettage, the products of conception are evacuated.&nbsp; Laboratory results include the following:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>Hemoglobin</td><td>8.9 g/dL</td></tr><tr><td>Blood type</td><td>AB, Rh-negative</td></tr><tr><td>Antibody screen</td><td>negative</td></tr><tr><td>&#946;-hCG</td><td>2,112 mIU/mL</td></tr></tbody></table><p>After the procedure, blood pressure is 110/80 mm Hg and pulse is 90/min.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T32531\" style=\"overflow-x:auto;\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td><p align=\"center\"><strong>Indications for prophylactic administration of anti-D<br>immunoglobulin for Rh D-negative patients<sup>*</sup></strong></p></td></tr><tr><td><ul><li>At 28-32 weeks gestation</li><li>&lt;72 hours after delivery of Rh D-positive infant</li><li>&lt;72 hours after spontaneous abortion</li><li>Ectopic pregnancy</li><li>Threatened abortion</li><li>Hydatidiform mole</li><li>Chorionic villus sampling, amniocentesis</li><li>Abdominal trauma</li><li>2nd- &amp; 3rd-trimester bleeding</li><li>External cephalic version&nbsp;</li></ul></td></tr><tr><td><p>*Antepartum prophylaxis is not indicated if the father is Rh D-negative.</p></td></tr></tbody></table></div><p>The Rhesus (Rh) blood group is composed of 5 antigens that induce antibody formation.&nbsp; The most common antigen involved in fetal and neonatal disease is the <strong>D antigen</strong>.&nbsp; Rh D antigen alloimmunization (ie, <a href=\"1151\">sensitization</a>) occurs when Rh D-positive fetal erythrocytes enter the bloodstream of an <strong>Rh D-negative pregnant woman</strong>, who develops antibodies against the D antigen present on the fetal erythrocytes.&nbsp; Although the anti-D antibodies do not affect the fetus of the first pregnancy, these antibodies are destructive in subsequent pregnancies.&nbsp; If the alloimmunized woman has a subsequent pregnancy with an Rh(D) positive fetus, her anti-D antibodies will bind and lyse the fetal erythrocytes.</p><p>Therefore, this unsensitized Rh D-negative pregnant woman should receive <strong>anti-D immunoglobulin</strong> (RhoGAM) to lower her risk for alloimmunization and the development of <strong>hemolytic disease of the newborn</strong> (eg, <a href=\"23610\">hydrops fetalis</a>) in subsequent pregnancies.&nbsp; The placenta is a barrier between the pregnant woman and fetus, but fetal erythrocytes may enter the woman&#39;s circulation during <strong>abortion</strong> (induced or spontaneous, as in this patient), procedures (eg, amniocentesis), or delivery.&nbsp; Anti-D immunoglobulin is administered at these critical times and binds the D antigens on the fetal erythrocytes in the pregnant woman&#39;s circulation, thereby preventing the formation of anti-D antibodies.</p><p>Because the risk of harm in future pregnancies is so substantial while the risk of anti-D immunoglobulin administration is minimal, all women who are Rh(D) negative and not previously alloimmunized (ie, no elevated antibody titers) must receive anti-D immunoglobulin following any potential sensitizing event <strong>(Choice D)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Methotrexate is the medical treatment for an ectopic pregnancy, which is unlikely in this patient with visible intrauterine products of conception on examination.</p><p><strong>(Choice C)</strong>&nbsp; Recurrent pregnancy loss (&#8805;2 consecutive losses) can be due to hormonal, anatomic, or chromosomal abnormalities.&nbsp; However, having a single spontaneous abortion is common, and most patients have normal future pregnancies; therefore, a work-up with fetal karyotyping is not yet indicated.</p><p><strong>(Choice E)</strong>&nbsp; The risk for disseminated intravascular coagulation increases after 15 weeks gestation.&nbsp; In addition, this patient&#39;s vaginal bleeding and vital signs improved following surgery; therefore, coagulation studies are not indicated.</p><p><strong>Educational objective:</strong><br>Spontaneous abortion can cause Rh D alloimmunization in Rh D-negative women due to fetomaternal blood mixing and maternal anti-D antibody production if the fetal blood type is Rh D-positive.&nbsp; Therefore, Rh D-negative women require anti-D immunoglobulin after spontaneous abortion.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 15363,
            "topic": "Rhesus alloimmunization",
            "titleId": 15363,
            "title": "Rhesus alloimmunization",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administration of methotrexate",
                    "choiceNumber": 1,
                    "correctTaken": 8635,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Anti-D immunoglobulin administration",
                    "choiceNumber": 2,
                    "correctTaken": 3453,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Karyotype of the products of conception",
                    "choiceNumber": 3,
                    "correctTaken": 925,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional management indicated",
                    "choiceNumber": 4,
                    "correctTaken": 535,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Order coagulation studies",
                    "choiceNumber": 5,
                    "correctTaken": 229,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28742673",
                    "mediaDataId": 0,
                    "title": "Practice bulletin no. 181: prevention of Rh(D) alloimmunization.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28742673",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25899660",
                    "mediaDataId": 0,
                    "title": "Haemolytic disease of the fetus and newborn.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25899660",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 129,
            "othersAvgTimeSpent": 47,
            "notes": null,
            "peopleTaken": 13777,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 25,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 30,
            "questionId": 4793,
            "questionIndex": 4793,
            "questionText": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td id=\"vignettedescriptor\">The following vignette applies to the next <strong>2</strong> items.&nbsp; The items in the set must be answered in sequential order.&nbsp; Once you click <strong>Proceed to Next Item</strong>, you will not be able to add or change an answer.</td></tr></tbody></table><p>A 32-year-old primigravid woman comes to the office for a follow-up appointment at 28 weeks gestation.&nbsp; The patient has gestational diabetes mellitus diagnosed at 25 weeks gestation and has been managing it with dietary modification.&nbsp; She follows a low-carbohydrate diet and eats 3 small meals and 2 snacks daily, as recommended by her dietitian.&nbsp; Fasting blood glucose levels have been 110-130 mg/dL for the past 3 weeks, and most of the patient&#39;s 2-hour postprandial blood glucose levels have been &gt;140 mg/dL.&nbsp; Review of systems is negative for polyuria or polydipsia.&nbsp; BMI is 38 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Blood pressure is 134/80 mm Hg, and pulse is 76/min.&nbsp; Physical examination is unremarkable.&nbsp; Urinalysis results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"170px\"><tbody><tr><td style=\"vertical-align:middle;\">Color</td><td style=\"vertical-align:middle;\">yellow</td></tr><tr><td style=\"vertical-align:middle;\">Glucose</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Protein</td><td style=\"vertical-align:middle;\">negative</td></tr></tbody></table><p><strong>Item 1 of 2</strong><br>Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32380\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Gestational diabetes mellitus</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>Human placental lactogen secretion</li></ul></td></tr><tr><td><p align=\"center\"><strong>Screening</strong></p></td><td><ul><li>24-28 weeks gestation</li><li>1-hr 50-g GCT</li><li>3-hr 100-g GTT</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>1st line: diet</li><li>2nd line: insulin, glyburide, metformin</li></ul></td></tr><tr><td><p align=\"center\"><strong>Target blood glucose goals</strong></p></td><td><ul><li>Fasting: &le;95 mg/dL</li><li>1-hr postprandial: &le;140 mg/dL</li><li>2-hr postprandial: &le;120 mg/dL</li></ul></td></tr><tr><td><p align=\"center\"><strong>Postpartum management</strong></p></td><td><ul><li>Fasting glucose at 24-72 hr</li><li>2-hr 75-g GTT at 6- to 12-week visit</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>GCT</strong> = glucose challenge test; <strong>GTT</strong> = glucose tolerance test.</p></td></tr></tbody></table></div><p>This patient has <strong>gestational diabetes mellitus</strong> (GDM), which is increasingly common due to the obesity epidemic.&nbsp; Other risk factors include GDM in a prior pregnancy and a prior macrosomic infant.&nbsp; All women require <strong>screening at 24-28 weeks gestation</strong> because GDM is associated with increased risk for gestational hypertension, preeclampsia, fetal macrosomia, and cesarean delivery.&nbsp; Patients with risk factors benefit from earlier screening (eg, early second trimester) and rescreening at 24-28 weeks if the initial screen is negative.</p><p>Patients diagnosed with GDM, such as this one, are monitored with serial <strong>blood glucose level measurements</strong> (ie, fasting and either 1- or 2-hr postprandial).&nbsp; Dietary modification (eg, low-carbohydrate diet, small meals with intermittent snacks) is the initial approach to management.&nbsp; However, patients with glucose levels consistently <strong>above the target range</strong> (ie, fasting &gt;95 mg/dL, 1-hr &gt;140 mg/dL, 2-hr &gt;120 mg/dL), such as this patient, require additional pharmacotherapy because dietary modification alone has proved insufficient <strong>(Choice B)</strong>.</p><p><strong>Insulin</strong> is first-line pharmacotherapy because it does not cross the placenta and dosing is easily adjustable.&nbsp; Oral antiglycemic medications (eg, metformin, glyburide) may be used in patients who decline insulin or have difficulty administering or adhering to insulin therapy.</p><p><strong>(Choices A and D)</strong>&nbsp; Canagliflozin, a sodium-glucose cotransporter-2 inhibitor, reduces blood glucose levels in patients with type 2 diabetes mellitus by increasing glucose excretion in the urine.&nbsp; Pioglitazone, a thiazolidinedione, improves insulin sensitivity by activating peroxisome proliferator-activated receptors.&nbsp; Neither is recommended in pregnancy due to possible adverse fetal effects.</p><p><strong>(Choice E)</strong>&nbsp; Although dietary modification and exercise are advised for patients with GDM, weight loss is not recommended due to increased risk for a small-for-gestational-age infant and possible preterm delivery.</p><p><strong>Educational objective:</strong><br>Patients with gestational diabetes mellitus are initially prescribed dietary modification and exercise.&nbsp; If dietary modification fails to produce euglycemia (ie, blood glucose levels that are consistently above the target range), insulin or oral antiglycemic medications are indicated.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 18237,
            "topic": "Gestational diabetes",
            "titleId": 18237,
            "title": "Gestational diabetes",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 4793,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Canagliflozin",
                    "choiceNumber": 1,
                    "correctTaken": 818,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dietary modification",
                    "choiceNumber": 2,
                    "correctTaken": 1233,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Insulin",
                    "choiceNumber": 3,
                    "correctTaken": 13692,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pioglitazone",
                    "choiceNumber": 4,
                    "correctTaken": 412,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Weight loss",
                    "choiceNumber": 5,
                    "correctTaken": 1852,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 6,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25884746",
                    "mediaDataId": 0,
                    "title": "Screening, diagnosis, and management of gestational diabetes mellitus.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25884746",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 99,
            "othersAvgTimeSpent": 53,
            "notes": null,
            "peopleTaken": 18007,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 76,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 31,
            "questionId": 4794,
            "questionIndex": 4794,
            "questionText": "<p><strong>Item 2 of 2</strong><br>Despite starting the recommended therapy, the patient&#39;s 2-hour postprandial blood glucose levels remain &gt;140 mg/dL.&nbsp; At 37 weeks gestation, ultrasound examination reveals an estimated fetal weight of 4 kg (8 lb 13 oz).&nbsp; At 38 weeks gestation, the patient comes to the hospital in spontaneous labor and has a protracted labor course, pushing for 3 hours.&nbsp; Following delivery of the fetal head, the anterior shoulder cannot be delivered.&nbsp; A tight nuchal cord is palpated.&nbsp; She is instructed not to push.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T35359\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Management of shoulder dystocia (BE CALM)</strong></p></td></tr><tr><td style=\"width: 10%;\"><p style=\"text-align: center;\"><strong>B</strong></p></td><td style=\"width: 90%;\"><p>Breathe; do not push</p></td></tr><tr><td><p style=\"text-align: center;\"><strong>E</strong></p></td><td><p>Elevate legs &amp; flex hips, thighs against abdomen (McRoberts)</p></td></tr><tr><td><p style=\"text-align: center;\"><strong>C</strong></p></td><td><p>Call for help</p></td></tr><tr><td><p style=\"text-align: center;\"><strong>A</strong></p></td><td><p>Apply suprapubic pressure</p></td></tr><tr><td><p style=\"text-align: center;\"><strong>L</strong></p></td><td><p>En<strong>L</strong>arge vaginal opening with episiotomy</p></td></tr><tr><td><p style=\"text-align: center;\"><strong>M</strong></p></td><td><p>Maneuvers:</p><ul><li>Deliver posterior arm</li><li>Rotate posterior shoulder (Woods screw): apply pressure to anterior aspect of the posterior shoulder</li><li>Adduct posterior fetal shoulder (Rubin): apply pressure to the posterior aspect of the posterior shoulder</li><li>Mother on hands &amp; knees: &#x22;all fours&#x22; (Gaskin)</li><li>Replace fetal head into pelvis for cesarean delivery (Zavanelli)</li></ul></td></tr></tbody></table></div><p>This patient is experiencing <strong>shoulder dystocia</strong>, or <strong>impaction</strong> of the fetal <strong>anterior shoulder</strong> behind the maternal pubic symphysis that impairs delivery of the shoulders with routine gentle traction.&nbsp; Risk factors include gestational diabetes mellitus (as in this patient) and associated fetal macrosomia (ie, birth weight &#8805;4.5 kg [9 lb 14 oz]).&nbsp; Shoulder dystocia is an <strong>obstetric emergency</strong> that can lead to both fetal and maternal complications.&nbsp; Fetal complications include <a href=\"2683\">brachial plexus injuries</a>, clavicular or humeral fractures, and hypoxic encephalopathy.&nbsp; Maternal complications include fourth-degree (ie, rectal mucosa) <a href=\"24036\">perineal lacerations</a> and postpartum hemorrhage.</p><p>Management of shoulder dystocia requires maneuvers to dislodge the anterior shoulder or reorient the fetus to deliver through the widest diameter of the bony pelvis.&nbsp; The initial step in relieving shoulder dystocia is the <strong>McRoberts maneuver</strong>&mdash;flexing the patient&#39;s hips back against her abdomen&mdash;and applying <strong>suprapubic pressure</strong>.&nbsp; The <a href=\"1126\">McRoberts maneuver</a> flattens the sacral promontory and decreases obstruction through the bony pelvis.&nbsp; Suprapubic pressure may then dislodge the anterior shoulder to allow delivery.&nbsp; The combination of these maneuvers relieves shoulder dystocia in nearly half of cases without further intervention.</p><p><strong>(Choice A)</strong>&nbsp; Forceps are applied to guide the fetal head under the pubic symphysis to expedite the second stage of labor.&nbsp; After delivery of the head, forceps are removed, and the shoulders are delivered with maternal expulsive efforts.&nbsp; Forceps are not indicated in the management of shoulder dystocia.&nbsp; In addition, increased traction on the fetal head increases the risk of brachial plexus injury.</p><p><strong>(Choice B)</strong>&nbsp; The impediment to this patient&#39;s delivery is the impacted fetal shoulder, not the <a href=\"51050\">tight nuchal cord</a> (umbilical cord that is looped around the neck and can be manually reduced).&nbsp; During <strong>shoulder dystocia</strong>, clamping and <strong>cutting the umbilical cord</strong> (even a nuchal cord) is <strong>absolutely contraindicated</strong> because it would sever the only source of oxygen to the fetus, resulting in fetal hypoxia, hypoxic encephalopathy, and fetal <strong>death</strong>.</p><p><strong>(Choices D and E)</strong>&nbsp; Replacement of the fetal head into the maternal pelvis (ie, Zavanelli maneuver) is performed if all other maneuvers fail and an emergency cesarean delivery must be performed.</p><p><strong>Educational objective:</strong><br>Shoulder dystocia, an obstetric emergency, is impaction of the fetal anterior shoulder behind the maternal pubic symphysis that results in the inability to deliver the shoulders with routine gentle traction.&nbsp; Initial management is the McRoberts maneuver (ie, flexion of the patient&#39;s hips back against her abdomen) and application of suprapubic pressure.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14045,
            "topic": "Shoulder dystocia",
            "titleId": 14045,
            "title": "Shoulder dystocia",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "4",
            "parentQuestionId": 4793,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 1,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Apply traction to the fetal head with forceps",
                    "choiceNumber": 1,
                    "correctTaken": 650,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Clamp and cut the nuchal umbilical cord",
                    "choiceNumber": 2,
                    "correctTaken": 1879,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Flex the patient&#39;s hips against her abdomen",
                    "choiceNumber": 3,
                    "correctTaken": 9529,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform emergency cesarean delivery",
                    "choiceNumber": 4,
                    "correctTaken": 4011,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Push the fetal head back into the maternal pelvis",
                    "choiceNumber": 5,
                    "correctTaken": 1929,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 6,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21555962",
                    "mediaDataId": 0,
                    "title": "A comparison of obstetric maneuvers for the acute management of shoulder dystocia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21555962",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 96,
            "othersAvgTimeSpent": 38,
            "notes": null,
            "peopleTaken": 17998,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 53,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 32,
            "questionId": 19258,
            "questionIndex": 20742,
            "questionText": "<p>A 36-year-old primigravid woman at 34 weeks gestation arrives at the emergency department after being found unresponsive on the floor by her husband.&nbsp; She was found unconscious about 30 minutes ago and became gradually responsive over a few minutes.&nbsp; The husband reports the patient has had increasing nausea and vomiting over the past few hours and a severe frontal headache.&nbsp; Currently she has no symptoms other than the headache.&nbsp; Medical history is significant for migraines, and the patient takes no daily medications.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 138/98 mm Hg, pulse is 78/min, and respirations are 20/min.&nbsp; Cranial nerves are intact, and the neck is supple.&nbsp; Funduscopic examination is normal.&nbsp; The lungs are clear to auscultation bilaterally.&nbsp; Cardiac examination demonstrates normal heart sounds.&nbsp; The abdomen is nontender, and the uterine fundus measures 34 weeks gestation.&nbsp; There is minimal pretibial edema, and deep tendon reflexes are 3+.&nbsp; Motor examination is normal.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>13.8 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>360,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>11,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\"></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td>132 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td>3.8 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Chloride</td><td>100 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Bicarbonate</td><td>22 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td>1.1 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td>80 mg/dL</td></tr><tr><td colspan=\"2\"></td></tr><tr><td colspan=\"2\">Liver function studies</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td>180 U/L (normal: 38-229)</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase (SGOT)</td><td>12 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase (SGPT)</td><td>24 U/L</td></tr><tr><td colspan=\"2\"></td></tr><tr><td colspan=\"2\">Urinalysis</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Protein</td><td>1+</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Blood</td><td>negative</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td>negative</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Ketones</td><td>present</td></tr></tbody></table><p>Urine drug screen is negative.&nbsp; CT scan of the head reveals bilateral frontal lobe edema but no mass lesions or bleeding.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T68143\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Eclampsia</strong></p><p align=\"center\"><strong>(preeclampsia + new-onset seizure)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Hypertension, typically severe (ie, SBP &#8805;160 or DBP &#8805;110 mm Hg)</li><li>Seizure, typically tonic-clonic with postictal phase</li><li>Severe headache</li><li>Visual disturbances (ie, scotoma)</li><li>Hyperreflexia</li><li>Proteinuria</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Mainly clinical</li><li>Bilateral frontal lobe edema on CT scan of the head</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Magnesium sulfate infusion</li><li>Antihypertensive agent for severe hypertension</li><li>Delivery</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>DBP</strong> = diastolic blood pressure; <strong>SBP</strong> = systolic blood pressure.</p></td></tr></tbody></table></div><p>This pregnant patient was found unconscious and gradually became more responsive, suggestive of a postictal state.&nbsp; She also has a headache and <strong>hypertension</strong>,&nbsp;defined <strong>in pregnancy</strong> as a systolic blood pressure (SBP) &#8805;140 mm Hg or <strong>diastolic blood pressure (DBP) &#8805;90 mm Hg</strong> (with severe hypertension defined as SBP &#8805;160 mm Hg or DBP &#8805;110 mm Hg), consistent with&nbsp;<strong>preeclampsia with severe features</strong>.&nbsp; Pre-eclampsia accompanied by new-onset seizures is diagnostic of&nbsp;<strong>eclampsia (eclamptic seizure)</strong>.</p><p>Patients with preeclampsia are at risk for developing <strong>generalized tonic-clonic seizures</strong> (eclampsia) due to preeclampsia-induced cerebrovascular dysfunction (eg, vasospasm with subsequent brain ischemia).&nbsp; Although eclampsia classically presents with seizure activity, many patients are found in the <strong>postictal state</strong> because eclamptic seizures are usually brief (&lt;1 minute), as in this patient.&nbsp; The postictal confusion and unresponsiveness typically resolve in 10-20 minutes, but patients continue to have signs of preeclampsia with severe features, such as severe <strong>headache</strong>, nausea, vomiting, <strong>hyperreflexia</strong>, and <strong>elevated creatinine</strong> levels.</p><p>Eclampsia is usually a clinical diagnosis.&nbsp; However, CT scan of the head is performed in patients with atypical or prolonged symptoms and usually reveals bilateral frontal or occipital lobe <strong>edema</strong>, as seen in this patient.&nbsp; Because eclamptic seizures can cause brain injury and increased risk for stroke, eclampsia requires emergency treatment with <strong>magnesium sulfate infusion</strong> to prevent seizure recurrence.&nbsp; Fetal delivery is required for definitive cure.</p><p><strong>(Choice A)</strong>&nbsp; CT venography can diagnose cerebral venous thrombosis (CVT), which may present with severe headache and seizure.&nbsp; However, CVT typically causes papilledema and focal neurologic deficits, which are not seen in this patient.</p><p><strong>(Choice B)</strong>&nbsp; Lumbar puncture can diagnose CNS infection, idiopathic intracranial hypertension, or subarachnoid hemorrhage (particularly when CT scan of the head appears benign).&nbsp; However, these diagnoses are unlikely in this patient with no fever, nuchal rigidity, or signs of elevated intracranial pressure (eg, no papilledema on funduscopic examination).</p><p><strong>(Choice D)</strong>&nbsp; Triptan abortive therapy can treat migraines but is not used during pregnancy due to risks of fetal growth restriction and preterm labor.&nbsp; In addition, migraines typically cause unilateral (not bilateral) throbbing pain; however, loss of consciousness, hyperreflexia, and frontal lobe edema are not usually present.</p><p><strong>(Choice E)</strong>&nbsp; Video EEG may be used to diagnose patients with suspected psychogenic nonepileptic seizures; however, this management is inappropriate and potentially life-threatening in this patient with an emergent, medical cause of seizure.</p><p><strong>Educational objective:</strong><br>Eclampsia, generalized tonic-clonic seizures, can develop in patients with preeclampsia with severe features (eg, hypertension with elevated creatinine).&nbsp; Patients may present in a postictal state with persistent headache and hyperreflexia.&nbsp; Treatment is with magnesium sulfate infusion.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4219,
            "topic": "Preeclampsia",
            "titleId": 4219,
            "title": "Preeclampsia",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "CT venography",
                    "choiceNumber": 1,
                    "correctTaken": 3989,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lumbar puncture",
                    "choiceNumber": 2,
                    "correctTaken": 2627,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Magnesium sulfate infusion",
                    "choiceNumber": 3,
                    "correctTaken": 10707,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Triptan abortive therapy",
                    "choiceNumber": 4,
                    "correctTaken": 768,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Video EEG",
                    "choiceNumber": 5,
                    "correctTaken": 1160,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "572",
                    "mediaDataId": 0,
                    "title": "Preeclampsia",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19211496",
                    "mediaDataId": 0,
                    "title": "Magnesium sulfate treatment for the prevention of eclampsia: a brief review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19211496",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 94,
            "othersAvgTimeSpent": 99,
            "notes": null,
            "peopleTaken": 19251,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 47,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 33,
            "questionId": 4146,
            "questionIndex": 4146,
            "questionText": "<p>A 34-year-old primigravid woman at 37 weeks gestation comes to labor and delivery for painful, regular contractions.&nbsp; She has had no vaginal bleeding or leakage of fluid.&nbsp; The patient&#39;s pregnancy was complicated by iron deficiency anemia, for which she took daily iron supplementation.&nbsp; She has no chronic medical conditions and takes no other daily medications.&nbsp; Blood pressure is 120/80 mm Hg, pulse is 104, and respirations are 22/min.&nbsp; Fetal heart rate tracing shows a baseline of 130/min, moderate variability, accelerations, and no decelerations.&nbsp; Tocodynamometer shows contractions every 2-3 minutes.&nbsp; The abdomen has palpable uterine contractions.&nbsp; The cervix is 6 cm dilated and 100% effaced, and the fetal head is at 0 station.&nbsp; The patient is admitted in active labor and requests epidural analgesia for pain control.&nbsp; Shortly after induction of analgesia, she begins to feel light-headed.&nbsp; Repeat blood pressure is 90/55 mm Hg, pulse is 120/min, and respirations are 15/min.&nbsp; The patient has normal strength and sensation of the upper extremities.&nbsp; Which of the following is the most likely cause of this patient&#39;s hypotension?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"52170\" src=\"https://www.uworld.com/media/highresdefault/L81381.jpg\"  ></p><p>This laboring patient had <strong>epidural analgesia</strong> placed for pain management, which provides pain relief throughout labor by allowing for continuous infusion of local anesthetic and opioid via catheter insertion below the L4 vertebrae (below spinal cord termination) into the epidural space (between the ligamentum flavum and dura).&nbsp; This placement allows for a targeted block of pain fibers (T10-L1 during the first stage, S2-S4 fibers during the second stage) of labor, which corresponds with fetal descent into the pelvis.</p><p>However, epidural analgesia also <strong>blocks sympathetic nerve</strong> fibers responsible for vascular tone in the lower extremities, resulting in <strong>vasodilation</strong> (venous pooling), decreased venous return to the heart, and decreased cardiac output.&nbsp; Therefore, many patients develop <strong>hypotension</strong> and compensatory tachycardia (because sympathetic innervation to the heart via T1-T4 is unaffected by the block).&nbsp; Those with significant hypotension can have decreased placental perfusion (eg, late decelerations, fetal hypoxemia).</p><p>Treatment of postepidural hypotension includes left uterine displacement (ie, positioning patient on the left side) to improve venous return, intravenous fluid bolus, and vasopressor administration (eg, phenylephrine, ephedrine).</p><p><strong>(Choice A)</strong>&nbsp; Anaphylaxis, which is caused by antigen activation of IgE, leads to histamine and leukotriene release and can present with hypotension and tachycardia.&nbsp; However, patients typically have significant bronchoconstriction (eg, wheezing) and an increased respiratory rate (to compensate for the bronchoconstriction).</p><p><strong>(Choice B)</strong>&nbsp; Depression of cervical spinal cord and brainstem activity occurs when local anesthesia ascends upward (ie, <a href=\"39370\">high spinal anesthesia</a>).&nbsp; High spinal anesthesia may occur with an intrathecal injection or overdose of the anesthetic, resulting in a sympathetic blockade (eg, hypotension, bradycardia) and complete motor blockade below the lower thoracic spinal levels (eg, upper extremity weakness, diaphragm paralysis [apnea]).</p><p><strong>(Choice C)</strong>&nbsp; Leakage of cerebral spinal fluid may occur if the dura is inadvertently punctured during epidural placement.&nbsp; This results in leakage of spinal fluid, which causes patients to develop postural headaches that classically present as headaches that are worse with sitting up and improved with lying down after delivery.&nbsp; Hypotension is not characteristic.</p><p><strong>(Choice D)</strong>&nbsp; Opioid toxicity is rare with neuraxial administration; however, patients with opioid toxicity typically have mild hypotension and/or bradycardia and a depressed respiratory rate (&lt;12/min) (not seen in this patient).</p><p><strong>Educational objective:</strong><br>Hypotension, a common adverse effect of epidural anesthesia, is caused by blood redistribution to the lower extremities because of venous pooling from sympathetic blockade.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23467,
            "topic": "Anesthesia",
            "titleId": 23467,
            "title": "Anesthesia",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antigen activation of IgE",
                    "choiceNumber": 1,
                    "correctTaken": 715,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Depression of brainstem activity",
                    "choiceNumber": 2,
                    "correctTaken": 2117,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Leakage of spinal fluid",
                    "choiceNumber": 3,
                    "correctTaken": 1194,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Saturation of opioid receptors",
                    "choiceNumber": 4,
                    "correctTaken": 1016,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vasodilation and venous pooling",
                    "choiceNumber": 5,
                    "correctTaken": 11453,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "12908685",
                    "mediaDataId": 0,
                    "title": "Recent advances in obstetric anesthesia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/12908685",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 102,
            "othersAvgTimeSpent": 69,
            "notes": null,
            "peopleTaken": 16495,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 4,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 34,
            "questionId": 2524,
            "questionIndex": 2524,
            "questionText": "<p>A 39-year-old woman, gravida 3 para 2, comes to the emergency department at 37 weeks gestation due to leakage of fluid for the last 2 hours.&nbsp; She has also had some vaginal bleeding and contractions for the last hour.&nbsp; Fetal movement is normal.&nbsp; The patient immigrated to the United States 6 months ago and has had no prenatal care this pregnancy.&nbsp; Her previous pregnancies were uncomplicated and delivered vaginally at term.&nbsp; Blood pressure is 100/60 mm Hg, pulse is 102/min, and respirations are 16/min.&nbsp; On speculum examination, rupture of membranes is confirmed and the patient has some small blood clots at the cervical os.&nbsp; An ultrasound reveals an active fetus in cephalic presentation whose growth is consistent with gestational age and placental tissue covering the cervix.&nbsp; Fetal heart rate baseline is 150/min with accelerations and no decelerations.&nbsp; Tocodynamometry shows contractions every 3 minutes.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"2778\" src=\"https://www.uworld.com/media/L23978.jpg\" ></p><p>This patient&#39;s ultrasound is consistent with <strong>placenta previa</strong>, which occurs when the <strong>placenta covers the cervix</strong>.&nbsp; Risk factors include multiparity and advanced maternal age (&#8805;35), as in this patient; additional risk factors are prior cesarean delivery and prior previa.&nbsp; Patients are at risk for severe antepartum hemorrhage, which typically presents as <strong>painless vaginal bleeding</strong> and occurs with or without contractions.</p><p>Placenta previa is usually diagnosed during a routine ultrasound; however, in patients without prenatal care, it may be found incidentally at term with vaginal bleeding (as seen in this patient).&nbsp; During labor, contractions or cervical manipulation can shear the placenta off the cervix (ie, partial detachment), resulting in <strong>massive maternal hemorrhage</strong>.&nbsp; Therefore, even in patients with minimal bleeding, stable vital signs, and reassuring fetal heart rate tracings, <strong>cesarean delivery is indicated</strong> after 36-37 weeks gestation <strong>(Choices D and E)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Anti-D immunoglobulin is administered in pregnancy to prevent Rh-isoimmunization in an Rh-negative mother.&nbsp; Prior to delivery, the fetal Rh status is typically unknown but presumed to be Rh positive.&nbsp; This patient requires urgent cesarean delivery to prevent hemorrhage.&nbsp; Because anti-D immunoglobulin is protective when given up to 72 hours after delivery, it can be administered postpartum if indicated (ie, Rh-negative mother and Rh-positive infant).&nbsp; If the patient is Rh-positive or the infant Rh-negative, anti-D immunoglobulin has no benefit.</p><p><strong>(Choice C)</strong>&nbsp; <a href=\"19154\">Digital cervical examination</a> is contraindicated in patients with placenta previa as digital examination enters the cervical canal, disrupting the previa and leading to severe hemorrhage.&nbsp; In contrast, speculum examination can be used in patients with known or suspected placenta previa to verify and quantify vaginal bleeding as it does not enter the cervical canal.</p><p><strong>Educational objective:</strong><br>Placenta previa occurs when the placenta covers the cervix, creating the potential for massive antepartum hemorrhage from cervical dilation.&nbsp; Labor and vaginal delivery are contraindicated in these patients; therefore, cesarean delivery is typically performed at 36-37 weeks gestation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14133,
            "topic": "Antepartum bleeding",
            "titleId": 14133,
            "title": "Antepartum bleeding",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administer anti-D immune globulin",
                    "choiceNumber": 1,
                    "correctTaken": 1678,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cesarean delivery",
                    "choiceNumber": 2,
                    "correctTaken": 11760,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Digital cervical examination",
                    "choiceNumber": 3,
                    "correctTaken": 1017,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Expectant management",
                    "choiceNumber": 4,
                    "correctTaken": 1784,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Labor augmentation",
                    "choiceNumber": 5,
                    "correctTaken": 463,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26244528",
                    "mediaDataId": 0,
                    "title": "Abnormal placentation: placenta previa, vasa previa, and placenta accreta.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26244528",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 79,
            "othersAvgTimeSpent": 60,
            "notes": null,
            "peopleTaken": 16702,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 70,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 35,
            "questionId": 3341,
            "questionIndex": 3341,
            "questionText": "<p>A 29-year-old woman, gravida 1 para 1, is evaluated due to recurrent fevers on day 5 after a cesarean delivery for arrest of descent after a prolonged induction of labor.&nbsp; Gentamicin and clindamycin were administered for fever on postoperative day 1.&nbsp; Ampicillin was added on postoperative day 3 as the patient continued to be intermittently febrile.&nbsp; She has had no nausea, vomiting, hemoptysis, dyspnea, hematuria, dysuria, or diarrhea.&nbsp; Temperature is 39 C (102.2 F), blood pressure is 120/80 mm Hg, and pulse is 108/min.&nbsp; Oxygen saturation is 98% on room air.&nbsp; The lungs are clear to auscultation bilaterally.&nbsp; Breast examination shows full, slightly tender breasts with no erythema.&nbsp; Abdominal examination shows mild bilateral lower quadrant tenderness to deep palpation and an incision with minimal serosanguineous drainage but no erythema or induration.&nbsp; Pelvic examination reveals a nontender uterine fundus that is below the umbilicus.&nbsp; Examination of the lower extremities shows no swelling, tenderness, or erythema.&nbsp; Hemoglobin is 10.8 g/dL.&nbsp; Urinalysis is normal.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T31571\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Septic pelvic thrombophlebitis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Cesarean delivery</li><li>Pelvic surgery</li><li>Endometritis</li><li>Pelvic inflammatory disease</li><li>Pregnancy</li><li>Malignancy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>Hypercoagulability</li><li>Pelvic venous dilation</li><li>Vascular trauma</li><li>Infection</li></ul></td></tr><tr><td><p align=\"center\"><strong>Presentation</strong></p></td><td><ul><li>Fever unresponsive to antibiotics</li><li>No localizing signs/symptoms</li><li>Negative infectious evaluation</li><li>Diagnosis of exclusion</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Anticoagulation</li><li>Broad-spectrum antibiotics</li></ul></td></tr></tbody></table></div><p>This patient&#39;s presentation is consistent with <strong>septic pelvic thrombophlebitis</strong> (SPT), a complication associated with either pelvic surgery or the postpartum period.&nbsp; SPT is a thrombosis of the deep pelvic or ovarian veins (as seen in this patient&#39;s bilateral lower quadrant tenderness) that becomes infected.&nbsp; Several factors predispose postpartum patients to thrombosis:</p><ul><li>Hypercoagulable state of pregnancy</li><li>Pelvic venous stasis and dilation</li><li>Endothelial damage from infection and/or trauma during delivery</li></ul><p>Because the most common etiology for postpartum fever is endometritis, patients are initially treated empirically with antibiotics.&nbsp; <strong>Persistent fever</strong> unresponsive to broad-spectrum antibiotic therapy and a negative infectious evaluation (eg, blood and urine cultures, urinalysis) suggest SPT, which is a <strong>diagnosis of exclusion</strong>.&nbsp; Risk factors include cesarean delivery and chorioamnionitis/endometritis.&nbsp; Treatment is with <strong>anticoagulation</strong> and <strong>broad-spectrum antibiotics</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Acute pyelonephritis presents with costovertebral angle pain and dysuria, neither of which is seen in this patient.&nbsp; In addition, this patient has a normal urinalysis.</p><p><strong>(Choice B)</strong>&nbsp; In addition to fever, aspiration pneumonia typically presents with dyspnea, low oxygen saturation, and crackles in the lower lobes on pulmonary examination.</p><p><strong>(Choice C)</strong>&nbsp; Incisional infections can cause puerperal fever but present with incisional pain, erythema, and induration.&nbsp; The serosanguineous discharge from this patient&#39;s incision is normal.</p><p><strong>(Choice D)</strong>&nbsp; Although pulmonary embolism can present with fever, patients typically also have dyspnea, hemoptysis, pleuritic chest pain, and low oxygen saturation, none of which are seen in this patient.</p><p><strong>Educational objective:</strong><br>Septic pelvic thrombophlebitis refers to a postoperative or postpartum infected thrombosis of the deep pelvic or ovarian veins.&nbsp; Patients have persistent fever unresponsive to antibiotics.&nbsp; Treatment includes anticoagulation and broad-spectrum antibiotics.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4330,
            "topic": "Thrombophlebitis",
            "titleId": 4330,
            "title": "Thrombophlebitis",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute pyelonephritis",
                    "choiceNumber": 1,
                    "correctTaken": 816,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Aspiration pneumonia",
                    "choiceNumber": 2,
                    "correctTaken": 145,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Incisional infection",
                    "choiceNumber": 3,
                    "correctTaken": 1946,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pulmonary embolism",
                    "choiceNumber": 4,
                    "correctTaken": 351,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Septic pelvic thrombophlebitis",
                    "choiceNumber": 5,
                    "correctTaken": 13393,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "152",
                    "mediaDataId": 0,
                    "title": "Postpartum endometritis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19809519",
                    "mediaDataId": 0,
                    "title": "Postpartum ovarian vein thrombosis: two cases and review of literature.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19809519",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 127,
            "othersAvgTimeSpent": 80,
            "notes": null,
            "peopleTaken": 16652,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 80,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 36,
            "questionId": 17841,
            "questionIndex": 19301,
            "questionText": "<p>A 26-year-old woman, gravida 2 para 2, comes to the emergency department due to increased vaginal bleeding and abdominal cramping.&nbsp; A week ago, the patient underwent a prolonged induction of labor for gestational diabetes mellitus that was complicated by an intraamniotic infection treated with intravenous antibiotics.&nbsp; She had a vaginal delivery of a 4.7-kg (10.4-lb) male infant and was discharged from the hospital on postpartum day 3.&nbsp; The patient was doing well until this morning, when she started to bleed through a sanitary pad every hour and began to have increasing abdominal cramping.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 110/80 mm Hg, and pulse is 98/min.&nbsp; The uterus is firm, palpable at 6 cm above the pubic symphysis, and nontender to palpation.&nbsp; On speculum examination, there is active bleeding from the cervical os with passage of large clots.&nbsp; Which of the following is the most likely diagnosis for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t60035\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Secondary (late) postpartum hemorrhage</strong></p></td></tr><tr><td><p align=\"center\"><strong>Cause</strong></p></td><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><p align=\"center\"><strong>Management</strong></p></td></tr><tr><td><p align=\"center\"><strong>Retained POC</strong></p></td><td><ul><li>Heavy bleeding</li><li>&plusmn; Uterine atony</li></ul></td><td><ul><li>Dilation &amp; curettage</li></ul></td></tr><tr><td><p align=\"center\"><strong>Placental site subinvolution</strong></p></td><td><ul><li>Heavy bleeding</li><li>Uterine atony</li></ul></td><td><ul><li>Uterotonics (eg, oxytocin, methylergonovine, carboprost)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Postpartum endometritis</strong></p></td><td><ul><li>Fever</li><li>Uterine tenderness</li><li>Purulent lochia</li></ul></td><td><ul><li>Broad-spectrum IV antibiotics (eg, clindamycin &amp; gentamicin)</li></ul></td></tr><tr><td colspan=\"3\"><p><strong>IV</strong> = intravenous; <strong>POC</strong> = products of conception.</p></td></tr></tbody></table></div><p>This patient with <strong>heavy vaginal bleeding</strong> (eg, saturating &#8805;1 pad/hr, passage of large clots) &gt;24 hours after delivery has a <strong>secondary (late) postpartum hemorrhage</strong> (PPH).&nbsp; Risk factors for secondary PPH are similar to immediate-onset PPH and include prolonged labor, fetal macrosomia, and intraamniotic infection (all of which are seen in this patient).&nbsp; Common causes are retained products of conception, postpartum endometritis, and inadequate placental site involution (ie, subinvolution).</p><p>In this patient, the most likely cause of secondary PPH is <strong>retained products of conception</strong> from her prior intraamniotic infection and prolonged induction of labor.&nbsp; Patients with an intraamniotic infection are at risk for retained products of conception, even if the infection is adequately treated, because the intrauterine inflammation allows for adherence of the placental membranes to the uterine wall.&nbsp; In contrast to a retained placenta, which causes immediate PPH with uterine atony (eg, boggy, enlarged uterus), retained products of conception typically cause late PPH with either a boggy or <strong>firm uterus</strong> (as in this patient).</p><p>Evaluation is with <strong>pelvic ultrasound</strong> (which can identify the location of the retained products), and treatment is typically <strong>dilation and curettage</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Cervical laceration, often caused by trauma associated with operative vaginal delivery or fetal macrosomia (ie, &gt;4 kg), typically causes an immediate, not late, PPH.&nbsp; In addition, this patient&#39;s bleeding is from the cervical os rather than the cervix itself.</p><p><strong>(Choice B)</strong>&nbsp; After delivery, lochia can continue up to 6 weeks postpartum.&nbsp; Patients 1 week postpartum typically have lochia rubra (bright red blood, small clots) or lochia serosa (serosanguineous discharge) that soaks &lt;1 pad/hour.&nbsp; This patient&#39;s sudden onset of heavy bleeding makes a secondary PPH more likely.</p><p><strong>(Choice C)</strong>&nbsp; Postpartum endometritis is a common cause of secondary PPH and is more likely to develop in patients who had an intraamniotic infection (such as this patient).&nbsp; However, this patient has no fever or uterine tenderness, making this diagnosis unlikely.</p><p><strong>(Choice E)</strong>&nbsp; Uterine rupture can cause late PPH in patients with prior cesarean delivery and typically presents with severe uterine tenderness and abdominal pain (due to hemoperitoneum).</p><p><strong>Educational objective:</strong><br>Secondary (late) postpartum hemorrhage is heavy vaginal bleeding occurring &gt;24 hours after delivery.&nbsp; Common causes include retained products of conception, postpartum endometritis, and placental site subinvolution.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4183,
            "topic": "Postpartum hemorrhage",
            "titleId": 4183,
            "title": "Postpartum hemorrhage",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cervical laceration",
                    "choiceNumber": 1,
                    "correctTaken": 2795,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal lochia",
                    "choiceNumber": 2,
                    "correctTaken": 3154,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Postpartum endometritis",
                    "choiceNumber": 3,
                    "correctTaken": 1457,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Retained products of conception",
                    "choiceNumber": 4,
                    "correctTaken": 8859,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine rupture",
                    "choiceNumber": 5,
                    "correctTaken": 554,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29052024",
                    "mediaDataId": 0,
                    "title": "Multimodality imaging in secondary postpartum or postabortion hemorrhage: retained products of conception and related conditions.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29052024",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24558972",
                    "mediaDataId": 0,
                    "title": "Recurrent secondary postpartum hemorrhages due to placental site vessel subinvolution and local uterine tissue coagulopathy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24558972",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 104,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 16819,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 53,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 26,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 37,
            "questionId": 13396,
            "questionIndex": 14775,
            "questionText": "<p>A 28-year-old woman comes to the emergency department due to nausea, vomiting, and abdominal pain.&nbsp; For the past 2 days, the patient has had increasing abdominal pain and distension, which are now severe and causing persistent vomiting.&nbsp; She had an episode of watery diarrhea but has had no fevers, chills, or sick contacts.&nbsp; The patient has no chronic medical conditions.&nbsp; She has been undergoing ovulation induction for infertility treatment.&nbsp; Her last hCG injection was 7 days ago, and her last menstrual period was 3 weeks ago.&nbsp; Blood pressure is 100/60 mm Hg, pulse is 104/min, and respirations are 24/min.&nbsp; BMI is 21 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Cardiac examination reveals sinus tachycardia.&nbsp; The lungs have decreased breath sounds in bilateral bases.&nbsp; The abdomen is distended and has tympany but no rebound or guarding.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hematocrit</td><td style=\"vertical-align:middle;\">56%</td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">160,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">26,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&#946;-hCG</td><td style=\"vertical-align:middle;\">1102 IU/L</td></tr></tbody></table><p>Pelvic ultrasound reveals a small uterus with a thin endometrium, bilateral enlarged ovaries with multiple cysts, and a large amount of free fluid within the abdomen.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T35139\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Ovarian hyperstimulation syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>&#8593; hCG enhances ovarian vascular permeability</li><li>Acute fluid shift to extravascular space</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Ascites</li><li>Respiratory distress</li><li>Hemoconcentration</li><li>Hypercoagulability</li><li>Electrolyte imbalances</li><li>Multiorgan failure (eg, renal failure)</li><li>Disseminated intravascular coagulation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Evaluation</strong></p></td><td><ul><li>Fluid balance monitoring</li><li>Serial CBC, electrolytes</li><li>Serum hCG</li><li>Pelvic ultrasound</li><li>Chest x-ray</li><li>Echocardiography</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Correct electrolyte imbalances</li><li>Paracentesis &amp;/or thoracentesis</li><li>Thromboembolism prophylaxis</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CBC</strong> = complete blood count.</p></td></tr></tbody></table></div><p>This patient has <strong>ovarian hyperstimulation syndrome (OHSS)</strong>, a rare but life-threatening complication of <strong>ovulation induction</strong>.&nbsp; Ovulation trigger agents (eg, hCG injection) stimulate artificial maturation of multiple ovarian follicles in patients undergoing infertility treatment and can cause an exaggerated ovarian response (eg, <strong>bilateral enlarged, cystic ovaries</strong> with multiple follicles) as well as overexpression of vascular endothelial growth factor (VEGF), causing increased vascular permeability and capillary leakage.&nbsp; This causes massive extravascular fluid shifts (eg, <strong>third spacing</strong>) and VEGF leakage into the intraperitoneal cavity, leading to <strong>ascites</strong> and <strong>abdominal distension</strong>.</p><p>Affected patients typically develop OHSS 1-2 weeks after ovulation induction.&nbsp; Symptoms include nausea, vomiting, and abdominal pain.&nbsp; Other features include <strong>pleural effusions</strong> (eg, tachypnea, decreased breath sounds) and <strong>intravascular volume depletion</strong> (eg, tachycardia, <strong>hemoconcentration</strong>, leukocytosis) due to third spacing, which in severe cases can result in thromboembolism, renal failure, and death.</p><p><strong>(Choice A)</strong>&nbsp; An ectopic pregnancy can present with pain, abdominal free fluid, and a positive &#946;-hCG test; however, patients have unilateral adnexal findings (eg, hypervascular mass) and anemia rather than bilateral adnexal cysts and hemoconcentration.&nbsp; This patient&#39;s &#946;-hCG level is due to recent hCG injection, not pregnancy.</p><p><strong>(Choice B)</strong>&nbsp; Epithelial ovarian cancer can cause abdominal pain, ascites, and distension.&nbsp; However, patients typically have gradual onset of symptoms and a unilateral adnexal mass, not bilateral enlarged, cystic ovaries.</p><p><strong>(Choice C)</strong>&nbsp; A hydatidiform mole can cause bilateral ovarian cysts (ie, theca lutein cysts) and a positive &#946;-hCG test; however, patients typically have a markedly enlarged uterus (size &gt; gestational age).&nbsp; This patient has a small uterus with a thin endometrial lining.</p><p><strong>(Choice E)</strong>&nbsp; <a href=\"15237\">Polycystic ovary syndrome</a> can cause infertility and bilateral ovarian cysts.&nbsp; However, it does not cause acute third spacing (eg, ascites) or intravascular volume depletion (eg, hemoconcentration).</p><p><strong>Educational objective:</strong><br>Ovarian hyperstimulation syndrome is a complication of ovulation induction for infertility treatment.&nbsp; Patients develop symptoms within 1-2 weeks that include abdominal pain; ascites; bilateral enlarged, cystic ovaries; and third spacing leading to intravascular volume depletion (eg, hemoconcentration).&nbsp; Severe complications include thromboembolism, multiorgan failure, and death.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 7389,
            "topic": "Infertility",
            "titleId": 7389,
            "title": "Infertility",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Ectopic pregnancy",
                    "choiceNumber": 1,
                    "correctTaken": 2813,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Epithelial ovarian cancer",
                    "choiceNumber": 2,
                    "correctTaken": 559,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hydatidiform mole",
                    "choiceNumber": 3,
                    "correctTaken": 1279,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ovarian hyperstimulation syndrome",
                    "choiceNumber": 4,
                    "correctTaken": 11286,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Polycystic ovary syndrome",
                    "choiceNumber": 5,
                    "correctTaken": 777,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28322539",
                    "mediaDataId": 0,
                    "title": "Ovarian hyperstimulation syndrome management strategies: where are we going?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28322539",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27273307",
                    "mediaDataId": 0,
                    "title": "Pathophysiology, treatment and prevention of ovarian hyperstimulation syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27273307",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 201,
            "othersAvgTimeSpent": 80,
            "notes": null,
            "peopleTaken": 16716,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 38,
            "questionId": 13395,
            "questionIndex": 14774,
            "questionText": "<p>A 24-year-old woman, gravida 1 para 1, is evaluated on labor and delivery for heavy vaginal bleeding.&nbsp; Thirty minutes earlier, the patient underwent a forceps-assisted vaginal delivery of a 4.4 kg (9 lb 11 oz) male infant at 41 weeks gestation.&nbsp; She feels dizzy and nauseated.&nbsp; The patient has asthma and has had to use her albuterol inhaler with increasing frequency throughout her pregnancy.&nbsp; Temperature is 36.1 C (97 F), blood pressure is 104/78 mm Hg, and pulse is 102/min.&nbsp; Oxygen saturation is 98%.&nbsp; The patient appears pale.&nbsp; The abdomen is soft and nontender, and the fundus is boggy and palpable above the umbilicus.&nbsp; Pelvic examination shows an intact perineal repair, no vaginal or cervical lacerations, and profuse vaginal bleeding with passage of large clots.&nbsp; Uterine massage and high-dose oxytocin do not resolve the bleeding.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t35375\"><table class=\"table-default-style\" style=\"width:537px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Postpartum uterine atony</strong></p></td></tr><tr><td style=\"width: 25%;\"><p align=\"center\"><strong>Risk factors</strong></p></td><td style=\"width: 75%;\"><ul><li>Uterine fatigue from prolonged, induced, or precipitous labor</li><li>Intraamniotic infection</li><li>Uterine overdistension (multiple gestation, macrosomia, polyhydramnios)</li><li>Retained placenta</li><li>Grand multiparity (&ge;5 prior deliveries)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Most common cause of postpartum hemorrhage</li><li>Enlarged, soft, boggy, poorly contracted uterus</li></ul></td></tr><tr><td><p align=\"center\"><strong>Interventions</strong></p></td><td><ul><li>Bimanual uterine massage</li><li>Correction of bladder distension</li><li>High-dose oxytocin, misoprostol</li><li>Tranexamic acid</li><li>Carboprost, methylergonovine</li><li>Intrauterine balloon tamponade</li><li>Possible surgical intervention (if atony unresolved)</li></ul></td></tr></tbody></table></div><p>This patient with heavy vaginal bleeding and an enlarged, boggy uterus has <strong>uterine atony</strong>, the most common cause of <strong>postpartum hemorrhage</strong>.&nbsp; Uterine atony occurs due to insufficient uterine contractility after delivery, resulting in continued bleeding from open placental bed vessels.&nbsp; Risk factors include uterine overdistension (eg, macrosomia) and operative vaginal delivery, as in this patient.</p><p>First-line treatment for uterine atony includes <a href=\"26479\">bimanual uterine massage</a> and high-dose oxytocin.&nbsp; If atony persists, additional medications are indicated, and the <strong>best next step</strong> in management is the administration of <strong>tranexamic acid</strong>.&nbsp; Tranexamic acid is an antifibrinolytic agent that prevents the breakdown of blood clots to achieve hemostasis, and its use reduces maternal mortality rates from hemorrhage.</p><p><strong>(Choice A)</strong>&nbsp; Broad-spectrum antibiotics are not routinely administered after an operative vaginal delivery.&nbsp; They are indicated in patients with postpartum endometritis, which can present with heavy vaginal bleeding.&nbsp; However, endometritis also causes fever and uterine tenderness, which are not seen in this patient.</p><p><strong>(Choice B)</strong>&nbsp; In patients whose uterine atony does not respond to bimanual uterine massage, high-dose oxytocin, and tranexamic acid, the next step is to administer second-line uterotonics such as carboprost tromethamine, a prostaglandin that increases uterine contractility.&nbsp; However, carboprost tromethamine can cause bronchospasm and, therefore, is contraindicated in patients with asthma.</p><p><strong>(Choice C)</strong>&nbsp; If this patient&#39;s vaginal bleeding does not resolve with medical therapy and she continues to have massive hemorrhage, blood products (eg, fresh frozen plasma) may be required for patient stabilization.</p><p><strong>(Choice E)</strong>&nbsp; Vaginal packing with sterile gauze can be used to apply pressure to bleeding vaginal mucosa temporarily (eg, after vaginal sulcal laceration repair) to allow for clot formation.&nbsp; However, it does not treat postpartum hemorrhage caused by uterine atony and may delay diagnosis in these patients.</p><p><strong>Educational objective:</strong><br>Uterine atony is the most common cause of postpartum hemorrhage, and first-line treatment includes bimanual uterine massage and high-dose oxytocin.&nbsp; In patients with persistent bleeding, the best next step in management is administration of tranexamic acid, an antifibrinolytic agent that prevents the breakdown of blood clots to achieve hemostasis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4183,
            "topic": "Postpartum hemorrhage",
            "titleId": 4183,
            "title": "Postpartum hemorrhage",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Broad-spectrum antibiotics",
                    "choiceNumber": 1,
                    "correctTaken": 100,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Carboprost tromethamine",
                    "choiceNumber": 2,
                    "correctTaken": 3079,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fresh frozen plasma",
                    "choiceNumber": 3,
                    "correctTaken": 1533,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tranexamic acid",
                    "choiceNumber": 4,
                    "correctTaken": 10422,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vaginal packing with sterile gauze",
                    "choiceNumber": 5,
                    "correctTaken": 1599,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30379320",
                    "mediaDataId": 0,
                    "title": "Tranexamic acid for prevention and treatment of postpartum hemorrhage: an update on management and clinical outcomes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30379320",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31128974",
                    "mediaDataId": 0,
                    "title": "Tranexamic acid for post-partum hemorrhage: what, who and when.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31128974",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 54,
            "othersAvgTimeSpent": 56,
            "notes": null,
            "peopleTaken": 16733,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 12,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 39,
            "questionId": 2572,
            "questionIndex": 2572,
            "questionText": "<p>A newborn male infant is evaluated in the neonatal intensive care unit for growth restriction.&nbsp; The infant was born to a 29-year-old woman who did not receive prenatal care.&nbsp; The mother presented in active labor at approximately 38 weeks gestation and had a forceps-assisted vaginal delivery due to fetal heart rate abnormalities.&nbsp; Apgars were 6 and 8 at 1 and 5 minutes, respectively.&nbsp; Weight is 2.5 kg (5.5 lb).&nbsp; Physical examination shows microcephaly, a wide anterior fontanelle, cleft palate, and hypoplasia of the distal phalanges.&nbsp; Further evaluation of the mother would most likely reveal a history of which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"21327\" src=\"https://www.uworld.com/media/highresdefault/L46798.jpg\"  ></p><p>This infant mostly likely has <strong>fetal hydantoin syndrome</strong>, which occurs due to <strong>in utero exposure to an antiepileptic</strong> (eg, <strong>phenytoin</strong>, carbamazepine, valproate).&nbsp; Multiple antiepileptics have teratogenic effects due to their ability to cross the placenta, resulting in low folate levels and high oxidative metabolites levels in the fetus.&nbsp; The likely combined effects result in the associated <strong>cleft lip and palate</strong>, wide anterior fontanelle, <strong>distal phalange hypoplasia</strong>, and cardiac anomalies (eg, pulmonary stenosis, aortic stenosis).&nbsp; The associated neural tube defects and <strong>microcephaly</strong> can also result in developmental delay and poor cognitive outcomes.</p><p>Therefore, to minimize the risk of congenital malformation, patients who require antiepileptics during pregnancy should be titrated to the lowest dose for seizure control prior to conception and started on high-dose (4 mg) folic acid supplementation.</p><p><strong>(Choice A)</strong>&nbsp; <a href=\"757\">Fetal alcohol syndrome</a> can present with microcephaly and midfacial hypoplasia; however, there is no association with cleft lip or palate.</p><p><strong>(Choice B)</strong>&nbsp; Cocaine use during pregnancy is associated with preterm delivery, abruptio placentae, and fetal growth restriction.&nbsp; There is no association with congenital defects.</p><p><strong>(Choice C)</strong>&nbsp; Use of lisinopril (and other <a href=\"44458\">angiotensin-converting enzyme inhibitors</a>) during pregnancy can cause fetal renal failure and associated oligohydramnios that results in pulmonary hypoplasia, growth restriction, and limb defects (ie, Potter sequence).&nbsp; It does not cause cleft lip or palate.</p><p><strong>(Choice E)</strong>&nbsp; Most infants with congenital syphilis are asymptomatic at birth; those with symptoms typically have rhinitis (&#x22;snuffles&#x22;), hepatomegaly, and a maculopapular rash (none of which are seen in this patient).</p><p><strong>Educational objective:</strong><br>Fetal hydantoin syndrome results from in utero exposure to an antiepileptic (eg, phenytoin, carbamazepine) and presents with microcephaly, a wide anterior fontanelle, cleft lip and palate, and distal phalange hypoplasia.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 9582,
            "topic": "Teratogens",
            "titleId": 9582,
            "title": "Teratogens",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alcohol use",
                    "choiceNumber": 1,
                    "correctTaken": 3715,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cocaine use",
                    "choiceNumber": 2,
                    "correctTaken": 2040,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lisinopril use",
                    "choiceNumber": 3,
                    "correctTaken": 1123,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Phenytoin use",
                    "choiceNumber": 4,
                    "correctTaken": 12235,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Untreated syphilis",
                    "choiceNumber": 5,
                    "correctTaken": 1129,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28578158",
                    "mediaDataId": 0,
                    "title": "Fetal hydantoin syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28578158",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28472982",
                    "mediaDataId": 0,
                    "title": "Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28472982",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26838156",
                    "mediaDataId": 0,
                    "title": "Fetal hydantoin syndrome: a case report.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26838156",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 67,
            "othersAvgTimeSpent": 43,
            "notes": null,
            "peopleTaken": 20242,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 6,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 40,
            "questionId": 15533,
            "questionIndex": 16965,
            "questionText": "<p>A 37-year-old woman, gravida 2 para 1, at 22 weeks gestation comes to the office for a fetal anatomy ultrasound.&nbsp; The patient has had limited prenatal care this pregnancy but had a normal dating ultrasound in the first trimester.&nbsp; Her first pregnancy resulted in a term vaginal delivery.&nbsp; The patient has had no vaginal bleeding, contractions, or leakage of fluid, and she has been taking a daily prenatal vitamin.&nbsp; Vital signs are normal.&nbsp; Prepregnancy BMI was 22 kg/m<font size=\"2\"><sup>2</sup></font>, and she has had appropriate weight gain.&nbsp; Fundal height is 27 cm.&nbsp; The fetal ultrasound reveals a dilated fluid-filled stomach and dilated proximal intestinal segment, as seen below.&nbsp; The remainder of the bowel has no intraluminal air or fluid.&nbsp; Amniotic fluid measurement shows:</p><p><img draggable=\"false\" id=\"26693\" src=\"https://www.uworld.com/media/L52404.jpg\" ></p><p>Which of the following additional findings is most likely to be found on this fetal ultrasound?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"26694\" src=\"https://www.uworld.com/media/L52960.jpg\" ></p><p>This fetus has a fluid-filled stomach and proximal duodenum with no distal intestinal air or fluid, consistent with complete bowel obstruction caused by <strong>duodenal atresia</strong>.&nbsp; Due to the obstruction, duodenal atresia appears on ultrasound as a <strong>double bubble sign</strong> (ie, a fluid-filled stomach and duodenum).&nbsp; Duodenal atresia impairs fetal swallowing of amniotic fluid and, therefore, may cause <strong>polyhydramnios</strong> (single deepest pocket of amniotic fluid &#8805;8 cm), as in this patient.</p><p>Duodenal atresia is commonly associated with trisomy 21 (Down syndrome) and VACTERL (<strong>V</strong>ertebral, <strong>A</strong>nal atresia, <strong>C</strong>ardiac, <strong>T</strong>racheoesophageal fistula, <strong>E</strong>sophageal atresia, <strong>R</strong>enal, <strong>L</strong>imb) association.&nbsp; Because these syndromes involve multiple congenital anomalies, the presence of duodenal atresia requires <strong>evaluation for other malformations</strong>.&nbsp; This patient at advanced maternal age (age &gt;35) likely has a fetus with <strong>Down syndrome</strong>, which has a high rate (up to 50%) of associated endocardial cushion defects.&nbsp; Therefore, the most likely additional ultrasound finding in this fetus is a <strong>ventricular septal defect</strong>.&nbsp; Other fetal ultrasound findings associated with Down syndrome include a thickened nuchal fold, esophageal atresia, and a complete atrioventricular septal defect.</p><p><strong>(Choice A)</strong>&nbsp; A diaphragmatic hernia may be an isolated anomaly or associated with trisomy 18 (Edward syndrome), which can present on fetal ultrasound as <a href=\"26695\">rocker-bottom feet</a> or <a href=\"26696\">clenched hands</a> with overlapping fingers.</p><p><strong>(Choice B)</strong>&nbsp; <a href=\"3787\">Holoprosencephaly</a> is associated with trisomy 13 (Patau syndrome), which can cause multiple coexisting midline defects (eg, microcephaly, cleft lip/palate, omphalocele).</p><p><strong>(Choice C)</strong>&nbsp; 45,X (Turner syndrome) is associated with horseshoe kidneys that may become obstructed, causing oligohydramnios (not polyhydramnios).&nbsp; Turner syndrome is associated with cardiac defects (eg, coarctation of the aorta), <a href=\"26697\">cystic hygromas</a>, and hydrops fetalis.</p><p><strong>(Choice D)</strong>&nbsp; <a href=\"2542\">Myelomeningocele</a> (ie, spina bifida) is a neural tube defect (NTD) due to folate deficiency, which is unlikely in patients taking a daily prenatal vitamin.&nbsp; NTDs are typically an isolated finding.</p><p><strong>(Choice E)</strong>&nbsp; Congenital cytomegalovirus infection can cause periventricular calcifications, hydrops fetalis, and abnormal amniotic fluid volumes on ultrasound; however, it is not associated with duodenal atresia.</p><p><strong>Educational objective:</strong><br>Duodenal atresia, a congenital anomaly causing complete bowel obstruction, presents on fetal ultrasound as a fluid-filled stomach and duodenum (ie, double bubble sign) with associated polyhydramnios.&nbsp; Because it is commonly seen in Down syndrome and VACTERL (<strong>V</strong>ertebral, <strong>A</strong>nal atresia, <strong>C</strong>ardiac, <strong>T</strong>racheoesophageal fistula, <strong>E</strong>sophageal atresia, <strong>R</strong>enal, <strong>L</strong>imb) association, the presence of duodenal atresia requires evaluation for other fetal malformations (eg, ventricular septal defects).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 12637,
            "topic": "Down syndrome",
            "titleId": 12637,
            "title": "Down syndrome",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "6",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Diaphragmatic hernia",
                    "choiceNumber": 1,
                    "correctTaken": 3166,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Holoprosencephaly",
                    "choiceNumber": 2,
                    "correctTaken": 2341,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Horseshoe kidney",
                    "choiceNumber": 3,
                    "correctTaken": 2450,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Myelomeningocele",
                    "choiceNumber": 4,
                    "correctTaken": 916,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Periventricular calcifications",
                    "choiceNumber": 5,
                    "correctTaken": 564,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ventricular septal defect",
                    "choiceNumber": 6,
                    "correctTaken": 7214,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26578241",
                    "mediaDataId": 0,
                    "title": "Associated congenital anomalies among cases with Down syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26578241",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19798044",
                    "mediaDataId": 0,
                    "title": "Congenital duodenal obstruction: timing of diagnosis during the newborn period.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19798044",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 143,
            "othersAvgTimeSpent": 73,
            "notes": null,
            "peopleTaken": 16651,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 43,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 4,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 4,
            "name": "CUSTOM"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}